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Abstract 
β-catenin is a multifunctional protein, key component of adherent junctions and effector of 
the Wnt canonical pathway, was recently implicated in centrosomal functions. In the 
canonical Wnt pathway, when Wnt is present in the system, β-catenin escapes 
degradation, accumulates in the cytosol and translocates to the nucleus where, together 
with T-cell Factor (TCF) transcription factors, it regulates transcription of Wnt targets. 
Switching from adhesive to signaling functions (independent of Wnt) is achieved in part 
through phosphorylation of β-catenin at Tyr142 that promotes detachment of β-catenin 
from the adhesion complex and promotes migration by transcriptional regulation of target 
genes. Met receptor tyrosine kinase (the receptor for Hepatocyte Growth Factor (HGF)), is 
one of the kinases regulating β-catenin phosphoryation at Tyr142 during cell migration 
and axon outgrowth stimulated by HGF. On the other hand, β-catenin phosphorylation at 
Ser/Thr regulates β-catenin degradation and has been demonstrated to affect centrosomal 
cohesion/separation and spindle formation.  
Here we focus on PhosphoTyrosine142 β-catenin (PTyr142 β-cat) signaling. First, we 
demonstrate that chemokines of CC and CXC families promote axon outgrowth. 
Furthermore, chemokine signaling acts downstream to HGF/Met/β-catenin/TCF signaling 
to regulate axon morphogenesis in developing hippocampal neurons. We also show that 
CXCL2 promotes axon branching and is involved in sensory axon outgrowth from dorsal 
root ganglia. In the second part of the work, we find for the first time that phosphorylated 
Tyr142 β-catenin localizes to centrosomes in primary astrocytes and glioma cells, and that 
centrosomal levels drop in mitosis. We also demonstrate the novel centrosomal 
localization of Met phosphorylated at Tyr1234/35. Aiming at identifying which is the 
kinase(s) regulating centrosomal PTyr142 β-cat, we show that a Met inhibitor does not 
affect it. However, an inhibitor of Spleen Tyrosine Kinase (Syk) decreases centrosomal 
PTyr142 β-cat, suggesting that Syk regulates the phosphorylation of Tyr142 β-catenin at 
centrosome. In addition, β-catenin is involved in the correct positioning of centrosomes 
during astrocyte migration and phosphorylation of β-catenin at Tyr142 is needed for HGF-
stimulated cell migration. 
Collectively, this work demonstrates the multiple roles of PTyr142 β-cat signaling, 
influencing axon morphogenesis (via regulation of chemokines expression) as well as 
centrosomal functions, cell polarity and migration. 
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Resumen 
β-catenina es una proteína multifuncional, componente clave de las uniones adherentes y 
efector de la vía canónica Wnt, recientemente implicada en funciones centrosomales. En la 
señalización por Wnt, cuando Wnt está presente, β-catenina se acumula en el citosol y 
transloca al núcleo donde, junto con factores TCF, regula la transcripción de genes diana. 
La interelación entre funciones adhesivas y señalizadoras (independientes de Wnt) de β-
catenina se logra, en parte, a través de la fosforilación de β-catenina en Tyr142, que 
promueve la desunión de β-catenina del complejo de adhesión y la migración a través de la 
regulación transcripcional. El receptor tirosina quinasa Met (receptor del Factor de 
Crecimiento Hepático (HGF)) induce la fosforilación de β-catenina en Tyr142 durante la 
migración y el crecimiento axonal estimulados por HGF. Por otra parte, la fosforilación de 
β-catenina en Ser/Thr regula la degradación de β-catenina y afecta a la 
cohesión/separación de los centrosomas y la formación del huso mitótico.  
Aquí nos centramos en la señalización por β-catenina fosforilada en Tyr142. En primer 
lugar, demostramos que quimiocinas de las familias CC y CXC promueven el crecimiento 
axonal y que las quimiocinas actúan en la señalización inducida por HGF/Met/β-
catenina/TCF durante la morfogénesis del axón. También mostramos que CXCL2 
promueve la ramificación del axón en neuronas hipocampales y el crecimiento de axones 
sensoriales de los ganglios de la raíz dorsal. En segundo lugar, demostramos que β-
catenina fosforilada en Tyr142 localiza en centrosomas en astrocitos primarios y células 
de glioma, y que estos niveles centrosomales disminuyen durante la mitosis. También 
mostramos la localización centrosomal de Met activo. Con objeto de identificar cual es la 
quinasa que regula la fosforilación de Tyr142 β-catenina en el centrosoma, mostramos que 
un inhibidor de Syk disminuye los niveles centrosomales de esta forma de β-catenina, lo 
que sugiere que Syk fosforila β-catenina en Tyr142 en el centrosoma. Además, β-catenina 
está implicada en el posicionamiento del centrosoma durante la migración de astrocitos y 
la fosforilación de β-catenina en Tyr142 es necesaria en la migración celular estimulada 
por HGF.  
En conjunto, este trabajo ilustra las múltiples funciones señalizadoras de β-catenina 
fosforilada en Tyr142 en la morfogénesis del axón (a través de la expresión de 
quimiocinas), así como en funciones centrosomales y en polaridad celular y migración.
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Resum 
β-catenina és una proteïna multifuncional, component clau de les unions adherents i 
efector de la via canònica Wnt, recentment implicada en funcions centrosomals. En la  
senyalització per Wnt, quan Wnt està present β-catenina s'acumula en el citosol i transloca 
al nucli on, juntament amb factors TCF, regula la transcripció de gens diana. La 
interrelació entre funcions adhesives i funcions senyalitzadores (independents de Wnt) de 
β-catenina s'aconsegueix en part a través de la fosforilació de β-catenina en Tyr142, que 
promou la desunió de β-catenina del complex d'adhesió i la migració mitjançant la 
regulació transcripcional. El receptor tirosina quinasa Met (receptor del Factor de 
Creixement Hepàtic (HGF)) regula la fosforilació de β-catenina en Tyr142 durant la 
migració cel · lular i el creixement axonal estimulat per HGF. D'altra banda, la fosforilació 
de β-catenina en Ser/Thr regula la degradació de β-catenina i afecta la cohesió/separació 
centrosomal i la formació del fus mitòtic.  
Aquí ens centrem en la senyalització per β-catenina fosforilada en Tyr142. En primer lloc, 
demostrem que quimiocines de les famílies CC i CXC promouen el creixement axonal i 
que la senyalització per quimiocines és necessària en la senyalització induïda per 
HGF/Met/β-catenina/TCF durant la morfogènesi axonal en neurones de l'hipocamp. 
També mostrem que CXCL2 promou la ramificació de l'axó i que aquesta quimiocina està 
involucrada en el creixement d'axons sensorials dels ganglis de l'arrel dorsal. A la segona 
part, demostrem que β-catenina fosforilada en Tyr142 es localitza en els centrosomes en 
astròcits primaris i cèl · lules de glioma, i que els seus nivells centrosomals disminueixen 
durant la mitosi. A més, demostrem la localització centrosomal de Met actiu. Amb 
l'objectiu d'identificar quina és la quinasa que regula els nivells centrosomals de fosfo-
Tyr142 β-catenina, mostrem que un inhibidor de Syk disminueix els nivells centrosomals 
de fosfo-Tyr142 β-catenina, el que suggereix que Syk fosforila β-catenina en Tyr142 al 
centrosoma. A més, β-catenina està implicada en el posicionament del centrosoma durant 
la migració d'astròcits i la fosforilació de β-catenina en Tyr142 és necessària en la 
migració cel.lular estimulada per HGF.  
En conjunt, aquest treball demostra les múltiples funcions senyalitzadores de β-catenina 
fosforilada en Tyr142, en la morfogènesi de l'axó (a través de la regulació de l'expressió de 
quimiocines), així com en funcions centrosomals i en polaritat cellular i migració.
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A. Neuronal development and axon outgrowth 
1. Neurons and Glia 
The adult vertebrate central nervous system (CNS) comprises of four major cell types: 
neurons, oligodendrocytes, astrocytes and ependymal lining of the ventricle. These cells 
are derived originally from the early neuroepithelium that forms the neural plate along the 
midline of developing embryo. As the development advances, single layer of 
pseudostratified epithelium folds to form the neural tube, where differentiation of 
neuroepithelial stem cells (NSCs) into neurons and glia occurs in a temporal specific 
manner (Rao, 1999), which happens in three phases (Figure 1). 
 
Figure1. Illustration showing neural stem cells (NSCs) lineage (Shimojo, Ohtsuka, & 
Kageyama, 2011). NSCs divides symmetrically and expand their population in progenitor 
expansion phase, followed by the elongation of the cells to form radial glial cells (RGCs). 
RGCs later gives rise to immature neurons in neurogenic phase and glial cells 
(oligodendrocytes, astrocytes and ependymal cells) in gliogenic phase. 
The first phase starts with progenitor expansion, where each NSC of neural tube divides 
symmetrically into two NSCs (Miller, & Gauthier, 2007) followed by the elongation of 
NSCs and formation of RGCs, which have cell bodies in the ventricular zone and radial 
fibres in the pial surface. The RGCs further undergo asymmetric division, giving rise to 
RGC and immature neuron or basal progenitor (neurogenic phase or neurogenesis) 
(Miyata et al., 2001; Noctor et al., 2001). The immature neurons later migrate outside of 
the ventricular zone alongside the radial fibres into the cortical plate and attain maturity, 
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whereas basal progenitors migrate into subventricular zone (SVZ) proceeded by 
proliferation and formation of more neurons. Later RGCs add different types of neurons to 
the deep as well as superficial layers. Following the production of neurons, gliogenic 
phase takes place where RGCs give rise to oligodendrocytes, ependymal cells and 
astrocytes. 
Until 1990´s, neurogenesis was believed to occur only during embryonic and prenatal 
stages in an adult mammalian brain (Ming, & Song, 2005) with a widely accepted 
explanation that brain is too complex to allow generation and incorporation of newly born 
neurons. Many striking studies then demolished the prevailing hypothesis and brought into 
light the existence of “adult neurogenesis” in human brain throughout life, but only in 
selected regions (Neurogenic regions) (Altman, & Das, 1965; Eriksson et al., 1998; Curtis 
et al., 2003, 2007). New neurons are continuously being generated in the adult brain in 
selected regions- the subgranular zone (SGZ) in the dentate gyrus (DG) of the 
hippocampus, where NSCs generate cells that differentiate into newborn granule cells and 
the SVZ of the lateral ventricles, where new neurons are generated, which then migrate to 
rostral migratory stream (RMS) towards the olfactory bulb (OB) and differentiate into 
different types of olfactory neurons (Gage, 2000) (Figure 2). Neurogenesis in other adult 
regions is believed to be very limited under normal conditions but can be induced after 
injury (Gould, 2007). 
 
Figure 2. Neurogenic regions of an adult rodent brain (Ming, & Song, 2011). A sagittal 
section view highlighting the two restricted regions that exhibit active adult neurogenesis: 
dentate gyrus (DG) in the hippocampal formation (HP), and the lateral ventricle (LV) to 
the rostral migratory stream (RMS) to the olfactory bulb (OB). 
 
This piece of information raises future scope of utilizing the property of the cells from 
these regions to yield new ones for the replacement to those parts of brain damaged as a 
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result of neurodegenerative disease, brain injury or some external factors like stress. 
Nonetheless, till date the major regions of brain where this replacement was tested did not 
show promising results with significant replacement of large projection neurons (Eriksson 
et al., 1998; Curtis et al., 2003, 2007). 
 
1.1 Types of neurons 
A nerve cell with all its processes is called “neuron”, the structural and functional unit of 
nervous system. A neuron has a cell body called as soma and two types of processes: 
dendrites, which are the short cytoplasmic processes that receive the nerve impulse 
transmitted by a neighbouring cell towards the cell body and; axon, which is the long 
cytoplasmic process of the cell body, transmitting impulse (or action potential) from cell 
body to other neuron (Figure 3). 
 
Figure 3. Structure of a typical CNS neuron. 
 
The axon arises from the cell body in a conical elevation called axon hillock. Axons are 
covered by a myelin sheath formed by Schwann cells (in the Peripheral Nervous System, 
PNS) or by oligodendrocytes (in the CNS), and the region in between where myelin sheath 
is absent is the junction of adjacent myelinated segment called Node of Ranvier. Neurons 
communicate to each other by synapses through the presynaptic release of 
neurotransmitters, which trigger the action potential at the postsynaptic cell. Action 
potentials are propagated as electrical signals by exploiting the electrically excitable 
membrane of the neuron.  
Based on the variations in processes (Figure 4), neurons are divided as: multipolar 
neurons, which consists of one axon and two or more dendrites, like motoneurons, 
interneurons and pyramidal neurons; bipolar neurons, composed of one axon and one 
dendrite, example: neurons of retina in eye, inner ear and olfactory membrane; unipolar 
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neurons, which have single process, and pseudounipolar neurons, which share 
characteristics with both unipolar as well as bipolar cells. They have a single process that 
extends from soma (like unipolar cells) and branches later into two distinct structures (like 
bipolar cells), for example dorsal root ganglia neurons.  
 
       Figure 4. Types of neurons based upon the number and placement of axons. 
Hippocampal neurons 
 The Hippocampus is a neural structure in the medial temporal lobe of the brain that has a 
distinctive, curved shape resembling the sea horse. It is a part of limbic system, present at 
the surface of cerebral hemisphere in an indentation, where it attaches to the midbrain. 
Regarding the neural circuitry underlying the hippocampus, the first zone is the DG, where 
a tightly packed layer of small granule cells wrap around the end of the hippocampus 
proper, forming a pointed wedge in some cross-sections. Next comes a series of Cornu 
Ammonis (CA) areas: first CA4 (which underlies the dentate gyrus), then CA3, then a very 
small zone called CA2 and then CA1. The CA areas are filled with densely 
packed pyramidal cells similar to those found in the neocortex. After CA1 comes an area 
called the subiculum. After this comes a pair of ill-defined areas called the presubiculum 
and parasubiculum, then a transition to the cortex proper (mostly the entorhinal area of the 
cortex) (Figure 5). One edge of the “U” shape of hippocampus, field CA4, which is 
embedded into a backward facing strongly flexed V-shaped DG and comprises molecular, 
granular, subgranular cell layers and poly-morph layer called hilus. The major pathways of 
signal flow through the hippocampus combine to form a loop called as trisynaptic circuit, 
formed of perforant path-DG-CA3-CA1. 
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Figure 5. Neuronal circuitry in the hippocampus (Mccaffery, Zhang, & Crandall, 
2005). Representative pyramidal neurons are drawn in the hippocampal CA1 and CA3 
regions (shaded purple) and the granule neurons of the dentate gyrus (shaded purple), 
which can be renewed from progenitor cells situated in the subgranular zone (shaded 
green). The pathway crucial to memory formation leads from the association areas of the 
cortex passing via the entorhinal cortex to the hippocampus and returning to the 
entorhinal cortex via the subiculum. The three steps within this pathway compose the tri-
synaptic circuit (labeled in red: the perforant, mossy fiber, and Schaeffer collateral 
pathways). 
 
Different regions of hippocampus are characterized by different types of neurons. DG is 
predominantly characterized by granular cells, whose cell body is located in the granular 
layer and dendrites branch to the molecular layer. CA layers display pyramidal neurons as 
the principle cell type, where the neuronal soma is located in the granular layer. From their 
apical pole a thick dendrite arises that can branch profusely in the molecular layer and 
from its basal pole emerges a set of small dendrites, which ramify in the polymorphic 
layer and the axon. The granule neurons and pyramidal neurons are excitatory and 
glutamatergic, whereas interneurons harboured by the hippocampus are GABAergic. 
1.2 Glia 
The term “glial cells” denotes a broad category of cells made of many subtypes. They out-
number neurons and make up a large part of the nervous tissue. Glial cells, discovered first 
as the neuron supporting cells, now have well defined roles like homeostasis of the 
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extracellular environment by providing appropriate conditions for neurons and synapses 
(Theodosis,  Poulain, & Oliet,  2008); Myelination (Colman, Pedraza, & Yoshida, 2001); 
transmitting signals over long distances in form of Ca
2+ 
 waves (Perea, & Araque, 2005); 
regulation of synaptic transmission (reviewed in Araque, 2008) and promoting 
regeneration factors to the injured nervous system (Fu, & Gordon, 1997; Houle, & Tessler, 
2003).  
The main glial subtypes in CNS are astrocytes, oligodendrocytes and microglia; and 
Schwann cells, enteric glial cells and satellite cells in PNS 
1.2.1 Glial cells in the CNS    
a. Oligodendrocytes. Oligodendrocytes are the myelinating cells of the CNS. There are 
different subtypes of oligodendrocytes in spinal cord and brain derived from specialized 
domains of ventral ventricular zone in spinal cord and from medial ganglionic eminence 
and anterior entopeduncular area in ventral brain. They are derived from precursors by a 
complex cell lineage process that renders mature cells producing the insulating myelin 
sheath (Takebayashi et al., 2002;  Zhou, & Anderson, 2002). Oligodendrocyte injury and 
degeneration is involved in the pathology of Multiple Sclerosis (Lucchinetti, & Lassmann, 
2001). 
 
b. Astrocytes. Classically considered as supporting cells in the brain, astrocytes have been 
recently acknowledged for there role as dynamic regulators of many brain processes, 
including synaptogenesis and synaptic efficacy (Ullian et al., 2001; Christopherson et al., 
2005); supporting adult neurogenesis (Pixley, 1992; Song, Stevens, & Gage, 2002); and 
for acting as neural stem cells in the adult brain (Garcia et al., 2004; Sanai et al.,  2004). 
Thus astrocytes’s emerging role as the key regulator in brain function and plasticity 
highlights the critical need to better characterize the heterogeneity and developmental 
specification of different subpopulations of astrocytes both within adult neurogenic 
regions and throughout brain (Imura et al., 2006;  Sakaguchi et al., 2006). Astrocytes 
demonstrate heterogeneity at morphological, ultrastructural and molecular levels including 
growth factor receptor expression, proliferation capacity and electrophysiological 
properties within the SVZ and SGZ (Doetsch et al., 1997, 2002; Seri et al., 2001, 2004; 
Filippov et al., 2003; Kronenberg et al., 2003; Garcia et al., 2004): Radial astrocytes 
(nestin positive that extend a process into Granule Cell Layer (GCL)), Horizontal 
astrocytes (extending basal processes under the GCL and nestin negative) in the SGZ 
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(Kronenberg et al., 2003; Seri et al., 2004). In the SVZ, B1 and B2 types of astrocytes are 
present which differ in their location, cellular ultrastructure and proliferation profiles 
(Doetsch et al., 1997). In addition, based on its presence in white matter or grey matter 
(Ramon, & Cajal, 1909), they are divided into: 1) Protoplasmic astrocytes, which populate 
grey matter and have more irregular processes and less glial filaments (reviewed in 
Freeman, 2010); 2) Fibrous astrocytes, which populate the white matter and are 
characterized by more regular shapes and cylindrical processes exhibiting a “starlike” 
appearance with dense glial filaments (Figure 6).  
 
Figure 6. Subtypes of astrocytes in grey and white matter (Molofsky et al., 2012). The 
protoplasmic astrocyte (left), shown in close association with neuron in grey matter and 
fibrous astrocytes (right), in the white matter. 
 
With their end terminals surrounding blood vessels, astrocytes form gap junctions and are 
closely associated with vasculature and its basal lamina in the adult SVZ and SGZ. 
Astrocytes express a number of secreted factors, including cytokines (Barkho et al., 2006) 
and Wnt factors (Lie et al., 2005) that regulate proliferation and fate specification of adult 
neural precursors, as well as neuronal migration and synapse formation, maturation and 
plasticity (reviewed in Freeman, 2010). Thus, astrocytes express a range of 
neurotransmitter receptors, transporters and ion channels which let them sense neuronal 
activity and direct morphological changes (Verkhratsky, & Steinhäuser, 2000; Malarkey, 
& Parpura, 2009).  
During mammalian nervous system development, neural precursors generate neurons 
followed by the differentiation of astrocytes and glia (Freeman, 2010). In spite of the 
generation and expansion of astrocytes being completed by early postnatal stages, 
elaboration and refining their processes continues even after birth during active period of 
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synaptogenesis (Ullian et al., 2001). Astrocytic morphogenesis initiates with the cellular 
processes appearing on the 1
st
 week of postnatal development in nature. By 3-4 weeks, 
astrocytic processes increase bifurcation and distal appendages acquire a much thinner 
look (Bushong, Martone, & Ellisman, 2004). At postnatal day 7, astrocytes exhibit 
significant overlap of processes with the neighbouring astrocyte but by postnatal day 14-
21 they are pruned back along with the discrete border (Bushong, Martone, & Ellisman, 
2004) (Figure 7). This tendency called as “Tiling” is the way for complete coverage of the 
brain. 
Recent progress in the last two decades demonstrated that astrocytes are responsible for a 
wide variety of essential functions for a healthy CNS, including primary roles in synaptic 
transmission and information processing by neural circuit development (Clarke, &  Barres, 
2013). Consequently, the loss of normal astrocytes is involved in CNS pathologies 
including trauma, viral or bacterial infections and neurodegeneration (Mucke, & 
Eddleston, 1993), where astrocytes undergo a  reaction called “astrogliosis” with increased 
cell division and protein expression, and a characteristic morphological change (the 
hypertrophy of their cellular processes) associated with an increased motility (Ridet et al., 
1997).  
 
 
Figure 7. Coordination of astrocyte morphological growth and pruning (adapted from 
Freeman, 2010). Astrocytes initially extend large, filopodial processes that overlap 
significantly with neighboring astrocytes; however, by postnatal day 21, astrocytes refine 
their morphology to occupy unique spatial domains and elaborate fine processes that 
closely associate with synapses (Bushong et al., 2004) 
 
 
Astrogliosis and brain injury. The mechanism by which within hours of any type of 
brain injury, survived astrocytes of the affected region exhibit hypertrophy and 
proliferation is termed as reactive astrogliosis (Ridet et al., 1997). This process is usually 
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completed by the migration of microglia and macrophages to the affected area. Reactive 
astrocytes then increase the expression of its structural proteins: Glial Fibrillary Acidic 
Protein (GFAP) and vimentin (Eng, Ghirnikar, & Lee, 2000) and many others, for 
example copper-zinc superoxide dismutase, glutathione peroxidase and metallothionein 
are increased in reactive astrocytes upon ischemia (Liu et al., 1993; Takizawa et al., 1994; 
Neal et al., 1996) indicating reduction of reactive oxygen species (ROS). Also astrocytes 
express inducible form of Heme oxygenase in response to brain insults (Geddes et al., 
1996; Takeda et al., 1996), which is the first step of heme metabolism, which might be 
important in preventing heme iron precipitation after conditions such as trauma that 
liberate hemoglobin into the brain parenchyma. 
Astrocytes release a variety of trophic factors under normal conditions which have a 
positive influence on neuronal survival (Ridet et al., 1997). Reactive astrocytes increase 
the expression of several trophic factors, especially Nerve Growth Factor (NGF), basic 
Fibroblast Growth Factor (bFGF), Brain Derived Neurotrophic Factor (BDNF) and 
Neuregulins, which also have well defined roles in neurite outgrowth (Schwartz, & 
Nishiyama, 1994; Strauss et al., 1994; Mocchetti, & Wrathall, 1995; Tokita et al., 2001). 
Also chemokines of CXC and CC families especially CXCL1, CXCL2, CXCL12, CCL2, 
CCL3 are produced by astrocytes upon brain and spinal cord injury (reviewed in Jaerve, & 
Müller, 2012), thus involving astrocytes in brain and spinal cord trauma. 
 
1.2.2 Glial cells in the PNS  
a. Schwann cells. These are the major glial cell type in PNS. Named after the german 
biologist Theodor Schwann, there are a variety of Schwann cells (myelinating and non-
myelinating) which keep peripheral nerves alive. The myelinating Schwann cells form 
insulating sheath around the axon similarly as done by oligodendrocytes in CNS, whereas 
the non-myelinating ones are similar to astrocytes and likely to play metabolic and 
mechanical support functions. 
b. Olfactory ensheathing cells. They resemble non-myelinating Schwann cells and 
associate both with CNS and PNS primary olfactory axons.  
c. Enteric glia cells. They are found in the autonomic ganglia of the gut (enteric system), 
share similarity to astrocytes in both structure and biochemistry and are involved in the 
formation of synaptic interactions in the enteric system. 
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d. Satellite glial cells (SGCs). These cells cover the surface of nerve cell bodies in 
sensory, sympathetic and parasympathetic ganglia (Hanani, 2005, 2010). Literature of 
SGCs with respect to sensory ganglia is discussed here. Sensory ganglia contain the cell 
bodies of neurons that transmit sensory information from the periphery to CNS (spinal 
cord) (Aldskogius, Elfvin, & Forsman, 1986; Matthews, & Cuello, 1982). Most of the 
sensory signals are transmitted to CNS by Dorsal Root Ganglia (DRG) located near the 
entrance of spinal cord. An interesting feature of sensory ganglia is that somata of sensory 
neurons are wrapped by a layer of SGCs (Figure 8) (Hanani, 2005).   
 
Figure 8. Satellite glial cells surrounding sensory neurons (http://vanat.cvm.umn.edu/).  
Figure is showing spinal ganglion (H & E stain), where neuronal cell bodies are 
surrounded by satellite glial cells (shown by arrows in green).  
In general each sensory neuron has its own SGCs sheath, which usually consists of several 
SGCs, and thus the neuron and its surrounding SGCs form a distinct morphological and 
probably functional unit. These units are separated by regions containing connective 
tissue. However, a small percentage of neurons (5.6% in rat DRGs)  form small groups of 
2-3 cells enclosed in a common connective tissue, separated from each other by SGC 
sheets (Pannese et al., 1991) which are characterized best and specifically by a molecular 
marker glutamine synthase (GS). 
SGCs have been implicated in Neurotrophins (NTs)-regulated growth and survival of 
sensory neurons (Pannese, & Procacci, 2002), in NTs-mediated sympathetic nerve fibre 
sprouting upon injury to DRG neurons (Zhou et al., 1999) and in neural development and 
maintenance (De Koninck, Carbonetto, & Cooper, 1993; Sjogreen,  Wiklund, & Ekstrom, 
2000). 
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2. Neuronal migration  
The migration of newly born neurons is a precisely regulated process, essential for the 
development of proper brain circuitry. In the cerebral cortex, the two major types of 
neurons- glutamatergic excitatory projection (pyramidal) neurons and GABAergic 
inhibitory interneurons, arise from distinct sets of progenitor cells within the telencephalon 
and adopt two main strategies to disperse throughout CNS: Radial migration and 
Tangential migration (Figure 9) (Hatten, 1999; Marín, & Rubenstein, 2003).  
 
Figure 9. Major neuron migrations in neocortex (Cooper, 2013). Transverse section 
through the developing rodent brain, showing cortical interneurons (CINs, red), migrating 
tangentially along the marginal zone (1) and the intermediate zone (2) from their origins 
in the basal forebrain, which later migrate into the cortical plate (3). The same figure is 
also demonstrating the cortical projection neurons (CPNs, blue), migrating radially by 
three phases: mutipolar (1), locomotion (2) and somal translocation (3). Supporting cells 
for radial migration: radial glia (RG, green) is shown undergoing interkinetic nuclear 
movement (IKNM) with mitosis apical (1) and S phase basal (2). 
Neurons following radial migration move perpendicular to the ventricular surface and 
alongside the radial glial fibres, which are used as substrate. On the other hand, 
tangentially migrating neurons follow trajectories parallel to ventricular surface and 
orthogonal to radial glia, without needing any support. Correct positioning of newly born 
neurons in the six layered neocortex is crucial for the appropriate functional connectivity 
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between right types and number of neurons. The best structure illustrating both types of 
migration is the cerebral cortex; therefore, cortical neurons are discussed in the following 
part. 
Cortical projection neurons (CPNs) arise from undifferentiated NSCs in the ventricular 
zone (VZ) and SVZ of the telencephalon and reach their target location by radial 
migration (Ayala, Shu, & Tsai, 2007; Bystron, Blakemore, & Rakic, 2008). The earliest-
arriving neurons form the transient plate (PP) followed by the formation of cortical plate 
(CP) by neurons. The CP neurons, split the PP into superficial marginal zone (MZ) and the 
subplate (SP), which is located near the newly formed cortical layer (Ayala, Shu, & Tsai, 
2007). Successively migrating neurons add up to more superficial cortical layers. Hence, 
neurons belonging to the deepest cortical layers are generated first and arrive to their 
destination first followed by the neurons which will reside in the upper layers. Radial 
migration occurs by soma translocation and locomotion, with earliest formed neurons 
employing first mode and most of the cortical neurons using the latter to migrate 
respectively. Apart from this, several studies have also identified multipolar neurons in 
intermediate zone (IZ) and SVZ, which possess multiple thin processes that extends and 
retracts in a random fashion (Tabata, Kanatani, & Nakajima, 2009). These neurons do not 
require the support of RGCs, and have been suggested critical for the progressive 
emergence of different neuronal layers identities and proper cortical lamination (Miyoshi, 
& Fishell, 2012; Ohshima et al., 2007). 
Inhibitory interneurons of the cerebral cortex arise from the medial and caudal ganglionic 
eminences (MGE and CGE) and the preoptic area within ventral telencephalon and 
migrate tangentially into the developing neocortex (Figure 9) (Batista-Brito, & Fishell, 
2009; Kriegstein, & Noctor, 2004). Migration of CINs involves oriented exit from 
ganglionic eminence (GE) towards the cortex as well as migration within cortex towards 
specific positions. Once they reach the cortex, different subpopulations opt for different 
modes of migration. The first mode, helps dispersing interneurons across the neocortex to 
achieve proper laminar organization (Tanaka et al., 2006), where significant number of 
interneurons acquire multidirectional tangential migration in multiple zones of cortex 
(Yokota et al., 2007) so as to migrate long distance and in different directions. The second 
mode involves a subpopulation of interneurons exhibiting ventricle oriented migration 
(Nadarajah et al., 2002), where interneurons within the IZ migrate first towards the 
ventricle before migrating radially to their position within the CP, to obtain layer 
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information for correct cortical positioning. Finally, there is the third mode, where 
tangentially migrating streams of interneurons switch to radial migration as they move 
towards specific locations within the CP (Faux et al., 2012; Nadarjah et al., 2002). 
Guidance cues regulating neuronal migration represent a diverse class of secreted or 
substrate-bound molecules that act as either chemotactic, chemoattractant, or 
chemorepellent guides, some of which are: Class 3 Semaphorins (Sema3A-3G) that 
behave both as chemorepellent (Kolodkin, & Tessier-Lavigne, 2011) as well as 
chemoattractant (Chen et al., 2008);  Slit proteins that repel interneurons from ganglionic 
eminence so as to initiate their migration towards the neocortex (Hu, 1999; Wu et al., 
1999); Neuregulin 1 growth factor, which by binding to ErbB receptor tyrosine kinases 
controls the exit of MGE-derived interneurons towards the dorsal cortex (Flames et al., 
2004) and Netrin 1, which serves as both repellent as well as attractant, depending on the 
receptor binding (Marin, & Rubenstein, 2003). Apart from these, some of the secreted 
molecules used in this work have also been implicated in neuronal migration including 
Hepatocyte Growth Factor (HGF) and chemokines, which are described in next sections. 
Proper complex control of neuronal migration underlies the correct formation and 
physiology of the brain. Thus, mutations in α and β tubulin genes and the Microtubule 
(MT) binding protein doublecortin (DCX) among others, which disrupt neuronal cortical 
migration, have been implicated in Lissencephaly (lack of brain infoldings), Pachygyria 
(thick brain convolutions) and Polymicrogyria (excessive number of small brain 
convolutions) neurological syndromes in humans (Keays et al., 2007; Jaglin et al., 2009). 
Mutations in X-linked gene DCX that result in a large population of neurons failing to 
migrate, cause subcortical band heterotropia (Manent et al., 2009). Loss of 
excitatory/inhibitory neuron balance in specific brain circuitries has also been implicated 
in psychiatric disorders like schizophrenia, anxiety or depression (Di Cristo, 2007).  
3. The Centrosome: Introduction and its role in neural 
development  
The formation of the mammalian brain circuitry requires careful coordination of 
proliferation, migration and differentiation programs between distinct neuronal 
populations. The spectacular morphological modification of a neuroblast into a mature 
neuron and the establishment of  well developed axonal and dendritic arbours points at a 
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strictly regulated cytoskeletal reorganization (Higginbotham, & Gleeson, 2007;  
Hoogenraad, & Bradke, 2009). Therefore it is not surprising that many 
neurodevelopmental disorders are the result of mutations in cytoskeletal proteins, 
including tubulins (Thornton, & Woods, 2009; Tischfield et al., 2010). 
Indeed, a central component of the neuronal cytoskeletal structure is the microtubule (MT) 
array, the centrosome is the MT-organizing center (MTOC) of the cell. The centrosome is 
a membrane-less organelle typically 1µm that distinguishes prokaryotes from eukaryotes 
(Marshall, 2009). Eukaryotic cells have one centrosome, consisting of a pair of barrel-
shaped centrioles (composed of nine-tripled MTs) surrounded by pericentriolar material 
(PCM) (Bettencourt-Dias, & Glover, 2007; Bornens, 2012). MTs are the hollow tubes 
composed of 13 protofilaments of α and β tubulin dimers organized in a head to tail 
manner. Tubulin in MTs polymerizes in a way, such that the α-subunits of one tubulin 
dimer contacts the β-subunit of the next. Hence in each protofilament there will be, one 
end with α-subunits exposed while the other end will have β-subunit exposed, which are 
designated as the minus (-) and plus (+) ends respectively (Walker et al., 1988). PCM is 
organized around the centriole and contains MT nucleation factors, such as γ-tubulin, 
pericentrin, ninein and NEDD1, and MT nucleation complexes called γ-tubulin ring 
complexes (γ-TuRCs) (Figure 10) (Fu, & Glover, 2012; Lawo et al., 2012).   
 Figure 10 . Anatomy of the vertebrate 
centrosome (Tang, & Marshall, 2012). 
Centrosome is composed of two parallely 
placed centrioles surrounded by PCM, of 
which mother centriole can be distinguished 
by the two sets of appendages: the subdistal 
and distal (Dawe,  Farr, & Gull,  2007). 
Upon exit from the cell cycle, the mother 
centriole acts   as a nucleation site for the 
growth of primary cilia. 
 
The centrosome nucleates a radial array of MTs, whose minus ends (−) are anchored at the 
centrosome and plus ends (+) extend into the cell periphery (Conde, & Caceres, 2009). In 
vertebrate neurons, axons have a uniform arrangement of microtubules with + ends distal 
to the cell body (+ ends out), whereas dendrites have equal numbers of + and − end-out 
 Introduction 
 
35 
 
microtubules. The centrosome not only provides structural foundation for the MT array 
but also the major MT nucleation site, involved in many different cell processes like cell 
division, cell migration and differentiation (Azimzadeh, & Bornens, 2007; Bettencourt-
Dias, & Glover, 2007; Doxsey, McCollum, & Theurkauf, 2005; Nigg, & Raff, 2009). 
Recruitment of MT nucleation proteins is regulated in part by the cell cycle–dependent 
protein Plk1 (Polo-like kinase 1; Casenghi et al., 2003; Haren, Stearns, & Lüders, 2009; 
Eot-Houllier et al., 2010). Inhibition, depletion or mislocalization of Plk1 during mitosis 
perturbs bipolar spindle formation and leads to mitotic failure, in part through centrosome-
mediated defects.  
The centrosome cycle, ensures the equal distribution of centrosomes to daughter cells 
during cell division. It initiates during the early phase of cell cycle, so that by the time 
mitosis occurs there are two centrosomes. The centrosome cycle consists of four phases 
which are synchronized to cell cycle (Figure 11), that includes: centrosome duplication 
during G1 and S phase, centrosome maturation in G2 phase, centrosome separation in 
mitotic phase and centrosome disorientation/splitting in the late mitotic phase, that refers 
to the loss of orthogonality between the mother and daughter centrioles.  
 
Figure 11. Schematic view of centrosome cycle (Meraldi, & Nigg, 2002).  It initiates 
upon centriole disengagement in G1 phase which licenses centrioles for duplication in S 
phase along with the nucleation of daughter centrioles. Later the procentrioles mature in 
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G2 phase followed by building up of poles of bipolar mitotic spindles resulting in their 
separation in M phase (Mitotic phase). Mature centrioles are shown in dark blue, 
immature centrioles in blue, pro-centrioles in light blue and PCM in green. 
The first phase of centrosome cycle is centrosome duplication which is highly regulated by 
Cyclin-Dependent Kinase 2 (Cdk2) and its binding partners cyclin E (Matsumoto, & 
Maller, 2004) and cyclin A (Meraldi et al., 1999) in embryonic cells and somatic cells, 
respectively. Nucleophosmin (NPM/B23) and Monopolar spindle-1 (Mps1) have been 
demonstrated as the candidate substrates downstream to Cdk2 for centrosome duplication 
(Loncarek, & Khodjakov, 2009). Apart from Cdk2, two other protein kinases have also 
been implicated in centrosome duplication, namely ZYG-1 (O’Connell et al., 2001) and 
Calcium-calmodulin kinase II (CaMKII) (Matsumoto, & Maller, 2002). The next phase is 
centrosome maturation, which is defined by the increase of γ-TuRCs upto three to five 
fold (Khodjakov, & Rieder, 1999) that allows the mature centrosome to have a greater 
ability to nucleate MTs. Polo-like kinase (Sillibourne et al., 2010), Aurora kinases 
(Hannak et al., 2001) and Nek2 (Prigent, Glover, & Giet, 2005) also plays very important 
role in the recruitment of γ-tubulin and other proteins to form PCM around the centrioles. 
Next comes the separation of duplicated centrosomes into distinct MTOCs at G2/M 
transition in two distinct steps during centrosome separation phase, where demolition of 
connection between the parental centrioles occurs in the first step, followed by complete 
centrosome separation via microtubule motor proteins in the second step (Meraldi, & 
Nigg, 2002). Centrosomal-Nek2-associated protein1 (C-Nap1) and Rootletin has been 
described to work as the physical linker between the two centrosomes, which upon 
phosphorylation dissociate from the centrosomes, resulting into centrosomal separation 
(Yang, Adamian, & Li, 2006). The last phase of the centrosome cycle occurring during the 
late mitosis/early G1 exhibits the striking loss of orthogonal orientation between the 
centrioles. Once disorientation occurs, mature centriole begins to move towards the 
cleaving furrow, marking the termination of cell cycle and re-establishment of linker 
between the parent centrioles (Mayor et al., 2000) which was disassembled in the previous 
cycle 
Mutations in centrosome-localized proteins are associated with pathologies such as 
Huntington disease and Lissencephaly (Sathasivam et al., 2001; Badano, Teslovich, & 
Katsanis, 2005; Kuijpers, & Hoogenraad, 2011). Here, I will discuss briefly the role of 
centrosome positioning during different stages of neural development. 
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3.1 Centrosome positioning during neurogenesis 
During corticogenesis, apical progenitor cells either undergo proliferative symmetrical 
divisions or neurogenic asymmetric divisions. The balance between these two types of 
divisions determines the size of the progenitor cell pool and ultimately the number of 
neurons generated in the brain. One hypothesis proposes that centrosomes are required for 
proper neural progenitor cell fate specification through the regulation of mitotic spindle 
orientation such that vertical cleavage correlates with asymmetrical divisions and 
horizontal cleavage favors symmetrical divisions. NSCs are attached to the apical and pial 
surfaces, polarized along the apico-basal axis. During S-phase DNA replication, the 
nucleus of the NSCs moves basally and returns to the apical surface (Figure 12; i-iv) 
before entering into mitosis, but centrosomes retain their position at apical surface during 
G1, S and G2 phases. As neurogenesis initiates, NSCs divide by symmetrical proliferative 
division (Figure 12; v,vi) where they complete cytokinesis and bisects the apical 
membrane such that both daughter cells receive a centrosome and apical membrane 
proteins, but remain attached to each other while adopting neuroepithelial fate. This is 
followed by asymmetrical division, where only one daughter cell receives apical 
membrane and adherens junction and remains a NSC, while the other one detaches from 
apical surface and migrates sub-ventrically, developing into either a basal progenitor or a 
neuron (Figure 12; viii,ix). 
 
Figure 12. Variation in centrosome positioning during neurogenesis (Thornton, & 
Woods, 2009). Processes of neuroepithelial cells (blue) contact the apical (ventricular) 
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and pial (basal) surfaces. The nuclei (nuclei) migrate basally during G1 (i,ii) undergoes S 
phase (iii); and migrate apically during G2 (iv), but centrosomes (red dots) stay at  apical 
membrane (green). When mitosis occurs at apical surface, centrosomes form the spindle 
poles. Symmetrical division leads to production of two identical neuroepithelial cells 
(v,vi), whereas asymmetrical division (vii) leads to the production of one neuroepithelial 
and other one detaches from the membrane (viii) and becomes either a basal progenitor 
(ix) or  neuron. Basal progenitors (ix) lack processes and polarity and predominantly 
divide, resulting in the production of two neurons (x) 
 
Both apico-basal polarity and regulation of cell cleavage plane depend on the MT network 
and centrosome function. Several centrosomal proteins regulating mitotic spindle 
orientation in neuronal progenitors have been identified (Fietz, & Huttner, 2011). A 
complete control of centrosome over its position during the spindle pole orientation is very 
important for the proper distribution of fate factors in order to maintain a balance between 
propagation of progenitor pool and neurogenesis. A slight imbalance can lead to disorders 
like Microcephaly (Cox et al., 2006; Chenn, & Walsh, 2002). The human gene 
Centromere-associated protein J (CENPJ) is mutated in some patients with autosomal 
recessive primary microcephaly, characterized by hypoproliferation of neuronal 
precursors.  
3.2 Centrosome positioning during neuronal migration 
In many non polarized cells, such as interphase fibroblasts, the centrosome is located near 
the cell center and is physically linked to the nucleus, with MTs radiating out to the cell 
cortex (Figure 13A).  The centrosome is often found in close proximity to the neurite that 
becomes the axon, suggesting a role in determining the site of axon outgrowth. The first 
observation regarding the centrosomal localization ahead of the nucleus in migrating 
neurons was made in 1970’s (Gregory et al., 1988; Rakic, 1972). Migrating neurons 
undergo major morphological changes regulated by changes in the cytoskeleton structure 
and centrosome positioning (Higginbotham, & Gleeson, 2007). In migrating neurons, the 
centrosome is sometimes positioned ahead of the nucleus, suggesting that it drives the 
forward movement of the nucleus along microtubules. However, live imaging of radial 
migration of granule cells in cultured developing mouse cerebellum demonstrated that 
nucleus migration is not always correlated with the movement of the centrosome (see for 
details Tang, & Marshall, 2012). The implication of the centrosome in migration has been 
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reported in tangentially migrating cortical interneurons (Vitalis, & Rissier, 2011; Wonders, 
& Anderson, 2006), where failure to maintain the proper positioning of centrosome in 
facial branchiomotor neurons leads to ecotopic migration (Figure 13A) (Grant, & Moens, 
2010). Experiments in radially migrating cortical pyramidal neurons (Kriegstein, & 
Noctor, 2004) and other motile cells like endothelial cells and astrocytes (Yvon et al., 
2002) support the same conclusion, but not those performed in leukocytes and keratocytes 
(Huang, Silverstein, & Malawista, 1991; Verkhovsky,  Svitkina, & Borisy, 1999), where 
centrosome is not required for cell movement or chemotaxis but considered important in 
specific case of wound healing (Wakida et al., 2010). Wound healing experiments have 
demonstrated that centrosome becomes oriented between the nucleus and the leading edge 
(Gotlieb et al., 1981) along with Golgi complex and the endocytic recycling compartment 
in several cell types (Koonce et al., 1984; Yvon et al., 2002) (Figure 13). However, even 
within a single cell type, the relative position of the centrosome and the nucleus can vary 
as a function of myosin II activity (Szabó et al., 2011) or the type of substrate 
(Schütze, Maniotis, & Schliwa, 1991). 
 
Figure 13. Centrosome positioning dependence upon cell type and cell state. (Tang, & 
Marshall, 2012). Figure is demonstrating: (A) Fibroblasts in non-polarized state (left) 
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where centrosome is physically linked to the nucleus and located near the centre of the 
cell, with MTs radiating from the centrosome to cell cortex. Wound healing (right), makes 
centrosome reorient between the nucleus and the leading edge. (B) Epithelial cells in the 
polarized state (left) locates centrosomes on the apical surface of the cell, accompanied by 
a loss of radial MT organization and the formation of a predominantly apical-basal array 
of MTs. The mother centriole of the centrosome becomes a basal body, which gives rise to 
a primary cilium. In multiciliated epithelial cells (right), hundreds of centrioles are 
assembled at once in a single cell, leading to the formation of multiple cilia. (C) Resting 
neurons (left) show centrosome proximity to the neurite destined to become an axón, 
whereas in migrating neurons (right) centrosome positions ahead of the nucleus with MTs 
connecting centrosome and the nucleus. (D) In the unstimulated Cytotoxic T lymphocytes 
(CTLs)(left), centrosome is located near the nucleus and lytic granules are distributed all 
long the MTs. However upon stimulation (right), their centrosome directs the delivery of 
lytic granules by moving along the MTs to the plasma membrane followed by the point of 
secretion for release of lytic granules to the immunological synapse. Red ovals indicates 
centrosome, centrioles are shown as black lines, Blue ovals are showing nuclei and Green 
lines are indicating MTs. 
Cell migration mechanism (Neural and non-neural) 
Cell polarization during migration involves the asymmetrical distribution of signaling 
molecules and the cytoskeleton, in addition to directed membrane trafficking. A polarized 
migrating cell has a single leading edge and filopodia at the front; MTOC and Golgi 
apparatus orienting towards the direction of migration and; temporal capture and 
stabilization of MT plus ends near the leading edge (Figure 14).  
 
Figure 14. Microtubule polarization in migrating cells (Watanabe, Noritake, & 
Kaibuchi, 2005). Figure demonstrates the rearrangement of MTs upon transforming from 
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a resting state (left) to a polarized state (right). In resting cells, the minus ends of MTs are 
anchored at the MTOC, which reorients towards the direction of migration, once 
encountered with the signal. During cell migration, selective stabilization of Plus ends of 
MTs occurs, enabling MTOC to reorient towards the leading edge, resulting into 
polarized MT which facilitates cell migration. During migration, MT plus ends get curved 
(MT reffuling). N: nucleus   
Cell migration requires the coordination of processes, especially the reorganization of 
cytoskeleton and MTs (Hall, 2012; Goode, Drubin, & Barnes, 2000). MTs minus ends 
localize predominantly at MTOC (Figure 14), with their plus ends alternating between two 
phases of growth and shrinkage (a state of dynamic instability) to explore intracellular 
spaces (Kirschner,& Mitchison, 1986). Via this search process, plus ends are captured and 
stabilized at target destinations like kinetochores on the mitotic spindle and cell cortex. 
This enables the MTOC to reorient towards the leading edge, resulting in a polarized MT 
array which facilitates cell migration.  
  
4. Neuronal differentiation: establishment of the neuronal  
morphology 
After neurons are born and differentiate, they break their previous symmetry, change 
shape dramatically and two compartments are structurally and functionally established: 
axon and dendrites, which differ from each other in the composition of proteins and 
organelles. Microtubule-associated proteins (MAPs) are thought to be involved critically 
in the development of polarity. Tau is a MAP protein typically confined to the axon, 
whereas MAP-2 is localized to the soma and dendrites (Binder, Frankfurter, & Rebhun, 
1986). Axons are typically long and thin, with a uniform width and branching at right 
angles from the cell body. On the other hand, dendrites are relatively shorter, appears 
thicker as they emerge from the cell body, thinner as the distance is increased from the cell 
body and bifurcates into Y-shaped branching. Axons contain synaptic vesicles from which 
neurotransmitters are released in response to electric signals, whereas dendrites exhibit 
spines, which contain receptors for neurotransmitters. 
In vitro dissociated neuronal cultures greatly contributed to our understanding of neuronal 
polarity (Goslin, & Banker, 1989; Craig, & Banker, 1994). Cultured cortical and 
hippocampal neurons show morphology transition through several stages (Figure15) from 
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freshly plated stage-1 cells to stage-5 (achieved from about 2 weeks in culture), when they 
show a well developed axon and dendrites, dendritic spines and functional synapses 
(Dotti, Sullivan, & Banker, 1988; Craig, & Banker, 1994; Arimura, & Kaibuchi, 2007). 
This work has focused on stage-3 (DIV2) hippocampal neurons, in which the longest cell 
process present typically corresponds to the axon.  
 
Figure 15.  Events leading to the polarization of hippocampal neurons in vitro  
(Polleux, & Snider, 2010) . Changes in the morphology of neurons upon plating and 
during  the development (days in vitro, DIV) of the culture. Immature neurons display 
lamellopodial and filipodial protrusions (stage 1, 0DIV), which lead to immature neurites 
budding out (stage 2). This is followed by the breaking of the symmetry (stage 3), when 
one neurite grows faster and becomes the axon, while other neurites will develop later 
(from 4DIV) and become dendrites. Axon and dendrites can be distinguished by specific 
immunostainings against tau and MAP-2, respectively.  Stage 4 is characterized by rapid 
axonal and dendritic outgrowth, leading to the complex morphology of terminally 
differentiated neurons that display dendritic spines and functional synapses (stage-5).  
Axon development includes three important phases: 1) Axon specification during neuronal 
polarization, 2) Axon outgrowth and guidance, and 3) Axon branching and presynaptic 
differentiation (Barnes, & Polleux, 2009; Donahoo, & Richards, 2009).  
Neuronal polarization is the process of breaking symmetry in the newly born cell so as to 
form axon and dendrites (Dotti, & Banker, 1987). Among the several important signaling 
pathways involved in axon specification is the phosphatidylinositol-3-kinase (PI3K) 
pathway (Arimura, & Kaibuchi, 2007; Barnes, & Polleux, 2009), where PI3K and its lipid 
product- phosphatidylinositol-3,4,5-triphosphate (PIP3), accumulate at the tip of the 
prospective axon, as well as the mPar3/mPar6/aPKC polarity complex (Shi, Jan, & Jan, 
2003). Roth et al., recently reported tension induced signaling to be significant in axon 
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specification by the use of micropatterns of curved paths, where it was demonstrated that 
the neurite which grows on a straight path and subjected to largest tension was most likely 
to be fated as the axon (Roth et al., 2012). In addition, Cytochalasin D (an actin 
depolymerising drug) applied to stage 2 neurons causes multiple axon-like neurites, 
suggesting that instability of actin filaments is necessary for axon formation (Bradke, & 
Dotti, 1999).  
An instructive role for the centrosome in axon specification has been proposed in 
hippocampal neurons, cerebellar granule cells (Witte, & Bradke, 2008) and cortical 
neurons (de Anda et al., 2010). The idea behind this was that asymmetrical stabilization of 
MTs occurs only in one neurite, which is specified as the future axon (Witte, Neukirchen, 
& Bradke, 2008). Extra numerary centrosomes led to the formation of two axon-like 
neurites (de Anda et al., 2010). During neuronal development, as centrosome position 
coincides with the localization of the Golgi complex, it was also hypothesized that 
centrosome position in front of the future axon directs polarized MT-dependent secretory 
transport (Sutterlin, & Colanzi, 2010). However, studies in zebrafish and mutant flies 
disagreed with this hypothesis both in vitro and in vivo, suggesting a predominant role for 
extrinsic cues (Distel et al., 2010; Zolessi et al., 2006; Basto et al., 2006). If neurite 
outgrowth is generated several hours after the last mitosis, the positioning of the 
centrosome may not be important for initial neuronal polarization (Conde, & Caceres, 
2009).  
  Followed by axon specification, axon growth continues which is the product of two 
opposite forces: slow axonal transport and polymerization of MTs providing a pushing 
force from the axonal shaft; and the retrograde flow of actin providing a pulling force at 
the front of the growth cone (Letourneau, Shattuck, & Ressler, 1987; Suter and Miller, 
2011). At the leading edge of the growth cone, MTs tend to persist in growth but do not 
grow into lamellipodia. However if actin is blocked, neurite extension still continues 
through MTs extension into lamellipodia that bend against the plasma membrane 
(Andersen, & Bi, 2000). As per Anderson and Bi, feedback loops (positive and negative) 
specify axon and its sustained growth. The positive feedback includes: physical 
components (cytoskeletal assembly and addition of new membrane), accumulation of 
vesicles for the future axon and preferential exocytosis (Ca
2+ 
, receptor tyrosine kinases 
and phosphatases) at axonal growth cone (Anderson, & Bi, 2000). Negative loop is 
characterized by the nature of inhibitory signals, which could be high Cyclic Adenosine 
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Monophosphate (cAMP) concentrations (Zheng, Zheng, & Poo, 1997; Mattson, Taylor-
Hunter, & Kater, 1988) with the possible involvement of cAMP/PKA pathway. 
Propagation of inhibitory signals results into decrease in actin dynamics, MT 
polymerization and membrane insertion in the processes destined to be dendrites,  
Axons reach their targets with the help of a dynamic structure at the tip of the axon called 
“Growth cone” (Ramon, & Cajal, 1890). A growth cone consists of the leading edge with 
dynamic finger-like filopodia, considered as the guiding sensors at the front line of the 
growth cone (Mattila & Lappalainen, 2008), separated by the sheets of membrane in 
between called lamellipodia (Figure 16). 
 
 
 
 
 
 
 
 
 
 
Figure 16. Structure of a Growth cone (Lowery, & Van Vactor, 2009) consists of 
filopodia, separated in between by lamellipodia-like veils. The cytoskeleton elements on 
the “P” domain are F-actin bundles, with “C” domain harboring stable bundled MTs that 
enter the growth cone and “T” zone, which lies at the interface between P and C domains. 
 
Based on the cytoskeletal distribution, the growth cone can be divided into three domains 
(Dent & Gertler, 2003): The peripheral (P) domain containing long, bundled actin 
filaments {Filamentous-actin (F-actin) bundles} which form filopodia as well as mesh-like 
branched F-actin network giving rise to lamellipodia-like veils; the central (C) domain, 
which encloses stable, bundled MTs that enter the growth cone from the axon shaft; and 
the transition (T) zone, present at the interface between P and C domains, where actin arcs 
lie perpendicular to F-actin bundles and form hemicircumference rings (Schaefer, Kabir, 
& Forscher, 2002). 
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The growth cone, with the help of its cytoskeleton moves into the direction of attractive 
cues in three stages, protrusion, engorgement and consolidation (Goldberg, & Burmeister, 
1986; Dent, & Gertler, 2003) (Figure17), which initiate when the distal end of the growth 
cone comes in contact with an adhesive substrate (Figure 17a). Adhesive substrate 
includes adhesive molecules on neighbouring cell’s surface (Maness, & Schachner, 2007) 
or molecules embedded into the extracellular matrix (Evans, 2007), providing a defined 
surface to which the growth cone can adhere and activate intracellular signaling pathways. 
This results in a rapid extension of filopodia and lamellar extensions along the leading 
edge of the growth cone in the “protrusion phase”.  It anchors the actin with respect to the 
substrate, such that F-actin polymerization continues in front and the lamellipodia-like 
veils and filopodia of the P domain move forward to extend the leading edge (Mogilner, 
2006) (Figure 17b). After actin clears off from the corridor between the substrate and the 
C domain, engorgement occurs where F-actin arcs reorientate from the C domain towards 
the site of new growth (Suter & Forscher, 2000, 2001; Lee & Suter, 2008), followed by 
migration of C domain MT’s into this region (Figure 17c). Finally, consolidation of the 
newly migrated C domain at the growth cone neck forms a new part of axon shaft (Figure 
17d).  
 
 
 
Figure17. Description of axon outgrowth stages (Lowery & Van Vactor, 2009). (a) 
Distal end of the growth cone encounters adhesive substrate resulting in the activation of 
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intracellular signaling that links actin cytoskeleton to the substrate. (b) F-actin 
polymerization continues in front making P domain move forward to extend the leading 
edge. (c) Followed by clearing of actin from the space between adhesion and C domain, F 
actin is removed leading C domain MTs into this region. (d) Finally happens the 
consolidation of recently advanced C domain as the proximal part of the growth cone to 
form a new segment of the axon shaft. 
The last step of the axon development is terminal branching, which allows a single axon to 
connect to a multiple set of targets. Axon branching witnesses similar F-actin and MT 
reorganization as described in axon elongation except that the growth cone “splits” during 
the engorgement phase (Dent, & Kalil, 2001) (Figure18). Briefly, F-actin reorganization 
gives rise to protrusion, followed by MTs invasion of the transient structure for 
consolidation, before the mature branch starts elongating through MT bundling.  
 
Figure 18. Cytoskeletal changes during branch formation in the axon (Lewis, Courchet, 
& Polleux, 2013). Similarly to axon growth mechanism, filopdia and lamellipodia get 
invaded by MTs resulting in elongation upon MT bundling. 
Signaling molecules involved in neurite outgrowth 
A range of secreted molecules, including growth factors and morphogens promote axon 
and neurite outgrowth, among which Neurotrophins (NTs), Hepatocyte growth factor 
(HGF) and Wnts (Maina, & Klein, 1999; Korhonen et al., 2000; Chao, 2003; Yu, & 
Malenka, 2003; Ciani, & Salinas, 2005; Nakano et al., 2007; Park & Shen, 2012). Wnt 
family of secreted proteins have been reported to function as axon pathfinding cues and 
target-derived factors that regulate axon terminal arborization, and act retrogradely for the 
induction of axon remodelling (characterized by axon spreading and growth cone 
enlargement) and synapse formation (Hall, Lucas, & Salinas, 2000; Ciani, & Salinas, 
2005; Zou, 2006; Purro et al., 2008). In addition, adhesion molecules like β-catenin, a 
component of the cell–cell adhesion complex and effector of canonical Wnt signaling, also 
plays key roles in axon outgrowth, dendritogenesis  and synapse formation (Murase, 
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Mosser, & Schuman, 2002; Bamji et al., 2003, 2006; Yu, & Malenka, 2003; Lu et al., 
2004; David et al., 2008). These molecules and evidence implicating them in the 
regulation of neurite outgrowth will be described here in more detail.  
5. HGF and Met  
Hepatocyte Growth Factor (HGF) also known as Scatter Factor, was originally identified 
as a molecule that could trigger motility, proliferation and morphogenesis in a variety of 
epithelial cells (Birchmeier, & Gherardi, 1998). Its well described roles in cell migration 
and tumor invasion came from its involvement in neural induction during gastrulation 
(Birchmeier et al., 1997; Jeffers, Rong, & Vande Woude, 1996).  
 
Figure 19.(A) Structural domain of HGF (Trusolino, Bertotti, & Comoglio, 2010) 
showing amino-terminal hairpin loop domain (HL), four kringle domains (K1-K4) and a 
serine protease homology (SPH) domain, and (B) conversion from inactive precursor to 
active and mature HGF (Nakamura, & Mizuno, 2010). Secreted pro-HGF is cleaved by 
HGF activators to convert it into the mature and active form, whit the α and β chains.  
 
It is a multidomain protein similar to plasminogen, a circulating proenzyme that promotes 
the lysis of fibrin blood clots in its active form as plasmin. HGF is synthesized as a single-
chain inactive precursor, converted by serine proteases into an active form with two 
subunits – α and β with molecular weight of 69 kDa and 34 kDa linked by a disulfide bond 
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(Naka et al., 1992; Naldini et al., 1992) (Figure 19B). HGF consists of six domains: an 
amino-terminal hairpin loop domain (HL), four kringle domains (K1-K4) and a serine 
protease homology (SPH) domain, which lacks enzymatic activity (Figure 19A). 
 
The HGF receptor Met, a tyrosine kinase receptor first identified in 1980’s as an oncogene 
(Cooper, 1984; Park et al., 1986; c-Met), is a disulfide-linked heterodimer, comprised of 
an extracellular α-subunit and a transmembrane β-subunit that contains the enzymatic 
activity (Figure 20).  
 
Figure 20. Structure of HGF receptor (Met)  (Faria, Smith, & Rutka, 2011). It is 
composed of extracellular α-subunit and transmembrane β subunit. The extracellular unit 
is formed of 3 domains (sema, PSI and IPT), whereas the intracellular part is composed of 
juxtamembrane sequence, catalytic region (with docking sites at Tyr 1234 and Tyr 1235), 
and multifunctional docking site involved in the recruitment of adaptors.  
 
The extracellular region of Met is composed of three domains: the sema domain which 
spans the first 500 residues at the N terminus covering the complete α-subunit and a part 
of β-subunit; the PSI domain (also present in plexins, semaphorins and integrins) covering 
approximately 50 residues and containing four conserved disulfide bonds; the remaining 
400 residues, connecting the PSI domain to the transmembrane helix are organized into 
four IPT (Immunoglobulin-like fold shared by plexins and transcriptional factors) 
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domains. The intracellular segment is composed of three portions: a juxtamembrane 
sequence that downregulates kinase activity followed by phosphorylation at Ser975; a 
catalytic region positively modulating kinase activity following trans-phosphorylation at 
Tyr1234 and Tyr1235; and a carboxy terminal multifunctional docking site that contains 
two docking tyrosines (Tyr1349 and Tyr1356) which are involved in the recruitment of 
several transducers and adaptors.  
Met receptor gets activated upon binding of the active HGF. Precursor HGF is converted 
into active HGF by a protease called HGF activator (HGFA) (Miyazawa et al., 1993). 
HGF activation is regulated by serine protease inhibitors called SPINT1 and SPINT2 
(Kawaguchi et al., 1997; Shimomura et al., 1997) (Figure 21).  
 
Figure 21. Pathways downstream to the HGF-Met activation (Faria, Smith, & Rutka, 
2011) and the promoted cellular effects.  
Kinase activity of Met gets activated upon HGF binding, receptor dimerization and trans-
phosphorylation of two tyrosine residues in the catalytic region (Tyr1234 and Tyr1235) 
followed by the phosphorylation of two additional tyrosines in the carboxy-terminal tail 
(Tyr1349 and Tyr1356). The latter phosphorylated tyrosine residues create docking sites 
for a number of adaptor proteins including the growth factor receptor-bound protein 2 
(Grb2), Grb2-associated adaptor protein (Gab1), son of sevenless (SOS), SRC homology 
protein tyrosine phosphatase 3 (Shp3), PI3K and signal transducer and activator of 
transcription 3 (STAT3). which leads to the activation of MAPK, PI3K/AKT and STAT 
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pathways mediating Met dependent cell proliferation, survival, migration and invasion  
(Faria, Smith, & Rutka, 2011). 
Met mutation is causative for familial carcinomas, such as renal carcinoma or head-and-
neck carcinoma in humans (Schmidt et al., 1997). In tumors, HGF is often produced by 
stromal cells, while Met is overexpressed by cancer cells, which was suggested as a 
paracrine loop that determines a malignant behavior (Nakamura et al., 1997; Matsumoto et 
al., 1996; Vermeulen et al., 2010). 
 
5.1 HGF/Met signaling in neurite morphogenesis 
A number of studies involving different neuronal cellular types described the implication 
of HGF signaling in neurite elongation and guidance. HGF was reported to increase 
neurite outgrowth and enhance dendritic maturation in the CNS:  in hippocampal neurons 
(Lim & Walikonis, 2008; Korhonen et al., 2000), cortical neurons (Gutierrez et al., 2004; 
Hamanoue et al., 1996) and thalamic neurons (Powell et al., 2003). In addition to its role 
as a neutrophic factor, HGF serves as a chemoattractant to a subset of motoneuron axons 
expressing Met and guides them towards their targets in the mesenchyme (expressing 
HGF) (Ebens et al., 1996). In the PNS, HGF/Met have been described for their role in 
sensory neuron development by promoting neurite outgrowth induced by NGF  in DRG 
explants (Maina et al., 1997). Thus, mutant mice embryos lacking Met, showed enhanced 
apoptosis in DRG as well as a reduction in sensory fibres innervating the skin of the limbs 
and thorax (Maina et al., 1997). 
Classical downstream pathways to HGF/Met implicate the activation of Akt in promoting 
dendritic maturation in hippocampal neurons (Lim, & Walikonis, 2008). HGF signaling 
activates Akt, which makes GSK-3β inactive by phosphorylation and reduces MAP-2 
phosphorylation, resulting in dendritic elongation, which was further confirmed by 
utilizing Met and Akt inhibitors (Lim, & Walikonis, 2008).  
Decreased Met expression has been linked to autism susceptibility, thus highlighting the 
importance of Met signaling in neuronal development (Campbell et al., 2006). 
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5.2 HGF and Met signaling in cell migration 
HGF and Met are expressed not only in neurons but also non-neuronal cells within 
nervous system like microglia (Di Renzo et al., 1993), Schwann cell (Krasnoselsky et al., 
1994), oligodendrocytes (Yan & Rivkees, 2002; Ohya et al., 2007) and astrocytes 
(Shimazaki et al., 2003). HGF/Met motogenic activity is a highly conserved mechanism 
regulating migration of cortical neurons (Powell, Mars, & Levitt, 2001; Powell et al., 
2003), Gonadotrophin releasing hormone-1 (GnRH-1) secreting neurons (Giacobini et al., 
2007) and Spinal motor neurons (Ebens et al., 1996, Wong et al., 1997). Mice lacking 
tissue type plasminogen activator or urokinase plasminogen activator receptor (key 
components of HGF activation) exhibited deficient scattered activity in forebrain due to 
abnormal interneuron migration from the ganglionic eminescence ( Powell, Mars, & 
Levitt, 2001) and reduced migration of GnRH-1 neurons in the forebrain (Giacobini et al., 
2007).  
Outside the nervous system, HGF induces migration of retinal endothelial cells (Cai et al., 
2000), and mesenchymal stem cells (Forte et al., 2006). HGF binding to Met, activates 
signaling cascades downstream amongst which ERK1/2 and PI3K/Akt signaling 
particularly have been reported in HGF-mediated migration,  invasion and metastasis 
(Menakongka, 2010; Ye et al., 2008 ) , by regulating PI3-kinase (Royal, & Park, 1995).  
 
6. Neurotrophins (NTs) and NT receptors 
NTs are secreted proteins with central functions in the CNS ranging from differentiation 
and neuronal survival to synaptogenesis and activity-dependent forms of synaptic 
plasticity (Lewin & Barde, 1996; Huang & Reichardt, 2001). In the mammalian brain, the 
four identified Neurotrophins are: Nerve Growth Factor (NGF), Brain Derived 
Neurotrophic Factor (BDNF), Neurotrophin-3 (NT-3) and Neurotrophin-4 (NT-4), which 
act by binding to two distinct classes of receptor: p75 neurotrophin receptor (p75
NTR
) and 
the Tropomyosin receptor kinase (Trk) family of tyrosine kinase receptors (TrkA, TrkB, 
TrkC) (Dechant, & Barde, 2002; Huang, & Reichardt, 2003; Kaplan, & Miller, 2000; 
Chao, 2003).  
Similar to other proteins, NTs also arise from precursors termed as pro-neurotrophins (30-
35 kDa), which are proteolytically cleaved to produce mature proteins (12-13 kDa) 
(Seidah et al., 1996). Unusually, the pre-neurotrophins are not inactive as they have been 
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shown to bind with high affinity to p75
NTR 
, which was underestimated as a low affinity 
NT receptor. Mature NTs bind to specific Trk receptors with high affinity and to p75NTR 
with low affinity ( Lu, Pang, & Woo, 2005).  
The Trk receptors are transmembrane glycoproteins of ~140 kDa. They are the tyrosine 
kinase receptors containing extracellular immunoglobulin G (IgG) domains for ligand 
binding and a catalytic tyrosine kinase sequence in the intracellular domain. The 
extracellular portion of p75
NTR
 contains four cysteine-rich repeats and the intracellular part 
contains death domain (Chao, 2003) (Figure 22). Whereas the tyrosine kinase domains are 
highly related (80% amino acid identity), the extracellular domains are more divergent 
(30%). Binding of NTs to Trk receptors occurs mainly through IgG domains, with the 
domain closer to transmembrane region playing a prominent role (Perez et al., 1995; Urfer 
et al., 1995; Arevalo et al., 2001). The preferred receptor for NGF is TrkA, TrkB for 
BDNF and TrkC for NT-3 (Barbacid 1994), but these specificities are not absolute as NT-
3 is also a ligand for TrkA and TrkB. 
 
Figure 22. NTs and their receptors: Trk and p75
NTR 
(Chao, 2003)
 
. Each NT receptor has 
its specific affinity towards different NTs, NGF binds to TrkA, BDNF and NT-4 to TrkB, 
and NT-3 to TrkC with high affinity. ProNTs and mature NTs can also bind to p75NTR 
with low affinity. 
Binding of NTs to the Trk receptors leads to receptor dimerization and phosphorylation in 
trans of the receptors, which leads to the recruitment of different adaptors and activation of 
several pathways downstream among which the Shc-Ras-MAPK, Rap-MAPK, PI3K-Akt, 
and PLCγ- PKC pathways are the best studied (Figure 23) (Chao, 2003).  
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Figure 23. Signaling pathways activated upon NT receptor dimerization (Chao, 2003). 
NTs binding to their specific receptors leads to receptor dimerization, activating several 
transduction pathways downstream like MAPK, PI3K, Phospholipase C (PLC-γ) 
(downstream to Trk activation) and NF-κB and JNK (downstream to p75). 
 
These signaling pathways are common for other receptor tyrosine kinases also, but the 
unique combination of Trk receptor docking site, recruitment of different adaptors and 
enzymes results in specific responses for NTs.  Two specific phosphorylated tyrosine 
residues, located in the juxtamembrane domain and in the C terminus (Tyr490 and Tyr785 
in TrkA), serve as docking sites for adapter molecules (Obermeier et al., 1994; Stephens et 
al., 1994). 
On the other hand, p75
NTR
 is the founding member of the TNF (Tumor Necrosis Factor) 
family of receptors. Although it does not have a catalytic intracellular tyrosine kinase 
domain, it is capable of mediating the NT signals. This happens both by modulating TrkA 
signaling and independently of Trks (Kaplan, & Miller, 2000). The ligand binding to 
p75NTR increases the binding to TrkA, enhances TrkA autophosphorylation and the 
selectivity for NT ligands. The Trk-independent pathway of p75
NTR
 increases intracellular 
ceramide levels and further activates NFkB transcription factor (Carter, Lewin, & Delbru, 
1997) and c-Jun N terminal kinase (JNK) (Casaccia-Bonnefil et al., 1996). Conversely, 
TrkA activation can inhibit p75
NTR
-mediated signaling.  
NTs are known for their wide range of roles in the nervous system, including survival, cell 
fate, axon growth and guidance, dendrite structure and pruning and synaptic plasticity 
(Chao, 2003; Park, & Poo, 2013). Here their role in neurite morphogenesis and neuronal 
survival is further discussed.  
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6.1 Role in neurite morphogenesis 
NTs have strong neuritogenic properties, both in neuron development and after injury 
(Boyce, & Mendell, 2014). They have been shown to regulate neuritic outgrowth, 
dendritic and axonal morphology both in vitro (Bosco, & Linden, 1999; Gavazzi et al., 
1999) and in vivo (Coumans et al., 2001; Yip, & So, 2001; Altschuler et al., 1999). 
Following deafening and deafferentiation, NT-3 and BDNF promote axon outgrowth 
within the cochlea (Altschuler et al., 1999). Both NT-3 and BDNF also enhance 
supraspinal axonal outgrowth following spinal cord transection in the adult rat (Coumans 
et al., 2001). The role of NT signaling in axon growth appears to be mediated by an 
increased polymerizationof of F-actin in growth cones and axon shafts, as indicated by 
experiments using NT-3, NGF and BDNF in growth cones of sensory neurons (Paves, & 
Saarma, 1997). In addition, axons in contact with NT-coated beads showed localized 
induction of axonal filopodia rich in F-actin (Gallo, & Letourneau, 1998). Regulation of 
cytoskeletal-associated proteins like ADF/cofilin (Meberg et al., 1998), Rho family 
members like Rac1 and Cdc42 (Gallo, & Letourneau, 2000) downstream of NT signaling 
have also been reported. It has been postulated that NTs regulate axon cytoskeleton by 
binding with their Trk receptors and activation of downstream signaling cascades. 
Classical effectors downstream of Trk signaling implicated in neurite outgrowth are PKA, 
PI3-K and PLC-γ. NGF- mediated neurite outgrowth in PC12 cells have been shown to be 
promoted by the activation of PLC-γ downstream to TrkA (Inagaki, Thoenen, & 
Lindholm, 1995). Also, NT-3 influenced the localization of β-actin to growth cones in a 
manner dependent on the activation of PKA (Zhang, Singer, & Bassell, 1999). 
Furthermore, the increase in axonal sprouting in DRG cultures by NGF-coated beads 
required PI3K and upon treatment with Wortmannin (specific blocker of PI3K) the 
response of NGF was inhibited (Gallo, & Letourneau, 1998). Additional work supports the 
role of PI3K in NGF mediated signaling in neurite outgrowth in PC12 cells (Jackson et al., 
1996) and retinal ganglion cells (Lavie, Dybowski, & Agranoff, 1997). Moreover, NGF 
has been shown to affect axon outgrowth by the localized inactivation of Glycogen 
Synthase Kinase 3β (GSK-3β) downstream to PI3K signaling pathway and MT (+) end 
protein Adenomatous Polyposis Coli (APC) regulation (Zhou et al., 2004). Previous work 
of our group also demonstrated a crosstalk between NTs/Trk signaling and β-catenin 
signaling in axon outgrowth and branching in hippocampal neurons, resulting in the 
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increased phosphorylation of Tyr654 β-catenin upon TrkB and C activation (David et al., 
2008).  
6.2 Role in neuronal survival 
In the PNS 
In vivo experiments of loss or gain of function of NGF demonstrated that NGF is a 
survival factor for sympathetic neurons and a subpopulation of DRG neurons (those 
sensing thermal stimuli that express TrkA receptor) (Ceni et al., 2014). Single allele loss 
of NGF gene reduces the survival of TrkA-expressing DRG neurons, whereas mice 
overexpressing NGF showed increased survival of TrkA expressing neurons, both in wild 
type (Albers, Wright, & Davis, 1994) and NGF null mice (Harrison et al., 2004) 
DRG neurons that sense stimuli from the mechanical displacement of muscle and joints 
express TrkC upon neurogenesis. These neurons and their end organs are lost in NT-3 and 
TrkC mutants (Ernfors et al., 1994; Klein et al., 1994). Their dependence on NT-3 occurs 
before final target innervation, as these neurons die immediately after neurogenesis in NT-
3 null mutants (Farinas et al., 1996).  
In the CNS  
In contrast to PNS, CNS responds to NTs modestly (Huang, & Reichardt, 2001; Rauskolb 
et al., 2010). Except NGF, all the NTs can promote survival of purified motor neurons in 
vivo (Sendtner, Holtmann, & Hughes, 1996). These neurons could however survive if they 
were lacking one of the factors BDNF, NT-3, NT-4/5 in vivo (Conover et al., 1995; 
Ernfors, Lee, & Jaenisch, 1994; Ernfors et al., 1994; Farinas et al., 1994; Jones et al., 
1994). In fact, only 20% deficit occurred in facial and spinal motor neurons from the triple 
mutant mice, lacking NT-3, BDNF and NT-4/5 (Agerman et al., 2000). Surprisingly, mice 
lacking TrkA and C showed only slight reduction in motor neurons, whereas null mice for 
TrkB exhibited a dramatic decline in motor neurons in facial nucleus and lumbar spinal 
cord. Other neurons from forebrain and cholinergic neurons showed alterations in 
neuronal differentiation (Smeyne et al., 1994) in NGF null mice, but perinatal survival was 
not affected.   
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7. Wnt signaling  
The development and specification of different organs and tissues taking place during 
embryonic development is coordinated by signaling molecules known as Morphogens 
which includes Sonic hedgehog (Shh), Transforming Growth Factor β (TGF β), Fibroblast 
Growth Factor (FGF) and Wnt factors. The Wnt signaling pathway is a conserved pathway 
in metazoan animals. The name Wnt is a resultant from a fusion of the name of the 
Drosophila segment polarity gene wingless and the name of the vertebrate homolog, 
integrated or int-1 (Wodarz, & Nusse, 1998). Despite the discovery of Wnt signaling 
about thirty years ago (Nusse, & Varmus, 1982), the first successful purification of a Wnt 
(Wnt-3a) happened two centuries later, which revealed that Wnts are lipid modified 
(Willert et al., 2003) secreted morphogens that regulate cell fate decision, cell polarity and 
embryonic patterning (Parr, & McMahon, 1994; Wodarz, & Nusse, 1998; Nusse, & 
Varmus, 2012). A great deal of evidence has demonstrated their requirement in early 
patterning by acting as posteriorizing signals for neural crest induction (reviewed in 
Mulligan & Cheyette, 2012). In recent years, the critical involvement of Wnt signaling in 
neural circuit development, including regulation of neural precursor proliferation, 
neurogenesis, neuronal migration, axon guidance, synapse formation, dendritic 
development and synaptic plasticity, has come into light (for reviews see Ciani, & Salinas, 
2005; Inestrosa, & Arenas, 2010¸ Toledo, Colombres, & Inestrosa, 2008). The relevance 
of Wnt signaling in brain development and physiology was highlighted by the discovery 
that deregulation of Wnt signaling associates to neurodegenerative diseases, such as 
Alzheimer disease, and to other brain pathologies like schizophrenia and autism (Dickins 
& Salinas, 2013) (discussed later). 
The complexity and specificity in Wnt signaling is in part achieved by the abundance of  
Wnt ligands (nineteen identified; Logan, & Nusse, 2004), which are cysteine-rich proteins 
of approximately 350–400 amino acids that contain an N-terminal signal peptide for 
secretion (He et al., 2004).  Interaction with their Frizzled (Fz) receptors and Low density 
lipoprotein-Related Protein-5/6 (LRP5/6) co-receptors is required to mediate Wnt 
canonical signaling (see below). In addition to the large number of Wnt factors, there are 
ten mammalian Fz proteins, which are seven-transmembrane (7TM) receptors and have 
large extracellular N-terminal cysteine-rich domains (CRD; Bhanot et al., 1996) that 
provide a primary platform for Wnt binding (Dann et al., 2001; Janda et al., 2012). Fzs 
cooperate with a single-pass transmembrane molecule of the LRP family, known as Arrow 
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in Drosophila (Wehrli et al., 2000) and LRP5 and 6 in vertebrates (Pinson et al., 2000; 
Tamai et al., 2000). Regulation of Wnt signaling at the extracellular membrane is also 
modulated by a number of antagonists (Cadigan, & Liu, 2006). Upon Wnt binding to the 
receptor complex, the signal is transmitted to the cytoplasmic phosphoprotein Dishevelled 
(Dvl) and at this level, Wnt signal branches into two main signaling cascades: canonical/β-
catenin signaling and non-canonical/β-catenin independent pathway (Planar Cell Polarity 
and Wnt/Calcium signaling pathways).  
 
7.1 Canonical Wnt/β-catenin pathway 
β-catenin is a central effector of the canonical Wnt signaling pathway, where its 
intracellular levels and phosphorylation status determines the downstream cascade 
(Angers, & Moon, 2009) .  Wnts and the receptors involved in canonical Wnt pathway 
(Wnt-1, Wnt-3a, Wnt-7a) are different from the ones involved in non-canonical Wnt 
pathways (Wnt-4, Wnt-5, Wnt-11) (Angers, & Moon, 2009). Similarly not all the Fz 
proteins are canonical, for example mammalian Fz7 acts both in canonical and non-
canonical Wnt pathway (reviewed in Cadigan & Liu, 2006) , and in flies  Fz1 and Fz2 acts 
redundantly in Wnt/β-catenin signaling (Chen, & Struhl, 1999). At present, there are two 
models for Wnt signaling, the classical one accepted for many years (current Wnt model) 
(Figure 24A) and a new model (proposed by Li et al., 2012) (Figure 24B), both of which 
will be explained here. 
 In the current Wnt canonical model (Figure 24A), when Wnt is absent, β-catenin is 
degraded by the proteasome upon formation of the “destruction complex” (comprising 
Dvl, Axin, APC), β-catenin, casein kinase-1 (CK-1 and Glycogen-Synthase-Kinase-3β 
(GSK-3β). Within this complex, β-catenin is phosphorylated by the Ser/Thr kinases CK-1 
and GSK-3β, which is then recognized by E3 ubiquitin ligase β-transducin repeat-
containing protein (β-TrCP). β-catenin phosphorylation  targets it for proteasomal 
degradation, thus helping to maintain the cytosolic levels of β-catenin low (Salic et al., 
2000; Price, 2006; Wu, & Pan, 2010). When Wnt is present, It binds to Fz and its 
coreceptor LRP5/6. Subsequently, CK-1 binds to the receptor complex, leading to the 
activation of scaffold protein Dvl that recruits APC and Axin to the receptor complex 
(MacDonald, Tamai, & He, 2009; Rosso, & Inestrosa, 2013). Thus, the destruction 
complex is disassembled and GSK-3β is inhibited. Therefore, β-catenin is stabilized, 
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accumulates in the cytosol and translocates to the nucleus (Gordon, & Nusse, 2006). In the 
nucleus, β-catenin associates with Transcription factor T Cell Factor/Lymphoid Enhancing 
Factor (TCF/LEF) and regulates the expression of Wnt targets, including Axin, c-Myc and 
cyclinD1 (Maretzky et al., 2005; Gavert et al., 2007; Clevers, & Nusse, 2012; Gordon, & 
Nusse, 2006) among many other genes (see the “Wnt web page”).  
A new modified model for canonical Wnt signaling was put forward in 2012 (Figure 24B) 
(Li et al., 2012). Here, in the absence of Wnt, the destruction complex residing in the 
cytoplasm binds and phosphorylates β-catenin resulting in the ubiquitination of β-catenin 
by β-TrCP. The proteasome then recycles the complex by degrading β-catenin. When Wnt 
is present, it induces the association of intact complex with phosphorylated LRP. After 
binding to LRP, the destruction complex (including GSK-3β) still captures and 
phosphorylates β-catenin, but β-catenin ubiquination is inhibited. Accumulation of newly 
synthesized β-catenin in the cytosol, results in its nuclear translocation resulting in the 
regulation of Wnt target genes.  
 
 
Figure 24. Canonical Wnt pathway (current and new). (A) Current model: when the Wnt 
is absent, destruction complex stays inact in cytoplasm and results in the Ser/Thr 
phosphorylation of β-catenin, which gets ubiquitinated by β-TrCP and degraded by the 
proteasome system. The presence of Wnt induces the association of axin with 
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phosphorylated LRP-1, leading to the disassembly of the destruction complex and β-
catenin stabilization. (B) In the new model (Li et al., 2012) absence of Wnt lets destruction 
complex free to phosphorylate β-catenin, which is degraded through the proteasome, 
followed by recycling of destruction complex. In the presence of Wnt, it induces 
association of the destruction complex to LRP and the receptor complex, where β-catenin 
is still phosphorylated. A pool of newly synthesized β-catenin accumulates in the 
cytoplasm followed by its translocation to nucleus and transcriptional regulation of target 
genes. 
Finally, another model proposes that upon Wnt signaling activation, GSK-3β and the “Wnt 
signalosome” (comprising LRP5/6, Axin and Dvl) are internalized into acidic vesicles/ 
multivesicular bodies, in which the enzymatic activity of GSK-3β is inhibited (Taelman et 
al., 2010; Vinyoles et al., 2014), therefore allowing β-catenin accumulation.  
7.2 Non- Canonical/β-catenin independent Wnt pathways 
There are two β-catenin independent pathways: the Planar Cell Polarity pathway 
(Wnt/PCP or Wnt/JNK pathway) and the Calcium pathway (Wnt/Ca
2+
 pathway) (Angers, 
& Moon, 2009), both initiating upon Wnt binding to its receptor Fz and alternate single 
transmembrane receptor tyrosine kinases (RTKs) Ror1/2 and Ryk (Van Amerongen,  
Mikels, & Nusse, 2008) 
a. Planar Cell Polarity pathway  
In this pathway (Figure 25, left branch), a Wnt ligand binds to its receptors and activates 
the scaffolding protein Dv1, followed by activation of Rho/Rac small GTPase and c-Jun-
N-terminal kinase (JNK), leading to changes in both actin and MT reorganization 
(Gordon, & Nusse, 2006; Rosso et al., 2005; Yamanaka et al., 2002). This pathway is 
responsible for asymmetric distribution of cytoskeleton and cell polarization (Huelsken, & 
Held, 2009).  
b. Wnt/Ca
2+
 pathway  
In this signaling cascade (Figure 25, right), Wnt binding to its receptors Fz and RTK leads 
to the production of IP3 and DAG from membrane-bound phospholipid phosphatidyl 
inositol 4,5-bisphosphate via the action of membrane-bound enzyme phospholipase-C 
(PLC). Intracellular levels of Ca
2+ 
 increased, resulting in the activation of Ca
2+ 
 sensitive 
kinases like Ca
2+ 
/Calmodulin-dependent protein kinase II (Camk II) and Protein Kinase C 
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(PKC), which further activates the nuclear translocation of transcription factors: Nuclear 
Factor of Activated T cells (NFAT) and cAMP Response Element-Binding protein 
(CREB) (Oliva,Vargas, & Inestrosa, 2013; Kohn, & Moon, 2005; Montcouquiol, 
Crenshaw, & Kelley, 2006). In CNS, this pathway has so far been associated with axon 
outgrowth and guidance, dendrite development, and synapse function (Ciani et al, 2011; 
Hutchins, Li,  & Kalil, 2011, 2012; Li, Hutchins, & Kalil, 2009; Varela-Nallar et al,  
2010). 
 
 
Figure 25. Planar cell polarity (PCP) and Wnt/Ca
2+ 
 Pathway (Wan et al., 2014). In the 
PCP pathway, Wnt binding to Fz activates the scaffolding by activation of Rho GTPases 
(Rho and Rac) and JNK, which leads to changes in actin and MT reorganization. In the 
Wnt/Ca
2+ 
 Pathway, Wnt binding to DVL, releases intracellular Ca
2+ 
 and activates Ca
2+ 
/Calmodulin-dependent protein kinase II (Camk II) and protein kinase C (PKC).  
7.3 Wnt signaling in neurodegenerative diseases. 
Dysfunctional Wnt signaling has been related to a number of neurological disorders 
including autism, schizophrenia, bipolar disorders, Alzheimer’s disease (AD) and 
Parkinson’s disease (Inestrosa, & Arenas, 2010; Okerlund, & Cheyette, 2011). The 
common feature shared by these neurological disorders is aberrant synapse function, 
disassembly of which often precedes or even triggers neuronal death (a hallmark of many 
neurodegenerative disorders) (Saxena, & Caroni, 2007; Rosen, & Stevens, 2010; Kessels, 
Nabavi, & Malinow, 2013). AD is a degenerative disorder characterized by progressive 
deterioration of cognitive functions caused by synaptic dysfunction and damage of specific 
brain regions (Mattson, 2004; Toledo, Colombres, & Inestrosa, 2008). More than a decade 
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ago, a voice in favour of a strong relationship between an impaired Wnt signaling and 
neuronal damage in AD was raised (De Ferrari and Inestrosa, 2000; Inestrosa et al., 2000; 
Garrido et al., 2002; De Ferrari et al., 2003; Inestrosa, &  Arenas, 2010). A number of 
studies have now demonstrated alterations in Wnt signaling components in AD  (Zhang et 
al., 1998; Inestrosa et al., 2002; Caricasole et al., 2004; Ghanevati, & Miller, 2005; De 
Ferrari et al., 2007; Magdesian et al., 2008) including β-catenin (Zhang et al., 1998), 
overexpression of the Wnt antagonist Dkk-1 (Caricasole et al., 2004; Rosi et al., 2010; 
Purro, Dickins, & Salinas, 2012), LRP5/6 (Caricasole et al., 2004; Killick et al., 2012) in 
addition to the pivotal role of GSK3β that is known to phosphorylate Tau (Alvarez et al., 
2004). Also Apo-lipoprotein E (apoE) allele 4, which has been linked to the increased risk 
for AD, has been shown to inhibit canonical Wnt signaling upon stimulation with Wnt-7a 
(Caruso et al., 2006).  
  
7.4 Wnt signaling in neurite morphogenesis 
Canonical Wnt-3a and Wnt-7a affect axon morphogenesis by targeting MTs. Loss of Wnt-
7a or its effector Dvl causes defects in terminal remodeling of axons in vivo, leading to 
defective recruitment of proteins to the synapse and alterations in synaptic function 
(Ahmad-Annuar et al., 2006; Hall et al., 2000) (Figure 26A). Wnt-3 increases axon 
branching and growth cone size in NT-3 responsive sensory neurons, but not in NGF 
responsive sensory neurones (Krylova et al., 2002) (Figure 26B).  
 
Figure 26. Wnts regulate the behavior of axons (Ciani, & Salinas, 2005). (a) Wnts 
function as the retrograde signals, which are released by the target for the modulation of 
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axon behavior. Here Wnts inhibit axon extension but enhanced growth cone size and 
branching, with regulation of MTs dynamics and reorganization. (b)Wnt-3, released by 
spinal lateral motor neurons (green) located at the limb levels, regulates the arborization 
and presynaptic differentiation of NT-3 sensory neurons (red) but not NGF-responsive 
ones (blue). 
Wnt-3a increases neurite outgrowth in DRG explants (Lu et al., 2004) and spinal neurons 
(David, Cantí, & Herreros, 2010). Wnt-3a decreases the speed of growth cone while 
increasing the growth cone size, a behaviour of growth cones typically observed in the 
proximity of target cells during synapse formation (Purro et al., 2008). In this process, Dvl 
increases MT stability by locally inhibiting GSK-3β and MAP1B (Ciani et al., 2004). 
Indeed, many protein regulators of cytoskeleton dynamics like MAP1B, Tau, MAP2 
(Berling et al., 1994; Lucas et al., 1998) and APC (Zumbrunn et al., 2001; Zhou et al., 
2004) are targets of GSK3β. Phosphorylation of these proteins by GSK3β affects MT 
stability (Gonazalez-Billault et al., 2004; Zhou et al., 2004; Baas, & Qiang, 2005), which 
might contribute to axon specification and growth. In addition, Wnt signaling regulates 
MTs by removing APC from the MT + plus at growth cones, leading to MT looping and 
increased growth cone size (Purro et al., 2008). On the other hand, Wnt-5a (non canonical) 
promotes axon outgrowth and branching in developing sympathetic neurons by regulating 
the expression of NGF (Bodmer et al., 2009). Wnt-5a promotes axon morphogenesis in 
hippocampal neurons also, but with Dvl and atypical protein kinase C (aPKC) (in complex 
with PAR3 and PAR6) as the downstream effectors (Zhang et al., 2007), where Wnt-5a 
effect on axonal differentiation was attenuated upon the inhibition of Dvl or aPKC. Wnt-
5a has been shown to promote axon outgrowth as well as repulsion axon guidance cue in 
cortical neurons by acting through distinct Wnt receptors (Ryk and Fz) and different 
calcium signaling pathways (IP3 and Transient receptor potential channels (TRP)) (Li, 
Hutchins, & Kalil, 2009). Similar to this, a novel role of Wnt/Ca
2+ 
 implicates Wnt-5a 
through regulation of calpain and calcium activity in the forward movement of growth 
cones (Yang et al., 2011). 
Since evidences accumulated in support of the role of Wnt signaling in axon 
morphogenesis, several studies also started coming up pointing to the role of Wnts in the 
regulation of the dendritic tree morphology (reviewed in Rosso, & Inestrosa, 2013). The 
first study in this field, postulated that β-catenin was critical for the dendritic morphology 
(Yu, & Malenka, 2003). Neuronal activity in cultured hippocampal neurons enhances 
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dendritic complexity by increasing Wnt-2 expression, mediated by Ca
2+
signaling 
(Wayman et al., 2006). Wnt-7a has been demonstrated to promote excitatory synapse 
formation by inducing the formation and growth of dendritic spines, which was deficient 
in the CA1 and CA3 regions of the hippocampus of Wnt-7a or Dvl mutant mice (Ciani et 
al., 2011). Although the mechanism by which Wnt-7a acts remains to be elucidated, it was 
proven that spine growth is induced through Dvl1 and local  activation of CaMKII at 
dendritic spines (Ciani et al., 2011). Also, in hippocampal neurons Wnt-7b/Dvl signaling 
has been shown to be involved in modulation of dendritic outgrowth and branching 
through changes in the activity of Rho GTPases and JNK (Rosso et al., 2005) (Figure 27).  
 
Figure 27. Wnt signaling regulates dendritic morphogenesis (Ciani, & Salinas, 2005). 
On the left, figure is showing the regulation of dendritic outgrowth and branching through 
Wnts, either in an paracrine manner (released from an incoming axons (green)) or 
autocrine manner (released by the responding neuron (orange)) the involvement of PCP 
pathway through Dvl, Rac and JNK in stimulation of growth and branching of dendrites. 
Upon Wnt binding to its receptor, PCP pathway involving Dvl, Rac and JNK, regulates 
dendritic morphogenesis by cytoskeleton regulation (right). 
Therefore, this Wnt/Dvl regulation of dendritic morphogenesis was “non-canonical” as the 
activation of GSK3β or inhibition of β-catenin was not involved (Rosso et al., 2005). 
8. β-catenin signaling  
β-catenin is a multifunctional protein that plays an essential role in cell-cell adhesion, Wnt 
signaling  and the centrosome cycle (Figure 28). Although its role in cell-cell adhesion and 
Wnt signaling (Nelson, & Nusse, 2004) has been extensively demonstrated, its function at 
the centrosome is poorly understood.  
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Figure 28. β-catenin involvement in cell adhesion, Wnt signaling and centrosome 
(Mbom, Nelson, & Barth, 2013). The figure is illustrating the presence of β-catenin at 
cell-cell contacts (associated to Cadherins and α-catenin), cytoplasm (involved in the 
destruction complex that controls its degradation), nucleus (acting as a cotranscritional 
activator of TCF/LEF) and centrosome (associated to other Wnt pathway components), 
suggesting a crosstalk between these distinct pools of β-catenin. 
 
In the late 1980’s, β-catenin was independently discovered based on its different functions 
structural and signaling by the group of Rolf Kemler. It was isolated together with two 
other molecules: α-catenin and γ-catenin, as proteins associated with E-cadherin  (Valenta, 
Hausmann, & Basler, 2012). The signaling ability of β-catenin was revealed through its 
Drosophila orthologue Armadillo, discovered in the seminal screens for mutations 
affecting segmentation of the Drosophila embryo (Wieschaus, Nüsslein-Volhard, & 
Jürgens, 1984). Further analysis of Armadillo revealed the conservation of its structural 
function in adherens junction (McCrea, Turck, & Gumbiner, 1990; Peifer, & Wieschaus, 
1990; Orsulic, & Peifer, 1996). Epistatic analysis later divulged Armadillo segmentation 
function regulation by Wingless (Riggleman, Schedl, & Wieschaus, 1990), which was a 
major breakthrough for describing the Wnt/β-catenin signaling pathway. In 1990’s the 
signaling function of β-catenin in the nucleus mediated by TCF/LEF transcription factors 
was demonstrated (Behrens et al., 1996; Huber et al., 1996).  
How can a single molecule mediate so many different pathways? The answer lies behind 
its structural conformation (Figure 29). β-catenin has a central armadillo (arm) repeat 
domain spanning 141 to 664 residues composed of 12 imperfect armadillo repeats. Each 
arm repeat of the central region comprises ~42 residues, which form three helices arranged 
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in triangular shape. The 12 contiguous repeats form a superhelix that features a positive 
charged groove, serving binding sites for many of the β-catenin binding partners. The N-
terminal region refuges the binding sites for α-catenin as well as GSK3β (at Ser33 and 
Ser37) (Meggy et al., 2005a,b; Wu et al., 2003) and CK-1, which are recognized by β-
TrCP ubiquitin ligase (Hart et al., 1999; Kitagawa et al., 1999). The N and C terminal 
domains are trypsin sensitive, hence are structurally flexible leaving the rigid scaffold for 
central domain (Huber, Nelson,  & Weis, 1997), which serve as an interaction platform for 
many binding partners of β-catenin, in the cytosol and nucleus (Huber,  Nelson,  & Weis, 
1997). 
 
Figure 29. The interaction domains of β-catenin. GSK3β phosphorylates β-catenin at 
Ser33/37, recognized by β-TrCP as ubiquitination sites; α-catenin binds at the N terminal 
and the first two armadillo repeats; central domain (in yellow colour) harbors the binding 
sites for APC, TCF/LEF-1 and E-cadherin. The position of two main tyrosine 
phosphorylation sites (Tyr142 and Tyr654) on β-catenin are indicated by the arrows. 
8.1 β-catenin regulation during cell-cell adhesion 
The majority of β-catenin is located in the cytoplasm as a component of cadherin based 
cell-cell junction in the absence of Wnt. These cadherin based cell junctions are important 
to form polarized epithelial tissues, which is necessary to maintain the organism integrity 
(Meng, & Takeichi, 2009). Cadherins are single pass transmembrane glycoproteins 
engaged in Ca
2+
 dependent homotypic interactions through their extracellular regions. 
They are named based upon their tissue location like E-Cadherin (Epithelial Cadherin). 
The newly synthesized E-cadherin associates with β-catenin (in a region comprising Tyr 
654 on the C-terminal domain of β-catenin), thus protecting β-catenin from the destruction 
complex (involved in β-catenin dependent Wnt signaling) (Figure 30) (Huber, & Weis, 
2001).  
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In the cell-cell adhesion complex, β-catenin also binds to α-catenin, in a region at the N-
terminus of β-catenin including Tyr142 (Pokutta, & Weis, 2000; Xing et al., 2008). 
Binding of α-catenin stabilizes β-catenin in the hinged form such that E-cadherin can bind 
simultaneously (Pokutta, & Weis, 2000; Huber, & Weis, 2001). In fact the β-catenin 
binding site on α-catenin and α-catenin’s homodimerization interface overlaps with each 
other, hence α-catenin can bind to β-catenin only as a monomer (Drees et al., 2005; 
Yamada et al., 2005). As a homodimer (when α-catenin cannot bind to β-catenin), α-
catenin interacts with actin and promotes bundling of actin filaments (Benjamin et al., 
2010). Therefore, binding of α-catenin to the cadherin complex negatively regulates actin 
polymerization mediated by α-catenin (Yamada et al., 2005).  
β-catenin function can be regulated through tyrosine phosphorylation. Of particular 
importance in this work are Tyr142 in the first armadillo repeat and Tyr654 in the last 
armadillo repeat. The region of β-catenin including Tyr142 is crucial for α-catenin binding 
(Piedra et al., 2003; Pokutta, & Weis, 2000; Brembeck et al., 2004). β-catenin 
phosphorylated at Tyr142 (PTyr142 β-cat) by Fyn, Fer or the RTK Met significantly 
reduces α-catenin binding and detaches PTyr142 β-cat from the adhesion complex, 
resulting in reduced cell adhesion and increased cell migration (Piedra et al., 2003; 
Brembeck et al., 2004; Bustos et al., 2006). PTyr142 β-cat translocates to nucleus, where it 
binds to cofactors like BCL9-2/Legless and TCF4 resulting in increased transcription  in 
epithelial cells and in neurons (Brembeck et al., 2004; David et al., 2008) (Figure 30).  
On the other hand, Tyr654 phosphorylation also reduces adhesion by interfering with the 
binding to cadherin and has been reported to enhance β-catenin mediated transcription 
(Piedra et al., 2001). In neurons, β-catenin phosphorylation at Tyr654, induces the 
detachment of β-catenin from N-cadherin. PTyr654 β-cat was found associated to the actin 
and MT cytoskeleton at growth cones, leading to the promotion of axon growth and 
branching (David et al., 2008; Figure 30).   
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Figure 30. Model for β-catenin tyrosine phosphorylation downstream of growth factor 
signaling in axon outgrowth and branching (David et al., 2008).  β-catenin (β)  
phosphorylation at Tyr142 upon HGF-Met signaling induces the detachment of  β-catenin 
from the adhesion complex and targets it to nucleus, where it regulates TCF4-mediated 
transcription to promote axon morphogenesis. On the contrary, activatation of NT-Trk 
signaling results in the phosphorylation of β-catenin at Tyr654, detaching it from N-
cadherin (N) that then associates to the cytoskeleton to promote axon outgrowth and 
branching. Tyr indicates Tyrosine; P is Phospho 
Regarding the involvement of β-catenin in neural progenitor migration, coupling of 
migration and neurogenesis is severely disrupted by the absence of β-catenin (Fancy et al., 
2009; Feigenson et al., 2009; Ye et al., 2009; Yang et al., 2012; Dai et al., 2014). β-catenin 
conditional inactivation in the mouse cortex and hippocampus leads to abnormalities in the 
organization of the neuroepithelium, which include disrupted interkinetic nuclear 
migration, loss of adherens junctions, impaired radial migration of neurons toward 
superficial layers and decreased cell proliferation (Machon et al., 2003). β-catenin plays a 
critical role deciding whether cortical progenitors should continue proliferating or 
differentiate (Zechner et al., 2003; Woodhead et al., 2006). In β-catenin overexpression, 
progenitor cells exit the cell cycle less frequently and continue to proliferate (Zechner et 
al., 2003). On the contrary, β-catenin depletion causes cortical progenitors to prematurely 
exit cell cycle and to differentiate into neurons that migrate to the cortical plate 
(Woodhead et al., 2006).  
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In glial cells, a role of β-catenin in wound-healing in astrocytes was related to the 
acquisition of an astrocytoma phenotype (Yang et al., 2012). In was shown that upon 
creating a wound in an astrocyte monolayer, destabilization of the cadherin-catenin 
complexes occurs, involving phosphorylation of Ser675 β-catenin that would to 
translocate to the nucleus and induce a malignant phenotype (Yang et al., 2012). 
8.2 β-catenin signaling in neurite morphogenesis 
Previous work from our group linked β-catenin dissociated from the adhesion complex to 
the promotion of axon outgrowth (“axon migration”) (David et al., 2008), where it was 
demonstrated that stimulation of Trks and Met by NTs and HGF induces the 
phosphorylatation of β-catenin at Tyr654 and Tyr142, respectively, in hippocampal 
neurons leading to promotion of axon outgrowth. Axon morphogenesis promoted by 
PTyr654 β-cat was TCF4-independent and likely involves cytoskeletal regulation (David 
et al., 2008). In contrast, HGF/Met signaling induced β-catenin phosphorylation at Tyr142, 
leading to the nuclear translocation of β-catenin and promoting axon outgrowth and 
branching by a TCF4-dependent transcriptional mechanism (David et al., 2008). 
In hippocampal neurons, β-catenin (as a component of the adhesion complex) has been 
acclaimed as a critical mediator of dendritic morphology, where its overexpression was 
shown to increase dendritic arborization through the interaction with N-cadherin and α-
Ncatenin (neural α-catenin) (Yu, & Malenka, 2003). Sequestering of endogenous β-
catenin or the addition of DKK-1 (Dickkopf-1, extracellular antagonist of Wnt) was shown 
to block the dendritogenic effect of depolarization by high K
+
, suggesting that Wnt 
expression regulation by neuronal activity in turn modulated dendritic arborization via β-
catenin (Yu, & Malenka, 2003). Conditional knock out of β-catenin from new-born 
neurons in post-natal hippocampal DG lead to defects in dendritic morphology such that 
neurons could not extend proper dendrites and resulting in neuronal death (Gao et al., 
2007). Depolarization critically increases the pool of  β-catenin at dendritic spine synapses 
by regulating the phosphorylation of Tyr654 β-cat, which when dephosphorylated 
associates tighly to cadherins to influence synaptic size and strength (Murase, Mosser, & 
Schuman, 2002). 
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9. Chemokines and chemokine receptors 
Chemokines (short term for chemoattractant cytokines) belong to a superfamily of small 
(8-14 kDa) secreted proteins, best known for their ability to regulate leukocyte migration 
during inflammatory responses. They have been highly conserved during evolution, 
indicated by sequence homology of chemokines expressed in mammals, birds and fish 
(reviewed in Cartier et al., 2005). Till date more than 50 chemokines have been identified 
(Rossi, & Zlotnik, 2000; Murphy et al., 2000; Murphy, 2002). Chemokines can be divided 
into subfamilies according to the position of a pair of cysteines located near the N 
terminus of each protein (Rossi & Zlotnik, 2000; Proudfoot, 2002; Proudfoot et al., 2002) 
as CXC, CC, C, and CX3C chemokines (Figure 31). Less commonly, these subfamilies 
are also referred to as the α, β γ and δ chemokines, respectively. CXC, CC and CX3C 
chemokines have four conserved cysteines, whereas C chemokines have only two, which 
correspond to the second and fourth cysteines present in the other groups. The first two 
cysteines in the CC chemokines are adjacent, whereas in the CXC and CX3C chemokines 
they are separated by one (CXC) or three (CX3C) amino acids. Considering their roles in 
the immune system, chemokines have also been classified as inflammatory and 
homeostatic (reviewed in Sallusto, Mackay, & Lanzavecchia, 2000). Inflammatory 
chemokines like CCL5 and CXCL2, which are expressed in inflamed tissue in response to 
pro-inflammatory cytokines or to pathogens recruit effector cells (monocytes, 
granulocytes and effector T cells), whereas homeostatic chemokines like CXCL12  are 
constitutively expressed in different environments within tissues and are involved in 
trafficking of cells that belong to adaptive immune system.  
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Figure 31. The different subfamilies of chemokine receptors and chemokine ligands 
(adapted from Tran, & Miller, 2003). Table listing the chemokines divided into different 
subfamilies (α, β, γ and δ ). It includes their “systematic name” as well as “common 
name” along with their receptor. Chemokines in the focus of this thesis work have been 
marked with the arrows. C- Cysteine residue and X - Amino acid. 
 
Chemokines carry out their functions by interaction with G protein-coupled receptors 
(GPCR’s), which are members of a superfamily of seven-transmembrane domain receptors 
(TM 1-7) that mediate intracellular signals through heterotrimeric GTP-binding proteins 
(Figure 32). In GPCR’s, the seven transmembrane domains are preceeded by an 
extracellular (ECL 1-3) and intracellular loops (three of each) and followed by an 
intracellular C-terminal domain. 
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Figure 32. Structure of chemokine receptor (Fernandez, & Lolis, 2002) showing N-
terminal, seven transmembrane domains (TM 1-7), extracellular domains (ECL 1-3) and 
intracellular loops (folds). 
The chemokine receptors have been classified as CC, CXC, XC or CX3C according to 
the chemokine class by which they are activated, followed by the letter “R” denoting 
receptor (as opposed to “L” in the case of the chemokine ligand). Nineteen chemokine 
receptors have been known so far, including six CXC receptors, ten CC receptors and two 
single receptor each for CX3CL1 and CXCL1 chemokines. It should be noted, as 
illustrated in Figure 31, that many chemokines can bind to several receptors and that 
chemokine receptors usually act as such for more than one chemokine. 
Chemokine binding to the corresponding receptor results in the activation of G proteins, 
which leads to the dissociation of the G protein heterotrimer into its α and βγ subunits 
(Figure 33). Activation of phosphatidyl-inositol specific Phospholipase C (PLC β2 and β3) 
leads to the generation of DAG and IP3, which upon binding to its specific receptor in the 
endoplasmic reticulum, triggers Ca
2+
 release from intracellular stores. DAG, in 
conjunction with Ca
2+
, activates various PKC enzymes (Figure 33). Temporary Ca
2+
 
elevation is the best characterized effect of chemokine stimulation and it has been widely 
used to study functional expression of chemokine receptors for a variety of chemokines 
(Bajetto et al., 1999; Boutet et al., 2001; Gillard et al., 2002). 
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Figure 33. Signaling pathways downstream to chemokine receptor activation along with 
the effects promoted (Cartier et al., 2005). AC: adenylyl cyclase; DAG: diacylglycerol; 
ERK1/2: extracellular signal-regulated kinase; IP3: inositol triphosphate; PI-3K: 
phosphoinositide 3-kinase; PKB-Akt: protein kinase B; PKC: protein kinase C; PLC: 
phospholipase C; PTX: pertussis toxin; PYK2: proline-rich tyrosine kinase 2. 
 
Chemokine-induced activation of P13K has also been described (Figure 33) (Sotsios et al., 
1999; Thelen, Uguccioni, & Bosiger, 1995) and knock out experiments in mice (Hirsch et 
al., 2000; Sasaki et al., 2000) have revealed it to be centrally involved in the cellular 
responses to chemokines, including cell polarization and chemotaxis.  
Several chemokines have been reported to activate Mitogen-Activated Protein Kinase 
(MAPK) cascade involving Extracellular signal-Regulated Kinase (ERK)-1/2 (Ganju et 
al., 1998; Knall, 1996; Bajetto et al., 2001;Wang & Richmond, 2001) and the calcium 
dependent-protein kinase Pyk2 (Del Corno et al., 2001; Dutt, Wang, & Groopman, 1998; 
Hatch et al., 1998) (Figure 33).  
Chemokine function in immune cell trafficking both in pathological and physiological 
conditions is well documented (Baggiolini, 1998; Moser, & Loetscher, 2001; Rot, & 
Andrian, 2004). Importantly, chemokine expression in the CNS links to their crucial roles 
in brain development, synaptic transmission and injury. Indeed, chemokine signaling has 
been specifically involved in neurogenesis, neuronal migration and axon elongation and 
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branching (Charo, & Ransohoff, 2006;  Ubogu et al., 2006; Bertollini et al., 2006; Lysko 
et al., 2011; Pujol et al., 2005, Yang et al., 2013; Edman, Mira, & Arenas, 2008; Edman et 
al., 2008). In this work, chemokines have been studied in the context of axon outgrowth, 
so the focus here will be restricted to it and briefly in connection to brain injury. 
9.1 Chemokines in brain injury 
Chemokine expression have been mainly observed in different glial cell types during CNS 
injury, amongst which the chemokines studied in this work- CXCL2 (Pineau et al., 2009; 
Ma et al., 2002; Szmydynger-Chodobska et al., 2009), CCL5 (Rice at al., 2007; Benton et 
al., 2008; Stefini et al., 2008), CCL7 (Ma et al., 2002; Helmy et al., 2009; Wang et al., 
1999), CCL20 (Mc Tigue et al., 1998; Terao et al., 2009).  
CXCR2 ligands (CXCL2, one amongst eight other members of CXC family) recruit 
neutrophils, expressing the CXCR2 receptor to the site of CNS injury, which is in 
agreement with the report demonstrating less recruitment of neutrophils to the injury site, 
less tissue damage and neuronal apoptosis in CXCR2 deficient mice (Semple et al., 2010) 
thus indicating CXCR2 antagonism as a beneficial therapy in posttraumatic inflammation.  
On the other hand, there are mixed views regarding a beneficial role of CCL5 and its 
receptors (CCR1, CCR3 and CCR5) (Braunersreuther et al., 2007) in the damaged CNS.  
Not only CCL5 but also CCR5 is upregulated in astrocytes, microglia, endothelial cells 
and neurons following CNS injury (Spleiss et al., 1998; Tripathy et al., 2010a, b). Its 
detrimental effects involves increased cerebral damage by secondary induction of pro-
inflammatory cytokines like Interleukin-6 (Shahrara et al., 2006), whereas beneficial ones 
include neuronal protection and survival (Tripathy et al., 2010a, b) and protection from 
excitotoxic NMDA-induced apoptosis (Eugenin et al., 2003). Furthermore, the interaction 
of CCL20 with CCR6 has been described to attract inflammatory monocytes and activate 
microglia, contributing to neuroinflammation followed by brain injury (Terao et al., 2009). 
In sum, a huge amount of information is now available regarding chemokine expression, 
regulation and signaling upon injury or stroke. Several therapeutic paradigms with 
chemokines in experimental CNS trauma models of spinal cord injury and traumatic brain 
injury have shown improvements in axon outgrowth, which might facilitate the 
development of therapies in CNS repair (Jaerve & Müller, 2012). Finally, the 
chemoattractant function of chemokines can be exploited as a thereapeutic intervention in 
neuroinflammation by suppressing or changing the course of infiltration of inflammatory 
cells. The success of chemokines in clinical transfer, however, depends on the elucidation 
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of their cell-subtype-specific action and cellular signaling pathways in CNS injury in order 
to identify selective drug targets. 
9.2 Chemokines in neurite morphogenesis 
Until recently not a lot of reports involved chemokine signaling in neurite outgrowth. 
Among the chemokines reported to be involved in neurite outgrowth there is mainly 
CXCL12/SDF-1 (Pujol, Kitabgi, & Boudin, 2005; Lysko, Putt, & Golden, 2011; Opatz et 
al., 2009).  Other works implicated CCL2, CCL5 and CCL7 (Edman, Mira, & Arenas, 
2008; Chou et al., 2008). CXCL12 and its receptors (CXCR4 and CXCR7) promote 
neurite outgrowth by overcoming myelin proteins induced inhibition (Opatz et al., 2009), 
which is among the major hindrance to the neuronal impair in the injured adult 
mammalian CNS (Filbin, 2003; Schwab et al.,2005). CXCL12 reduces axon elongation, 
but increases axonal branching in hippocampal neurons (Pujol, Kitabgi, & Boudin, 2005). 
CXCL12 has also been shown to modulate the branching of the leading process of 
interneurons, affecting the speed of migration (Lysko, Putt, & Golden, 2011). CXCL12 
reduces the branching frequency of the leading process, thus maintaining the stream 
migration of neuroblasts from the ventral ganglionic eminence. In contrast, blocking 
CXCL12 leads to increase in the branching frequency, stream exit and cortical plate 
invasion ( Lysko, Putt, & Golden, 2011). In addition, CCL2 and CCL7 have been 
identified as pro-differentiation factors, promoting neuritogenesis in midbrain 
dopaminergic neurons (Edman, Mira, & Arenas, 2008). Defects in transcription and 
release of CCL5 from astrocytes has been reported to contribute to neuronal dysfunction in 
Huntington’s disease (HD) (Chou et al., 2008). In the same work, a correlation between 
the amount of secreted CCL5 and neurite maturity (quantified as the differences in the 
length of neurites as well the number of sprouted branches) in primary cortical neurons 
was also demonstrated (Chou et al., 2008). 
9.3 Chemokine involvement in neural and non-neural migration 
Besides chemokines well studied roles in the immune system, chemokines and their 
receptors are expressed by a variety of cell types in the CNS, where they are clearly 
involved in neuronal migration (Mélik- Parsadaniantz, & Rostène, 2008; Mithal, Banisadr, 
& Miller, 2012; Zhu, & Murakami, 2012). Projection neurons in the intermediate zone 
(IZ)/SVZ of the cortex express CXCL12 (Stumm, & Höllt, 2007; Tiveron et al., 2006) that 
controls the tangential migration of CXCR4-expressing GABAergic interneurons (López-
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Bendito et al., 2008; Tiveron et al., 2006). In addition, CXCL12 is persistently expressed 
in the meninges (Paredes et al., 2006; Stumm et al., 2007), where it also regulates the 
tangential migration of GABAergic interneurons (López-Bendito  et al., 2008) and hem-
derived Cajal-Retzius cells throughout the marginal zone of the cortex (Borrell, & Marín, 
2006; Paredes et al., 2006). CXCL12/CXCR4 signaling is also responsible for the 
migration, assembly and positioning of cerebellar granule, Purkinje (Ma et al., 1998), 
precerebellar (Zhu et al., 2009) and olfactory neurons (Miyasaka, Knaut, & Yoshihara, 
2007), as well as facial motoneurons (Sapède et al., 2005). Moreover, CXCL12 signaling 
involving  both CXCR4 and CXCR7 is required for guiding the cortical interneurons 
(Wang et al., 2011; Abe et al., 2014; Sánchez-Alcañiz et al., 2011), whereas CXCL12 and 
CXCR4 regulate the initial trajectory of ventral motoneurons (Lieberam et al., 2005) and 
axon pathfinding of retinal ganglion cells and olfactory neurons (Li et al., 2005; Miyasaka, 
Knaut, & Yoshihara, 2007). Similarly, the migration and final position of trigeminal and 
DRG cells, as well as their target innervation, also require CXCL12/CXCR4 (Balabanian 
et al., 2005; Knaut et al., 2005; Odemis et al., 2005). Thus, CXCL12/CXCR4 signaling 
regulates the three key processes essential for the establishment of neural networks in 
different neuronal systems: neuronal migration, cell positioning and axon wiring.  
In cancer, a list of chemokines and their receptors are expressed and endogenously 
produced by tumor cells, including CXCL7 and CXCR1/CXCR2, CCL5 and CXCL12 
among others (Karatsu et al., 1993; Desbaillets et al., 1994, 1997; Barnes, Jones,  & Perez, 
1997; Zhou et al., 2002; Barbero et al., 2003). Amongst all the chemokines, 
CXCL12/CXCR4 has been studied in glioma cell invasion (Zhou et al., 2002; Bajetto et 
al., 2006; Zhang, Sarkar, & Yong,  2005; Ehtesham et al., 2006) , thus highlighting the 
role of chemokines in migration during development and in pathology.  
10.1 Role of centrosome in migration: centrosome reorientation 
In this work, centrosome positioning has been studied using primary rat astrocytes as the 
cell model, so the mechanism involved in this cell type is discussed. Centrosome re-
orientation has been studied in vitro using wound-healing assay where astrocytes are 
grown to reach confluency, followed by formation of a scratch. Astrocytes migrate 
towards the wound created in the monolayer by extending pseudopodium-like structure 
and re-orienting the centrosome and Golgi towards the wound (Etienne-Manneville & 
Hall, 2001). In astrocytes, centrosome re-orientation banks upon integrin stimulated 
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activity of the Rho-GTPase Cdc42, which regulates signaling from cell-surface receptors 
to actin and MT cytoskeleton (Raftopoulou, & Hall, 2004) (Figure 34). At the leading 
edge, Cdc42 recruits and activates mPar6-PKC complex, which phosphorylates and 
inactivates GSK-3β. GSK-3β inactivation causes APC bound to MT plus-end to bind to 
MT minus-end, thus facilitating MT capture at the leading edge by dynein (Etienne-
Manneville & Hall, 2001; Palazzo et al., 2001). The MT minus end motor activity of 
dynein, pulls captured MTs towards the leading edge and orients centrosome within the 
protrusion into the wound.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34. Proposed model for Centrosome positioning mechanism (Higginbotham & 
Gleeson, 2007). Through Cdc42 in the leading process, guidance cues stimulate actin 
(purple ovals) polymerization. The par complex is targetted by Cdc42 to the leading edge, 
where it phosphorylates and inactivates GSK3β resulting in APC binding to MT ends and 
stabilization of them. IQGAP1 is the link between actin and plus end MT proteins like 
APC. Pulling force on MTs, which orients centrosome within the leading process, is done 
by LIS1anddyenein  
 
A similar mechanism for centrosomal position applies to the process of cell migration and 
neurogenesis in the cerebral cortex  (Higginbotham, & Gleeson, 2007). 
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10.2 Wnt/β-catenin signaling at centrosome 
β-catenin’s recognition as a regulator of centrosome function came from the experiments, 
where its overexpression resulted in centrosome disorganization and loss of cortical 
anchoring of MTs (Ligon et al., 2001). Total β-catenin levels follow very well 
synchronized changes during different stages of the cell cycle in non-transformed 
epithelial cells, demonstrating an increase in S-phase, followed by maximum at late G2/M 
and an abrupt reduction in G1 (Olmeda, Castel, & Cano, 2003). Nevertheless, β-catenin 
levels do not appear to change significantly in cancer cell lines (Hadjihannas et al., 2012). 
The involvement of β-catenin in recruiting γ-tubulin to centrosomes has been pointed out, 
since the depletion of β-catenin inhibits MT nucleation (Huang, Senga, & Hamaguchi, 
2007) and β-catenin null neuronal progenitors lack γ-tubulin containing centrosome or  
MT network (Chilov et al., 2011). β-catenin siRNA expression suppresses the astral MT 
organization, an effect that was mimicked by the GSK-3β inhibitor, lithium chloride  
(Huang, Senga, & Hamaguchi, 2007). In addition, expression of stabilized mutant β-
catenin, which mimics mutations found in cancer, results in extra non-microtubule 
nucleating structures that contain a subset of centrosome proteins including γ-tubulin and 
centrin (Bahmanyar et al., 2010). These results indicate that β-catenin is required for 
centrosome amplification, and mutations in β-catenin might contribute to the formation of 
alterations of centrosomes observed in cancers (Bahmanyar et al., 2010). Regarding the 
establishment of bipolar mitotic spindle, loss of β-catenin leads to increased number of 
cells with monopolar spindles (Kaplan et al., 2004). Finally, a role for β-catenin regulating 
centrosome separation during mitosis has also been demonstrated, where activation of the 
Ser/Thr kinase Nek2 (by Polo-like kinase 1, Plk1) results in the phosphorylation of 
centriolar linker proteins Rootletin and C-Nap1 (centrosomal Nek2-associated protein 1), 
which is thought to cause the separation of centrosomes (Bahmanyar et al., 2008). β-
catenin binds to and is phosphorylated by Nek2, and is in a complex with Rootletin. In 
interphase, β-catenin colocalizes with Rootletin at the proximal end of centrioles. 
However, in mitosis, when Nek2 activity increases, β-catenin localizes to centrosomes at 
spindle poles independent of Rootletin. Increased Nek2 activity disrupts the interaction of 
Rootletin with centrosomes and results in binding of β-catenin to Rootletin-independent 
sites on centrosomes, an event that is required for centrosome separation (Bahmanyar et 
al., 2008) (Figure 35).  
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Figure 35. β-catenin and its interactor molecules at centrosome (Mbom, Nelson, & 
Barth, 2013). During G2/M transition (left), Nek2 phosphorylates the centrosome linker 
proteins C-Nap1 and Rootletin, resulting into centrosomes separation and bipolar spindle 
formation, in parallel with the increased expression of β-catenin at centrosome (especially 
during the centrosome seperation). PLK1 works as the upstream factor to Nek2 during 
this phase. During the spindle positioning (right), β-catenin gets involved in cortical 
anchoring of MTs in complex with dynein, and PLK1 negatively regulates the dynein-
dynactin complex at the cell cortex, ensuring the proper spindle positioning. This way 
centrosomes are separated and mitotic spindle formation takes place.  
Interestingly, expression of stabilized forms of  β-catenin (lacking N-terminal regions that 
regulate its degradation, thus showing longer life-times at centrosomes) leads to increasing 
distance between centrioles/centrosomes and higher number of cells with separared (split) 
centrosomes, as similarly found for Nek2A overexpression (Bahmanyar et al., 2008). 
These results indicate that like Nek2, β-catenin is a negative regulator of centrosome 
cohesion. 
Apart from total β-catenin, phosphorylated β-catenin has also been reported at the 
centrosome. β-catenin phosphorylated at Ser33/Ser37/Thr41 (phospho-β-catenin), which 
should be targeted for degradation by the proteasome in the canonical Wnt signalling 
 Introduction 
 
79 
 
pathway, accumulates in the centrosome. This form localizes preferentially to mother 
centrosome during interphase and is recruited to daughter centrosome during mitosis 
(Huang, Senga, & Hamaguchi, 2007). Expression of non-phosphorytable β-catenin 
mutants (Ser33Ala) cause disruption in MT regrowth and MT array, whereas 
overexpressing phospho-mimetic mutants of β-catenin (Ser33/Ser37/Thr41 mutated to 
Glu) leads to multiple centrosomes and aberrant denser radial MT arrays  (Huang, Senga, 
& Hamaguchi, 2007). 
Interestingly, phospho-β-catenin increases during cell cycle in synchronized cells and 
remains associated to the centrosome during mitosis (Huang, Senga, & Hamaguchi, 2007; 
Hadjihannas, Brückner, & Behrens, 2010). The levels of phosphoSer/Thr β-catenin 
parallel those of axin/conductin2, a negative regulator of Wnt signalling (Hadjihannas, 
Brückner, & Behrens, 2010) and are involved in centrosome cohesion. Conductin/axin2 
levels peak at G2/M followed by a rapid decline during return to G1. In line with this, 
Wnt/β-catenin target genes are low at G2/M and high at G1/S, and β-catenin 
phosphorylation oscillates during the cell cycle in a conductin dependent manner 
(Hadjihannas, Brückner, & Behrens, 2010). In the proposed model, Wnt signaling and 
dephospho-Ser/Thr β-catenin thus promote centrosome separation or splitting 
(Hadjihannas, Brückner, & Behrens, 2010). 
In neuronal progenitor cells, reduced levels of phospho-Ser/Thr β-catenin affected the 
orientation of the mitotic spindle, increased asymmetric cell divisions and caused 
premature differentiation, highlighthing a function for centrosomal phospho-Ser/Thr β-
catenin in maintaining MT and the polarity in neuronal progenitors (Chilov et al., 2011). 
Wnt signaling components modulate different aspects of mitosis like MT dynamics, 
spindle formation and centrosome division by localizing to centrosome. GSK-3β 
influences MT dynamics as its long term inhibition abolishes MT growth similar to axin 
ablation. On the contrary, its short term inhibition accelerates reorganization of MTs 
(Huang, Senga, & Hamaguchi, 2007). This results in stabilization of the MTs and mitotic 
spindle (Wakefield, Stephens, & Tavare, 2003; Fumoto, Hoogenraad, & Kikuchi, 2006) by 
reducing the phosphorylation of MT associated proteins (Hanger et al., 1992; Fumoto, 
Hoogenraad, & Kikuchi, 2006 ). 
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Interestingly, in addition to β-catenin, APC, Axin and other Wnt pathway components like 
GSK-3β localize to the centrosome (Olmeda, Castel, & Cano, 2003; Mbom, Nelson, & 
Barth, 2013) and regulate mitotic progression. Axin1 is involved in MT nucleation at the 
centrosome (Fumoto et al., 2009). In addition, GSK-3β, Axin2 and APC regulate mitotic 
spindle positioning and chromosome segregation (Tighe et al., 2007; Fodde et al., 2001; 
Hadjihannas et al., 2006), which in case of mutations in APC causes chromosome 
instability by impairing the linkage between MTs and kinetochores (Fodde at al., 2001). In 
a similar way, Dvl in collaboration with Fzd and LRP6 coreceptors are important to 
establish spindle orientation (Kikuchi et al., 2010). 
B. Glioblastoma multiforme 
Any tumor arising from the the glial cells or the supportive tissue in brain is called 
“Glioma”. Gliomas are the most common type of primary brain tumors, which are 
classified histologically and immunohistochemically as astrocytomas, oligodendrogliomas 
and oligoastrocytomas (sharing features of both astrocytes and oligodendrocytes). The 
incidence rate of primary brain tumors worldwide is approximately seven per 100,000 
individuals per year (Huang et al., 2007). 
The World Health Organization (WHO) classified the CNS tumors based on the 
malignancy as on a scale of I to IV (StLouis et al., 1999; Kleihues, Burger, & Scheithauer, 
1993). Grade I tumors are benign in nature which can be cured if surgically removed. 
Grade II astrocytoma tumors are characterized as low-malignant, but their diffuse 
infiltration render them incurable by surgery. Grade III Anaplastic astrocytoma exhibits 
increased anaplasia and proliferation over Grade II, and the Grade IV Glioblastoma 
multiforme (GBM), which is the most devastating and malignant astrocytic glioma is 
characterized by a high degree of cellularity, vascular proliferation, tumor cell 
chemoresistance and necrosis (Ohgaki, & Kleihues, 2005a, b). GBM is nowadays 
considered an incurable malignancy even after aggressive chemotherapy and neurosurgical 
resection (Denysenko et al., 2010). On the basis of clinical presentation, GBM is 
subdivided into primary and secondary GBM (Figure 36). Primary GBMs accounts the 
majority of cases in older patients with no evidence of prior symptoms or antecedent lower 
grade pathology whereas, secondary GBMs are the rare ones accounting for occurrence in 
patients below the age of 45 years and around 70% of cases are derived from the 
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progressive transformation of lower grade astrocytoma like grade II transforming into 
grade III/IV.   
The existence of brain tumor stem cells was proposed a decade ago, followed by the the 
advances in the stem cell field and the discovery of adult neurogenesis (Vescovi, Galli, & 
Reynolds, 2006; Ignatova et al., 2002; Gu, Janoschka, & Ge, 2013). GBM have been 
characterized by Glioma initiating cells (GICs, a type of cancer cells), exhibiting common 
features of neural stem cells including: the expression of CD133 (prominin), neurosphere 
forming ability and the reproduction of tumors (Singh et al., 2003, 2004). GBM, like any 
other cancer is characterized by genetic instability and complex alterations in chromosome 
structure and copy number. The somatic copy number alterations found in malignant 
gliomas include broad or regional alterations spanning segments or whole arms of entire 
chromosomes as well as focal events involving one or a few genes. A great amount of 
information compiled recruiting advanced techniques like Genomic Identification of 
Significant Targets in Cancer (GISTIC) (Beroukhim et al. 2007; Mermel et al. 2011) and 
Genomic Topography Scan (GTS) (Wiedemeyer et al. 2008), came out with somatically 
mutated genes that include TP53 (42%), PTEN (33%), Neurofibromatosis-1 (NF1) (21%), 
EGFR (18%), RB1 (11%), PIK3R1 (10%), and PIK3CA (7%) (Figure 36). Some of these 
mutations are more abundant in particular subclasses of GBMs (proneural, neural, 
classical and mesenchymal) (Verhaak et al., 2010).  
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Figure 36. Chromosomal and genetic aberrations underlying GBM (Furnari et al., 
2007). Figure shows the relationship between survival, pathobiology and the underlying 
molecular pathways in Grade II and III astrocytomas and leading to the formation of 
primary (de novo) and secondary (progressive) GBMs. (OE) Overexpressed; (amp) 
amplified; (mut) mutated. 
The comprehensive studies on genomics of GBM, revealed a set of core signaling 
pathways activated in GBM which are: the P53 pathway, the Retinoblastoma (RB) 
pathway and RTK/Ras/PI3K pathway (TCGA, 2008; Parsons et al., 2008). These 
pathways exhibit the majority of mutations, which enhance cell proliferation and survival, 
allowing the tumor to escape from cell cycle checkpoints, senescence and apoptosis. 
Specifically, p53 signaling was impaired in 87% of the samples through CDKN2A 
deletion (49%), MDM2 (14%) and MDM4 (7%) amplification, and mutation and deletion 
of TP53 (35%). Likewise, Rb signaling was impaired in 78% of the samples through 
CDKN2 family deletion; amplification of CDK4 (18%), CDK6 (1%), and CCND2 (2%); 
and mutation or deletion of RB1 (11%). Finally, evidence of RTK/RAS/PI3K activation 
was found in 88% of tumors, including contributions from unexpected mutations or 
deletions in NF1 (18%) and PIK3R1.  
Mutations in tumor suppressor gene neurofibromatosis type-1 (NF1) have been reported to 
increase the incidence of malignant glioma (Zhu et al., 2005). In addition to the core 
signaling pathways, heterozygous deletion of NFKB inhibitor A (NFKBIA) gene was also 
observed to be present in a quarter of GBM samples (Bredel et al., 2011).  
The information deduced from the efforts put forward to get into more details regarding 
the GBM over two decades characterized six intracellular events occuring in combination 
to cause and sustain GBM (Nakada et al., 2011). The very first event is the cell cycle 
control, where glioma cells develop various means for evading the cell cycle control so as 
to get the growth benefit. Alteration in atleast one of the component of (CDK)-4/RB 
pathway has been reported in anaplastic astrocyoma and the majority of gliomas. Second 
event involves the overexpression of growth factor and their receptors, amongst which 
Epidermal Growth Factor Receptor (EGFR) and Platelet-Derived Growth Factor Receptor 
(PDGFR) are best characterized. Other events include angiogenesis (formation of new 
blood vessels from the exisiting ones), involving growth factors like Vascular Endothelial 
Growth Factor (VEGF); invasion and migration, abnormality of apoptosis and genomic 
instability. 
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1. Epithelial-mesenchymal transition (EMT) in tumor invasion 
EMT, described first by Elizabeth Hay in chick primitive streak (Hay, 1995) is a 
biological process which allows a polarized epithelial cell to undergo the biochemical 
changes to assume the mesenchymal phenotype, which includes enhanced migratory 
capacity, invasiveness, elevated resistance to apoptosis and increased production of ECM 
components (Kalluri, & Neilson, 2003). This transition from epithelial to mesencymal 
phenotype is important during embyogenesis and organ development, tissue repair and 
pathological stress and in initiating the invasive and metastatic behavior of epithelial 
cancers (Kalluri & Weinberg, 2009). The reverse process-mesenchymal epithelial 
transition (MET) involving the conversion of mesenchymal cells to epithelial derivatives 
also occurs, which is associated with kidney formation (Lipschutz, 1998; Rothenpieler, & 
Dressler, 1993). 
EMT is clearly associated with tumor progression and metastasis. Uncontrolled epithelial 
cell proliferation and angiogenesis marks the initiation and early growth of primary 
epithelial cancers (Hanahan, & Weinberg, 2000). Many studies proposed EMT activation 
as the critical requisite to acquire the malignant phenotype by epithelial cancer cells 
(Thiery, 2002). The most convincing report regarding the EMTs in cancer came from the 
observation that EMT-derived migratory cancer cells establishes the secondary colonies at 
distant sites, resembling histopathologically primary tumors from which they arose 
(Kalluri, & Weinberg, 2009). Cancer cells undergo MET after extravasation into the 
parenchyma of distant organ because of the absence of heterotypic signals which were 
responsible for the induction of EMT in primary tumor (Thiery, 2002; Jechlinger, Grunert, 
& Beug, 2002; Bissell et al., 2002). Summarizing these reports, leads one to consider the 
induction of EMT to be central for the progression of carcinomas to metastatic stage and 
embroil MET for the further colonization process (Figure 37). 
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Figure 37. EMT contribution to cancer progression (Kalluri, & Weinberg, 2009). The 
development from normal epithelium to invasive carcinoma proceeds through several 
stages, which initiates when epithelial cells loose their polarity and detache from 
basement membrane and involves alteration in ECM-interactions and signaling networks. 
This is followed by an angiogenic switch, facilitating malignancy and enabling cancer 
cells to enter the circulation and exit the blood stream at a remote site, where they may 
form micro and macro-metastases. This may also involve METs (reversion to the epithelial 
phenotype) 
Studies have reported HGF, EGF, PDGF and TGF-β (Transforming Growth Factor) as 
EMT-inducing signals and identified EMT transcription factors, notably Snail,  Slug, Zinc 
finger E-box Binding homeobox1 (ZEB1), Twist, Goosecoid and FOXC2 (Thiery, 2002; 
Jechlinger, Grunert, & Beug, 2002; Shi, & Massague, 2003; Niessen, 2008; Medici, Hay, 
& Olsen, 2008; Kokudo et al., 2008). The respective signaling pathways involved are 
ERK, MAPK, Akt, Smads, RhoB, β-catenin, LEF, Ras and c-Fos as well as cell surface 
proteins, like β4 integrins, α5β integrin and αVβ integrin (Tse, & Kalluri, 2007).  
Apart from the mentioned factors, disruption of cell-cell adherens junctions and the cell-
ECM adhesions mediated by the integrins also activate EMT (Yang,  & Weinberg, 2008; 
Gupta et al., 2005; Mani et al., 2008; Hartwell et al., 2006). The concept in favour of the 
link between E-cadherin loss by cancer cells and induction of EMT has been well 
established (Tepass et al., 2000; Edelman et al., 1983). Reorganization of cell-cell 
adhesion complexes and suppression of proliferation occurs when cytoplasmic portion of 
E-cadherin (containing β-catenin binding site) is expressed, forcing cells to loose the 
mesencymal phenotype (Eger et al., 2000; Reichmann et al., 1992). Hence, association of 
β-catenin to Cadherin in cytoplasm is important for the preservation of epithelial features 
of cancer cells and, in contrast, its movement to the nucleus (associated with the loss of E-
cadherin) implies acquisition of an invasive phenotype (Kim, Lu, & Hay, 2002; Thiery, 
2002). 
2. Wnt signaling in GBM  
The aberrant activation of canonical Wnt signaling pathway in variety of tumors (Polakis, 
2000; Reya, & Clevers, 2005) did not come as surprise after the discovery of its crucial 
involvement in the induction of self renewal properties in embryonic stem cells (ESCs) 
and adult stem cell regulation (Reya, & Clevers, 2005; Wend et al., 2010; Inestrosa, & 
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Arenas, 2010). Wnt-target genes thus include ESC genes – Nanog, Oct-4, Sox-2 and c-
Myc- that have been mentioned for their association with both poorly differentiated as 
well as aggressive GBM (Ben-Porath et al., 2008). PLAGL2 (a novel protooncogene) 
promotes GICs proliferation and gliomagenesis by enhancing the expression of Wnt-6, Fz-
9 and Fz-2 (Zheng et al., 2010).  
Wnt pathway components (Dvl-3, FRAT-1, Pygo-2, TCF3 and Lef-1) (Sareddy et al., 
2009; Wang et al., 2010; Guo et al., 2010) and target genes (cyclin D1 and c-myc) 
(Sareddy et al., 2009; Liu et al., 2010) show increased expression in high grade 
astrocytoma and GBM (Figure 38) and have been involved in glioma proliferation. 
Keeping aside canonical Wnts, the role of non-canonical Wnt-5a has also been 
demonstrated in U251 cell line in regards to stimulation of cell proliferation (Yu et al., 
2007). Silencing β-catenin, Wnt-2 and Pygo (Pygopus)-2 affected proliferation of U251 
cell line in a negative manner (Wang et al., 2010; Pu et al., 2009). Apart from the 
association of Wnt members with glioma, expression of Wnt antagonists, including tumor 
suppressor Wnt Inhibitory Factor (WIF) have also been shown to be reduced in 
astrocytomas, linked to aberrant promoter hypermethylation (Yang et al., 2010). In 
addition, hypermethylation of sFRP and DKK (two more Wnt antagonists) has been linked 
to primary and secondary GBM, respectively (Gotze et al., 2010). 
Consistent with the role of non-canonical Wnt-5a in invasion and metastasis in other 
cancers (Pukrop et al., 2006; Weeraratna et al., 2002; Moon et al., 2004), Wnt-5a also 
enhances glioma cell migration by regulating Matrix Metalloproteinase (MMP)-2 
expression (Kamino et al., 2011), and its silencing reduces glioma cell invasion in U251 
glioma cell line (Pu et al., 2009; Kamino et al., 2011) 
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Figure 38. Wnt/β-catenin and β-catenin signaling in glioma cells (Nager et al., 2012). 
Absence (A) and presence (B) of Wnt influences β-catenin localization in the nucleus, 
followed by the transcription of Wnt target genes (as described in figure 24). The box 
shows the Wnt target genes implicated in proliferation and invasion of glioma cells or 
conferring ES cell signature to GICs (related to aggressive growth and recurrence). Text 
in red indicates Wnt pathway components that are overexpressed and green indicates Wnt 
antagonists repressed in high-grade astrocytomas and GBM. Wnt factors and Fz that have 
been reported to be upregulated in high-grade astrocytomas and GBM are shown in the 
figure. 
 
3. β-catenin signaling in GBM 
β-catenin has been proposed as a prognostic marker of malignancy in GBM at both mRNA 
and protein levels, which increase in high- grade astrocytomas as well as GBM (Sareddy 
et al., 2009; Liu et al., 2010, 2011).  
In GICs, protooncogene PLAGL2’s amplification correlates with increase in β-catenin 
levels in GBM (Zheng et al., 2010). Also PEG3 (paternally expressed gene 3 with tumor 
suppressing activity) (Jiang et al., 2010) and transcription factor Forkhead box M1 (Zhang 
et al., 2011) both utilize β-catenin in promoting proliferation and maintainance of GICs. 
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β-catenin has been reported as an important component of adherent junctions where it 
binds with E-cadherin and modulates cell-cell adhesion and migration (Clevers, 2006). 
The role of β-catenin in facilitating EMT of tumor cells is well described (Sánchez-Tilló et 
al., 2011; Schmalhofer, Brabletz, & Brabletz, 2009) (Figure 39).   
 
Figure 39. β-catenin in EMT (Dietrich, & Kaina, 2010). Figure is showing cell-cell 
adhesion in the epithelial phenotype, mediated by the interactions of β-catenin and E-
cadherin (left). Upon the overexpression of master regulators of EMT like Snail and Slug, 
leads to the association of β-catenin to the transcription factors (TF) of the TCF/LEF 
family in the nucleus, resulting in the induction of transcription of proliferative and 
mesenchymal genes and a mesenchymal phenotype. 
However, signals for the nuclear translocation of β-catenin in tumor development are not 
only conveyed by Wnt factors (Lu, & Hunter, 2004), but also by growth factor/RTK 
signaling. Phosphorylation of β-catenin at specific tyrosine residues is expected to increase 
migration (Lilien, & Balsamo, 2005; David et al., 2008). One such example is EGF/EGFR 
signaling, where via ERK 1/2 and casein kinase -2 (CK-2), α-catenin is phosphorylated at 
Ser 641 thus promoting β-catenin transactivation and glioma cell invasion (Ji et al., 2009).  
4. HGF and Met signaling in GBM 
HGF and Met are expressed in a variety of tumors, with their higher levels correlating 
with poor prognosis (Birchmeier et al., 2003). The implication of HGF/Met signaling in 
glioma is based upon the findings that their expression positively correlated with the 
glioma grade with the coexpression of HGF/Met more prevalent in high grade gliomas 
(Koochekpour et al., 1997; Moriyama et al., 1998; Rosen et al., 1996). HGF gene transfer 
to glioma cells enhanced their tumorigenecity, tumor growth and angiogenesis (Laterra et 
al., 1997a, b) and its inhibition lead to reduction of in vivo tumor formation and growth 
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(Abounader et al., 1999, 2002). These evidences were further confirmed by both 
overexpression (Abounader et al., 2004; Laterra et al., 1997a, b) as well as loss of function 
experiments (Abounader et al., 1999, 2002) for HGF and Met.  
Cellular level visualizes the effects of HGF/Met pathway on glioma by induction of cell 
cycle progression; tumor cell migration, invasion and angiogenesis; and tumor apoptosis 
inhibition (Abounader, & Laterra, 2005) (Figure 40 ).  
 
Figure 40. Met-induced cell scattering and invasion (Birchmeier et al., 2003). Figure 
depicts HGF-induced scattering and invasion of epithelial cells. In the absence of HGF, 
epithelial cells adhere to each other, are polarized and form tight cell sheets (left). Upon 
HGF treatment, epithelial cells decrease cell-cell adhesion, assume a mesenchymal 
morphology, express mesenchymal markers and detach from the neighbouring cells (right, 
top). When HGF-treated cells are grown on top of a collagen matrix, they migrate and 
invade the extracellular matrix (right, bottom).   
HGF induced proliferation has been shown in many brain tumor cell lines including those 
derived from glioma, medulloblastomas and neuroblastoma (Abounader et al., 2004; 
Hecht et al., 2004; Koochekpour et al., 1997). Beyond its name, HGF is now recognized as 
an essential organotrophic factor in almost all tissues (Nakamura, & Nizuno, 2010). It 
induces mitogenic, motogenic and morphogenic activities in various types of cells via its 
functional receptor, Met (Bottaro et al., 1991; Higuchi et al., 1992). As a component with 
mitogenic ability, HGF/Met activation allows the cells to escape G1/G0 arrest and alters 
multiple cell cycle regulators like p27, phosphor-Rb, E2F-1 and c-myc (Walter et al., 
2002). Furthermore, HGF have been identified as the most potent stimulator of glioma cell 
migration (Brockmann et al., 2003) with the supporting evidence demonstrating high 
content of HGF in extracts in brain tumor cyst fluid and brain tumor tissue and 
neutralizing antibodies against HGF reducing glioma cell migration upto 50% (Lamszus et 
al., 1998).  
Another mode by which HGF/Met signaling contributes to malignancy is inhibition of 
tumor cell death and apoptosis. Activation of HGF/Met signaling along with PI3K and Akt 
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dependent pathways have been shown to protect GBM cells and tumor xenografts from 
DNA-damaging agents (Bowers et al., 2000), which was further confirmed by inhibiting 
HGF and Met in vivo (Abounader et al., 2002).  
5. Centrosomal alterations in GBM 
The connection between centrosomal abnormalities and cancer has been proposed since 
long (Boveri, 1914) and had been observed in different types of cancers accompanied by 
extensive chromosome aberrations (D’Assoro et al., 2002; Pihan et al., 2003). Although 
genetic and epigenetic changes resulting in mitotic dysregulation has been recognised in 
many types of cancer cells (Wang et al., 2004b), only countable number of studies 
described it in glioma (Dietzmann et al., 2001; Roymans et al., 2001; Reichardt et al., 
2003; Klein et al., 2004; Katsetos et al., 2006; Saito et al., 2008). Centrosomes are 
regulated by many mitotic kinases like Aurora kinase A (AurA), Polo-like kinase 1 (Plk1) 
and Cyclin dependent kinase 1 (Cdk1) (Nigg, & Stearns, 2011), the inhibitors of which 
have been implicated as potential cancer therapeutics (Harrison, Holen, & Liu, 2009) . 
Plk1 is overexpressed in glioma (Dietzmann et al., 2001) and its inhibition for the 
selective killing of glioma stem cells enriched populations have been strategic (Lee et al., 
2012); AurA overexpression has been shown in GBM (Loh et al., 2010; Lehman et al., 
2012) and its expression levels have been correlated with prognosis (Barton et al., 2010). 
Apart from this, centrosome positioning in considered to determine cell polarity, which is 
widely disturbed in tumor cells (Humbert et al., 2003; Iden, & Collard, 2008). N-cadherin 
regulates centrosome reorientation in astrocytes, as the silencing of N-cadherin does not 
allow centrosomes to reorient in the direction of the wound in glioma cells (Camand et al., 
2012). 
6. Spleen tyrosine kinase (Syk) 
Syk along with Zeta-activated protein of 70kDa (ZAP-70) constitutes an autonomous 
family of non-receptor tyrosine kinases (Zhu et al., 2007). It was first identified as a 40 
kDa proteolytic fragment derived from a p72 tyrosine kinase present in spleen, thymus and 
lungs (Zioncheck et al., 1998). Originally cloned from porcine spleen (Taniguchi et al., 
1991), it has been studied intensively in hematopoietic cells (B and T lymphocytes, natural 
killer cells, mast cells, macrophages and platelets) (Sada et al., 2001). Recently, Syk 
expression has also been detected in other cell types including hepatocytes, fibroblasts, 
endothelial cells and neuronal cells, depicting it as as ubiquitinous signaling molecule 
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(Yanagi et al., 2001). Apart from its presence in cytoplasm and plasma membrane (Ma et 
al., 2001; de Virgilio et al., 2004; Stupack et al., 1999), Syk is also present in nucleus, 
where it affects transcription (Wang et al., 2005). Syk at adherens junctions  influences 
intercellular adhesion (Larive et al., 2009; Zhang et al., 2009) and in centrosomes, it 
affects cell division (Zyss et al., 2005; Sulimenko et al., 2006; Uckun et al., 2010; Xue et 
al., 2012).  
Structurally, Syk is composed of two adjacent Src homology 2 (SH2) domains and a 
kinase domain interrupted by two interdomains A and B  (Coopman, & Mueller, 2006) 
(Figure 41). SH2 domains are the structural motifs that bind phospho-tyrosine to promote 
protein-protein interactions (Liu et al., 2006). Each of the SH2 domains of Syk binds 
proteins containing the sequence pYXXL/I, where pY is phosphotyrosine, L and I are 
leucine and isoleucine respectively, and X denotes any amino acid. These SH2 domains 
are juxtaposed in such an orientation that allows them to interact simultaneously as a 
linker sequence, which contains two of these pYXXL/I cassettes separated by 6-10 amino 
acids (Fütterer et al., 1998). These high-affinity Syk-binding sites are known as 
immunoreceptor tyrosine-based activation motifs (ITAMs) because they are present in 
many receptors that are important in immune cells (Abram, & Lowell, 2007).  
 
Figure 41.   Structure of spleen tyrosine kinase (Syk) protein (Pamuk, & Tsokos, 2010). 
Syk consists of two tandem SH2 domains and a tyrosine kinase domain. There are two 
interdomains A and B, where A lies between the two SH2 domains and B is between 
between C-terminal SH2 domain and the tyrosine kinase domain. Ligands for Syk 
activation are diphosphorylated ITAM of immunoreceptors, which binds to SH2 domains 
(N and C). 
Syk is activated on the binding of its tandem SH2 domains to biphosphorylated 
immunoreceptor tyrosine-based activation motifs present in the intracellular part of 
immunoreceptors, leading to its autophosphorylation and phosphorylation of its effectors 
(Coopman, & Mueller, 2006). Signals from the Syk-immunoreceptor complex are 
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transmitted further through the phosphorylation of adaptor proteins such as B cell linker 
(BLNK)/ SLP-65 (SH2 domain leukocyte-specific phosphoprotein 65 kDa), SLP-76, and 
LAT (linker for activation of T cells) (Mócsai, Ruland, & Tybulewicz, 2010; Yablonski, & 
Weiss, 2001). When phosphorylated, these proteins serve as scaffolds to which effectors 
dock with SH2 or other related phosphotyrosine-binding motifs. Effectors include 
members of the Tec-family of tyrosine kinases, lipid kinases, phospholipases and guanine 
nucleotide exchange factors that further propagate the signal allowing for the activation of 
multiple pathways including PI3K/Akt, Ras/ ERK, PLC/ NFAT, Vav-1/Rac, and the IKK/ 
NF-kB pathway (Geahlen, 2009; Mócsai, Ruland, & Tybulewicz, 2010). 
Syk has been implicated in the pathogenesis of hematological malignancies including B-
lineage leukemias and lymphomas; autoimmune, allergic and neoplastic disorders 
(D’Cruz, & Uckun, 2012; Pamuk & Tsokos, 2010). In addition, Syk has been associated 
with tumor biology. Its ecotopic expression in breast cancer (Coopman et al., 2000; 
Toyoma et al., 2003; Moroni et al., 2004), melanoma (Hoeller et al., 2005) and pancreatic 
adenocarcinoma (Layton et al., 2009) cells inhibits motility and metastasis (Sung et al., 
2009) and therefore a tumor suppressor role was assigned (Coopman et al., 2000). 
Carcinomas exhibiting reduced Syk levels have also been documented, including classic 
Hodgkin lymphoma (Ushmorov et al., 2006), gastric (Wang et al., 2004a), ovarian 
(Dhillon et al., 2004), urinary bladder (Kunze, Krassenkova, & Fayyazi, 2008), 
hepatocellular (Yuan et al., 2006), oral squamous (Ogane et al., 2009) and cervical cancer 
(Zhao et al., 2010). Although the level of Syk expression alone is not prognostic for breast 
cancer survival, a signature set of Syk “interacting” genes effectively predicts patient 
outcome (Blancato et al., 2014). 
Syk is also a mitotic kinase that localizes to the centrosome and interacts with the key 
centrosomal component γ-tubulin and affects mitotic progression, by regulating γ-tubulin 
mediated MT (Zyss et al., 2005; He et al., 2002), yet another way of its involvement in 
cancer. Its overexpression has been reported to lead to abnormal multipolar mitotic 
spindles and multinucleated cells (Coopman et al., 2000; Moroni et al., 2004), which may 
be due to Syk hyperactivity at centrosomes (Zyss et al., 2005). Suppression of tumor 
growth by the reintroduction of Syk in athymic mice due to aberrant mitosis and 
cytokinesis has been described in a legendary work by Coopman and collegues, where 
overexpression of wild-type Syk in a Syk negative breast cancer cell line inhibits tumor 
growth and metastasis. Tumor growth is reverted back upon overexpression of kinase-
deficient Syk in Syk-positive breast cancer cell line (Coopman et al., 2000). Results from 
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the same group demonstrated that Syk is a centrosomal kinase, the centrosomal levels of 
which drop for the normal progression of mitosis and abnormal cell division state is 
adquired upon the sustained expression of Syk (Zyss et al., 2005).  
The downstream signaling events modulated by activated Syk are still under investigation, 
but activation of PI3K/Akt pathway is a likely contributor. Acute myeloid leukemia and B 
cell lymphomas involves the activation of mechanistic target of rapamycin (mTOR), 
which lies downstream of Akt, correlated with presence of activated Syk (Carnevale et al., 
2013; Leseux et al., 2006). Both retinoblastoma and B-cell chronic lymphocytic leukemia 
shows elevation in Syk expressing cells due to PKCδ and PI3K/Akt pathway (Baudot et 
al., 2009; Zhang et al., 2012; Gobessi et al., 2009). In diffuse large B cell lymphoma, Syk 
and Akt promotes B Cell Receptor (BCR) signaling by repressing the expression of pro-
apoptotic protein Harakiri and upregulating of cholesterol biosynthesis (Chen et al., 2013). 
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β-catenin is a key component of the cell-cell adhesion complex,  a critical Wnt effector in 
the Wnt canonical pathway (Nelson & Nusse, 2004) and a component of the centrosome 
(Kaplan et al., 2004; Mbom, Nelson, & Barth, 2013). In the Wnt canonical pathway, β-
catenin translocates to the nucleus and activates transcription of Wnt targets. Modulation 
of β-catenin at the adhesion complex is achieved in part by Tyrosine phosphorylation of β-
catenin, which results in decreased adhesion and increased cell migration. Our group 
demonstrated that PhosphoTyrosine142 β-catenin (PTyr142 β-cat) is induced by HGF/Met 
signaling during axon outgrowth in hippocampal neurons (David et al., 2008). In this 
context, PTyr142 β-cat translocates to the nucleus and may regulate expression of genes 
involved in cell migration. Here, on one hand, I studied the involvement of 
HGF/Met/PTyr142 β-cat axis in axon outgrowth by identifying which are the target genes 
regulating axon morphogenesis.   
On the other hand, β-catenin has been found at centrosomes and its phosphorylation in 
Ser/Thr acts by maintaining centrosome cohesion (Bahmanyar et al., 2008). On the 
contrary, β-catenin dephosphorylated on Ser/Thr and Wnt signaling activation promotes 
centrosome separation (Hadjihannas, Brückner, & Behrens, 2010), which is required 
during mitosis. I investigated the localization of PTyr142 β-cat at the centrosome and 
aimed at identifying the kinase(s) responsible(s) for maintaining this phosphorylated form 
at the centrosome.  
The summarized objectives therefore are: 
1. To investigate the target genes regulated downstream of HGF/Met and β-catenin 
signaling during axon morphogenesis in hippocampal neurons. 
1.1. Role of the identified target genes (i.e., chemokines) in axon morphogenesis in 
hippocampal neurons. 
 Role of recombinant chemokines in axon morphogenesis. 
 Effects of blocking chemokine signaling (chemokine receptor antagonists and anti-
chemokine antibodies).  
1.2. To study chemokine expression by HGF and β-catenin/TCF signaling.  
1.3. To study a possible involvement of chemokines in dorsal root ganglia neurite 
outgrowth. 
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2. To investigate the localization of PTyr142 β-cat at the centrosome.  
2.1. To study the localization of PTyr142 β-cat in unsynchronized cells and in mitosis, 
using different fixation protocols. 
2.2. To explore the role of β-catenin in the mechanism of cell migration and  
centrosome re-orientation during migration. 
2.3. To search for the tyrosine kinases that could be associated to the centrosome and 
may be responsible for phosphorylating PTyr142 β-cat at the centrosome (Met and 
Syk). 
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Table 1. Reagents 
 
 
 
 
 
Product category Product and manufacturer’s details 
 
 
 
 
 
 
Tissue culture 
reagents 
All reagents were purchased from Invitrogen: 
 Minimum Essential Media.         
 Dulbecco´s Modified Eagle Medium containing 4.5 g/l and 
1 g/l glucose. 
 Neurobasal media. 
 Hank’s balanced salt solution. 
 Opti-MEM. 
 Glutamine. 
 Sodium pyruvate. 
 Horse serum. 
 Foetal bovine serum.  
 Penicillin/Streptomycin. 
 N2 and B27 supplements. 
 
 
 
 
Growth factors, 
recombinant 
proteins and 
inhibitors 
                                                                  Working concentrations 
 Hepatocyte growth factor (Peprotech)   -50 ng/ml 
 Wnt-3a (Millipore)                                        -100 ng/ml 
 SU11274, c-Met inhibitor (Sigma)           - 2 µM 
 FH535, TCF inhibitor (Sigma)                   - 10 µM 
 Piceatannol, Syk inhibitor (Sigma)          - 200 µM 
 SB225002 (CXCR2 antagonist)(Tocris)  - 1.25 nM 
 SB328437 (CCR3 antagonist)(Tocris)     - 20 nM 
 Chemokines: cc5, ccl7                     - 10, 300 and 1000  ng/ml                  
ccl20 (R&D systems)                                
cxcl2 (Peprotech).  
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Table 1. continued 
 
Table 2. Antibodies 
Antibody Manufacturer Purpose 
of use 
Dilution Moleculr 
weight 
(kDa) 
Primary 
Antibodies 
 APC 
 α-tubulin  
 α-cxcl2  
 α-ccl20  
 βIII-tubulin  
 β-actin 
 
 
 
Santacruz Biotechnology 
Sigma 
R & D systems 
R & D systems 
Covance 
Sigma 
 
 
 
WB 
WB/IF 
IF 
IF 
IF 
WB 
 
 
 
1: 100 
1: 2000 
1: 2.5 
1: 2.5 
1: 3000 
1: 10,000 
 
  
 
260 
50 
 
 
50-55 
42 
 
Product category Product and manufacturer’s details 
  Neurotrophin-3 (R&D Systems)              - 50 ng/ml 
 Nerve Growth Factor (R&D Systems)    - 50 ng/ml 
                 
 
 
 
Miscellaneous 
                                                                                Working concentrations 
 Protein-G-sepharose beads (Sigma)                     - 50%  
 Nocodazole                                                                   - 0.2 µM                              
              (MT depolymerazing agent) (Millipore) 
 Cytochalasin-D                                                            - 1 µg/ml                                        
inhibitor of actin polymerization(Sigma) 
 Poly-D-lysine (Sigma)                                               - 500 µg/ml 
 poly-L-ornithine (Sigma)                                         - 1.5 µg/ml 
 Lipofectamine 2000 (Invitrogen)  
 Hoescht 33258, cell permeable (Sigma) 
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 γ-tubulin  
 β-catenin 
 PTyr142 β-
cat 
 Phopho-Tyr  
 Syk  
 
Secondary 
Antibodies 
 Anti-Mouse 
HRP  
 Anti-Rabbit 
HRP  
 Alexa488 
fluor goat 
anti-mouse 
IgG  
 Alexa595 
fluor goat 
anti-rabbit 
IgG  
 
 
 
 
 
 
                 
  Sigma 
BD transduction  
Abnova 
 
Upstate 
SantacruzBiotechnology  
 
 
 
                  Sigma 
 
Sigma 
 
Invitrogen 
 
 
 
Invitrogen 
 
 
 
 
 
 
WB/IF 
WB/IF 
WB/IF 
 
IF 
WB/IF 
 
 
 
WB 
 
WB 
 
IF 
 
 
 
IF 
 
1:10,000/1:25
0 
1: 500 
1:1000/1:200 
 
1: 200 
1: 500/1: 100 
 
 
 
1: 10,000 
 
1: 10,000 
 
1: 600 
 
 
 
1: 600 
 
 
 
 
 
50 
92 
92 
 
 
72 
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Table 3. Oligonucleotides used to amplify transcripts of chemokine genes 
 
Gene Sequence Length (bp) Annealing temp 
(°C) 
CXCL2 Forward: 
AGGGTACAGGGGTTGTTGTG 
Reverse: 
TTTGGACGATCCTCTGAACC 
203 55 
CCL5 Forward: 
ATATGGCTCGGACACCACTC 
Reverse: 
CCCACTTCTTCTCTGGGTTG 
167 55 
CCL7 Forward: 
GGGACCAATTCATCCACTTG 
Reverse: 
CCTCCTCAACCCACTTCTGA 
172 55 
CCL20 Forward: 
GCTTACCTCTGCAGCCAGTC 
Reverse: 
CGGATCTTTTCGACTTCAGG 
169 55 
 
Table 4. Real time (q PCR) probes used for chemokine genes 
 
 
 
Gene Reference number Manufacturer´s details 
CXCL2 Rn00586403 Applied Biosystems 
CCL5 Rn00579590 Applied Biosystems 
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1. Cell culture 
1.1 Primary cell culture 
Cells from primary cultures were obtained from rat embryonic as well as postnatal stages 
according to the protocols. All  animal procedures were in agreement with guidelines of 
ethical committee for research in Spain, following European standards. 
1.1.1 Hippocampal neurons 
To isolate rat hippocampal neurons, pregnant rat females were sacrificed at 18-19 days of 
gestation, embryos were removed and hippocampi isolated and kept in cold Hank’s 
balanced salt solution (HBSS). Subsequently they were trypsinized, triturated manually 
with narrowed pipettes and resuspended in DMEM (4.5 g/l glucose) supplemented with 
10% HS, 1mM sodium pyruvate, 2mM glutamine and 20 units/ml of 
penicillin/streptomycin (P/S). After three hours of cells plating, media was replaced by 
DMEM (4.5 g/l glucose) supplemented with N2 and B27. Neurons were plated on poly-D-
lysine (PDL) coated (500μg/ml) glass coverslips for immunocytochemistry (40 cells/mm2) 
or on plastic (1000-1500 cells/mm
2
) for RNA isolation, or lentiviral transduction. 
Experimental design 
Axon length quantification for different treatments:  Cells were treated overnight from 
1DIV to 2DIV with recombinant chemokines (CXCL2, CCL20, CCL5, CCL7 at different 
concentrations of 10, 300 and 1000 ng/ml), blocking antibodies against chemokines (α-
CCL20 and α-CXCL2 at 40µg/ml) and chemokine receptor antagonists [SB225002 
(antagonist of CXCR2) and SB328437 (antagonist of CCR3) at 1.25nM and 20 nM 
respectively], HGF 50ng/ml, SU11274 2µM or FH535 10µM.  
Pervanadate was prepared as following:  
First, 30% Hydrogen peroxide (H2O2) was diluted in sterile water in a ratio of 1: 83.3 (for 
example 12µl of H2O2 in 988 µl sterile water). Equal amounts of H2O2 mix and 100 mM 
stock of sodium orthovanadate were then mixed so as to dilute sodium orthovanadate to 
50mM.  Finally, pervanadate was added to the cell media to a final molarity of 1mM for 
10-15 min at 37°C.  
Semi-quantitative PCR (sq-PCR): Neurons were treated overnight from 1DIV to 2DIV 
with HGF 50 ng/ml. 
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Quantitative real time PCR (qPCR):  For evaluating CXCL2 and CCL5 expression 
levels, cells were either treated from 1DIV to 2DIV (HGF 50ng/ml, SU11274 2µM, 
FH535 10µM) or from 3DIV to 4DIV (HGF 50 ng/ml) in the case of cells transduced with 
lentiviruses expressing shRNAs against β-catenin. 
1.1.2 Striatal astrocytes 
The method used for the isolation and purification of rat striatal astocytes was described 
by Etienne-Manneville (2006). Before starting the dissection,  100-mm tissue culture 
petridishes were coated with 1.5µg/ml poly-L-ornithine (PLO) for 1h at 37°C, washed 
once with water followed by pouring Astrocyte Culturing media (ACM) (DMEM 1g/l 
glucose, 2mM glutamine, 20 units/ml P/S and 10% heat-inactivated FBS) into the 
petridish. P0-P1 (Postnatal day 0-1) rat pups were taken, skulls opened and brains placed 
in a Petridish on ice containing HBSS solution. After removal of the meninges, striata 
were dissected and transferred to cold HBSS. Following one wash with HBSS, striata were 
transferred to warm ACM. They were cut into pieces and mechanically dissociated into a 
cell suspension with the help of  narrowed glass pipettes (up and down at least 15 times). 
The suspension was allowed to sediment for 5 min, the top 1 ml suspension transferred to 
another tube and the rest of the suspension further dissociated. After decantation, 
suspension from this tube was pooled with the previous one and cell aggregates were 
discarded. This was later centrifuged at 800 rpm for 8 min, supernatant discarded and 
pellet resuspended in warm ACM. Cells were plated based on an estimation of 1 pup per 
petridish and were maintained at 37° in a moist 5% CO2, 95% air atmosphere. After one 
week, petridishes were flushed ten times with PBS to release unwanted debris, 
oligodendrocytes and microglial cells and returned with the fresh ACM to the incubator. 
They were ready to be used for experiments within 10-12 days. 
Experiment design   
Striatal astrocytes were used for immunocytochemistry,  in vitro scratch assay and 
centrosome reorientation assay. Whether it was glass coverslips or plastic, surface was 
always coated with PLO (1.5 µg/ml) before plating. For immunocytochemistry, cells were 
plated at a density of  50 cells/mm
2
 and treated with Pervanadate (15 min, 37°C) or with 
Piceatannol (Pic; 200µM). For scratch and centrosome reorientation assays, cells were 
plated at 300 cells/mm
2
. 
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1.1.3 Dorsal root ganglia (DRG) explant culture 
Before initiating the culture, M24 well plates were made ready by coating them with 
collagen (1:10 dilution in water; see below) for 1h at 37°C followed by aspiration and 
complete drying in the laminar air flow hood. To begin with the culture, P0 pups were 
sacrificed and spinal column was opened to access spinal cord. DRGs at either side of the 
spinal cord were picked. They are round with small pieces of nerve root on either side, 
which were trimmed. After isolation DRGs were kept in HBSS. One ganglia/M24 well 
was placed followed by addition of Neurobasal culture media supplemented with N2 and 
B27. After letting ganglia attach for 2-3h, Nerve Growth Factor (NGF) and Neurotrophin-
3 (NT-3) were added to the media together with the treatments (CXCL2 1000 ng/ml;  
CXCL2 1000 ng/ml along with SB225002 1.25nM) for 48h. 
Collagen purification from rat tails:  5 tails of 2-3 months old rats were taken. They 
were washed in 70% ethanol for 30 min and later for 15 min in sterile water. With the help 
of spencer tweezers inside a culture hood, tails were broken to expose collagen fibers. 
Fibres were cut and placed in 100 ml of acetic acid (diluted 1: 100 in sterile water). They 
were left under agitation for 2 days at room temperature (RMT). Finally the volume was 
brought up to 250 ml with acetic acid and the mix centrifuged at 13,000 rpm for 15 min in 
sterile tubes. Supernatant was aliquoted and freezed at -20°C. 
1.2 Cell lines culture 
All the cell lines used are available from ATCC and were maintained as recommended.  
1.2.1 Human Embryonic Kindney 293T (Hek293T)   
This cell line is rapidly growing and easy to transfect. It was grown in media containing 
DMEM (4.5 g/l glucose) with 10% FBS, 10% NEAA, 1mM sodium pyruvate and 20 
units/ml P/S. Cells were maintained at 37°C and 5% CO2 and were split in 1:10 dilution 
on reaching 80-90% confluency. This cell line was used for lentiviral production, in vitro 
scratch assay and centrosomal immunostainings. 
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1.2.2 Glioblastoma cell lines (U251MG and U87MG)  
These cell lines propagate well in media containing MEM, 10% FBS, 10% NEAA, 1mM 
sodium pyruvate, 2mM glutamine, 20 units/ml P/S. They were split at a dilution of 1:3 
upon reaching confluency. These cells were exploited for immunocytochemistry and 
centrosome isolation.  
For future use, cell line aliquots were frozen in storage vials in 850 µl of FBS followed by 
dropwise 150 µl DMSO in liquid nitrogen tanks.  
2. Transfection 
2.1 Transfection with Polyethilenimine  
Polyethilenimine (PEI) cell transfection just like usual transfection did not include any 
serum or antibiotics. This method was used to prepare lentiviral particles in Hek293T 
cells. DNA was prepared in sterile NaCl 150mM as well as PEI solution, which was 
diluted to a final concentration of 10µM. PEI was added to DNA vial, after mixing for a 
minute and left to incubate for 10 min at RMT so as to form PEI-DNA complex. The 
resulting transfection mix was added dropwise to the Hek293T culture plate containing 
DMEM (4.5 g/l glucose). After 3h media was aspirated and full-containing media added. 
2.2 Transfection with Lipofectamine-2000 
The day before the transfection, cells were plated such that they are 90% confluent while 
initiating transfection. Lipofectamine-2000 (Invitrogen; LFT) was used with a LFT : DNA 
ratio different for different cell types. For Hek293T, ratio was 2 µl LFT : 1µg DNA for 
M24 well. However, for glioma cell lines, ratio was 1,5 µl LFT : 1µg of DNA for M24 
well. To examine the transfection efficiency, Green fluorescent protein (GFP) DNA was 
co-transfected along with the specific DNA. In that case, amount of specific DNA was 
reduced to 0.8 µg/M24 well along with 0.3 µg of GFP DNA so as to make a total of 1.1 µg 
DNA/M24 well. 
To start with the procedure, LFT was added to 50 µl of warm opti-MEM and incubated for 
5 min at RMT. DNA (specific as well as GFP) were added to another vial of  50 µl opti-
MEM. Both the vials were mixed and incubated at RMT  for 15-20 min to form DNA-LFT 
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complexes. Before adding dropwise the transfection mix to the cells, M24 well media was 
aspirated and replaced by 200 ul DMEM 4.5 g/l glucose (Hek293T) or  opti-MEM 
(Glioma cell lines). After 3-4 h of transfection, media was aspirated and replaced by the 
complete media. Within 10h, cells observed under the fluorescence microscope started to 
show GFP expression. Transfection efficiency observed for Hek293T was around 90% 
whereas for glioma cell lines it was ~60% .  
3. Lentivirus production and transduction 
3.1 Lentiviral constructs 
shRNA primers specific for rat β-catenin were designed and chosen using algorithms 
available on Promega and Invitrogen websites. The primers selected correspond to 5_-
GTTTGTGCAGTTGCTTTAT-3_ (shRNA#1) and 5_-GGGTTCCGATGA -TATAAAT-
3_ (shRNA#2). Primers were designed for cloning into pSUPER plasmid using the BglII 
and HindIII sites. They were subcloned into the pLVTHM plasmid (from D. Trono, 
Geneva) together with the H1 promoter for RNA polymerase III. 
 
3.2 Lentiviral production 
Lentiviruses were produced as described (Naldini L et al., 1992). Vectors of 2
nd
 generation 
were used (from D.trono). First set of vectors were pEIGW/pLVTHM, used to overexpress 
or inhibit gene expression, respectively. In order to produce lentiviral siRNA construct, 
pLVTHM was designed in such a way that H1 Pol III promoter can be easily replaced by 
H1-siRNA cassette from Psuper.retro.puro using EcoRI-Cla I. 
Second vector psPAX2 codes for viral packaging proteins. It contains a very efficient 
promoter (CAG), which allows the expression of viral packaging compounds of which 
TAT protein, DNA polymerase and Reverse Transcriptase are the most relevant. Third 
vector, pM2G, codes for the virus envelope. 
For lentiviral production shRNA vectors specific for rat β-catenin were transfected into 
Hek293T cells together with the plasmids psPAX2 and pMD2G, as previously described 
(David et al., 2008). Briefly, Hek293T cells were plated at high density on 0.1% gelatin 
coated 100mm tissue culture plates, so that the next day they were 90% confluent. At 
confluency  they were transfected with: 
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Vector pWPI/pLVTHM  20µg 
PSPAX2    13µg 
pM2G     7µg 
Tranfection was performed by PEI transfection protocol. Hek293T cells were allowed to 
produce lentiviruses for 48h followed by the centrifugation of medium at 4000g for 5 min, 
discarding dead cells present in the supernatant and further clarification through 45µm 
filter. Lentiviruses were concentrated by centrifugation at 50,000g for 3h. To further 
obtaining higher infection efficiency, lentiviruses were finally suspended in a solution of 
1% BSA in PBS. The biological titer of the viral preparation was expressed as a number of 
transducing units per ml (TU/ml) and was determined by transducing Hek293T in 
different amounts. After 48h incubation, the percentage of GFP positive cells were 
counted and viruses at 5x10
8
-1x10
9
 TU/ml were used in the experiments. 
3.3 Transduction 
For lentiviral transduction different cell types were transduced at different times and were 
left with the viruses for different incubation times.  Hippocampal neurons were infected 
after 3h of plating, incubated overnight and media changed on DIV1. Cells were lysed and 
run for Western blotting to check the percentage of β-catenin silencing.  Striatal astrocytes 
were transduced for centrosome reorientation experiment on achieving 60% confluency  
for 11-12h, proceeded by media change.  
4. Western blotting 
For cell lysis, cells were first washed with PBS, lysed in 2% SDS and 62.5 mM Tris HCl 
pH 6.8, buffer and collected with a scrapper. Protein was quantified by Lowry assay. Cell 
lysates were resolved on Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) (usually 8% or 10% resolving gel and 5% stacking gel). Proteins were 
electrotransferred from the gel to a polyvinyledene difluoride (PVDF) Immobilon-P 
transfer membrane (Millipore, Billerica, MA) using a semi-dry Trans-Blot apparatus 
(Hoefer, Amersham Pharmacia Biotech). Membranes were blocked with Tris-buffered 
saline with Tween 20 (TBS-T) (20mM Tris-HCl pH 7.4, 150mM NaCl and 0.05% Tween 
20) containing 5% non fat dry milk for 1h at RMT, washed with TBS-T and incubated 
overnight with the primary antibody (diluted in TBS-T as per manufacturer´s instructions). 
Peroxidase-conjugated secondary antibodies (1:10000; Sigma) diluted in 5% milk- TBS-T 
were incubated with the membrane for 45 min. Membranes were developed with either 
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Enhanced chemiluminescence (ECL) (Thermoscientific, USA) or Supersignal (Millipore, 
Billerica, MA) on Super RX Fuji medical X-Ray film with the help of Optimax X-Ray 
film processor (Germany). Protein loadings were quantified with respect to β-actin (used 
as the loading control) using scion image software.  
5. Immunofluorescence  
Cells were plated on PDL-coated coverslips (500 µg/ml for hippocampal neurons; 25 
µg/ml for Glioma and Hek293T cell line) and PLO coated coverslips (1.5 µg/ml for 
striatal astrocytes) followed by washes with water and addition of media as per cell type. 
Most of the treatments were overnight (HGF 50 ng/ml; SU11274 2µM; FH535 10µM; 
recombinant chemokines, antibodies against chemokines) except (piceatannol 200µM for 
6h; pervanadate for 15 min). After the treatments cells were fixed either fixed with 4% 
Paraformaldehyde (PFA) for 15-20 min at RMT, with ice cold methanol (for centrosomal 
immunostainings;  5 min at -20°C) or with detergent fixation (that allows optimal 
cytoskeletal immunostaining: 0.3% PFA, 0.2% glutaraldeyde, 0.2% Triton X-100 and 10 
mM EGTA pH 7.2; 10 min at 37°C, (as described by Ciani & Salinas, 2007). After 
fixation, cells were washed thrice with Phosphate buffered saline (PBS) and later blocked 
and permeabilized with PBS containing 5% FBS, 5% HS, 0.2% Glycine and 0.1% Triton 
X-100 for 1h at RMT. In methanol-fixed cells Triton X-100 was omitted. This step was 
followed by incubation with primary antibodies (βIII-tubulin, PTyr142 β-cat, γ-tubulin, 
APC, α-tubulin, Phospho-Tyrosine (PTyr)) overnight at 4°C diluted in the same blocking 
solution. Subsequently, coverslips were washed with PBS and provided with secondary 
antibodies coupled to Alexa-488 or Alexa-564 (diluted 1:600 in blocking buffer) for 45 
min at RMT in the dark. Finally, cells were washed with PBS and mounted on Moviol 
(Moviol 488, glycerol 50%, 0.2M Tris-HCl buffer pH-8.5). Images were obtained using an 
inverted Olympus IX70 microscope (10x, 0.3 numerical aperture (NA; 20x, 0.4 NA;  32x, 
0.4 NA) equipped with epifluorescence optics and a camera (Olympus OM-4 Ti). 
FluoView
TM
 FV1000 Confocal Microscope (60x) was used to obtain centrosome 
immunostaining pictures and z-stacks. DPM Manager software was used together with 
Olympus IX70 microscope, whereas FV10-ASW was used for confocal images. 
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6. Immunofluorescence intensity quantification 
Relative IF intensities of PTyr142 β-cat (immunostained in red) and γ-tubulin 
(immunostained in green) in each single cell (U87MG and U251MG cell lines) were 
measured from merge images (overlapping PTyr142 β-cat and γ-tubulin immunostainings) 
in different conditions using the RGB plugin of ImageJ software (freely available online). 
The ratio of PTyr142 β-cat immunofluorescence intensity to γ-tubulin 
immunofluorescence intensity was also calculated. 
7. Axon length and branching quantification 
Hippocampal neurons cultured on glass coverslips were provided with treatments 1DIV to 
2DIV as mentioned before. Neurons were immunostained using mouse anti-βIII tubulin 
antibody (Covance) and Alexa-488-couple anti-mouse IgG. The axon was identified as the 
longest neurite at this stage (2DIV) of the hippocampal neuron development. Axon length 
was measured using Adobe Photoshop software. Axon branching was measured by 
counting Total Axonal Branch Tip Number (TABTN) (Yu, & Malenka, 2003). Typically, 
15–20 neurons were measured/condition in ≥ three independent experiments. 
8. Scratch assay 
Scratch / wound healing assay is a method to study cell migration in vitro adapted from 
(Liang, Park, & Guan, 2007).  This method is based upon the idea that upon creating of an 
artificial gap or “scratch” on a confluent cell monolayer, the cells on the edge will migrate 
towards the scratch until new cell to cell contacts are established again. The standard 
procedure includes the comparison of acquired images of scratch when it is created (T0) 
and later time intervals depending on the cell type in order to study the differences in 
migration upon different treatments. 
8.1 Scratch assay on non-transfected cells 
This was performed using striatal astrocytes by allowing them to grow on coverslips. On 
reaching confluency, scratch was created using a p200 pipette tip. Debris was removed 
followed by one wash with the ACM media. Phase-microscopy images were taken at this 
point of time as time 0 (T0) for all the conditions including control. Next, cells were 
treated with HGF50 ng/ml with or without Met inhibitor (SU 11274 2µM). After 24 hours 
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of scratch (T24), images were re-acquired and the percentage reduction in the width of 
scratch at T24 with respect to T0 was calculated with the assistance of Image J software. 
Width of the scratch in each image was the average of three measurements taken 
randomly. For each condition, 20 images were evaluated.   
8.2 Scratch assay on transfected cells 
To study cell migration on transfected cells using the scratch/wound-healing assay, 
Hek293T cell line was used as a cell model. Cells were grown on coverslips (coated with 
25ug/ml PDL) until they reached a confluency of 80%. Cells were transfected using LFT 
2000 reagent and GFP plasmid DNA (0.3 µg) together with WT (0.8 µg) or Tyr142Phe 
(0.8 µg) β-catenin plasmids . These plasmid´s  cDNAs were obtained and cloned into 
pcDNA3.1 as described (Piedra et al., 2003) and were a kind gift of Dr. Mireia Duñach. 
After 6-7 hours of transfection, scratch was created, cells washed with Hek293T media 
and treated. Images acquired at T0 under fluorescent microscopy were compared with 
final images taken at 24 hours (T24) using Image J software. 
9. Centrosome reorientation assay 
In a confluent astrocyte monolayer, centrosome is usually located near the nucleus at a 
random position. When a scratch in the monolayer is produced, centrosome localizes (“re-
orients”) in front of the nucleus facing the wound (Etienne-Manneville, & Hall, 2001) . 
Having plated rat striatal astrocytes at a density of 300 cells/mm
2
 on glass coverslips and 
letting them reach around 60% confluency, lentiviruses carrying the shRNA against β-
catenin or scrambled shRNA were added for 11-12h (0DIV). After this period, lentivirus 
were removed and fresh complete media added. Non-infected coverslips were used as 
controls. At 5DIV after lentiviral transduction, the scratch was created using a 200 ul 
pipette tip for  10h  followed by fixation with 4% PFA and immunostaining using anti-γ-
tubulin antibodies. Hoescht was used to stain the nucleus. Images were captured (40x , 
0.55 NA) using  Olympus 1X51 microscpe. Only the front row of cells at the edge of to 
scratch was analyzed. To score which cells present their centrosomes oriented towards the 
wound, the cell is divided into four equal quadrants starting from the center of the nucleus 
and one quadrant facing the scratch, as described ( Etienne-Manneville, 2006). Thus, a cell 
was considered as “reoriented” if the centrosome was located in the quadrant facing the 
scratch. Number of cells re-oriented vs non-oriented were calculated. 
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10. Mitosis arrest 
Mitosis arrest was carried out in U251MG and U87MG glioma cell lines. Procedure 
started from plating cells on coverslips coated PDL at a density  (50 cells/mm
2
)  in 
complete media. After a few hours of plating, cells were deprived of serum for 20h 
followed by complete  media addition for the next 16-20h. Next, cells were fixed with 
methanol and immunostained using antibodies against PTyr142 β-cat, γ-tubulin and α-
tubulin. Hoescht was used to stain the nucleus. Images were captured using an inverted 
Olympus IX70 microscope (32x, 0.40 NA) equipped with  epifluorescence optics and 
camera (Olympus OM-4Ti) and confocal microscope FV10-ASW (60x objective). 
11. Centrosome isolation 
Centrosomal isolation was performed as previously described (Hsu, & White, 1998) with 
minor modifications. Exponentially growing striatal astrocytes and U251MG cells were 
treated with Nocodazole (0.2 µM) and Cytochalasin D (1µg/ml) for 1h at 37°C to 
depolymerize actin and microtubule filaments. Cells were harvested after trypsinisation 
and lysed in 4 ml lysis buffer composed of 1 mM Hepes (pH-7.2), 0.5% Igepal, 0.5 mM 
MgCl2 and 0.1% β-Mercaptoethanol containing complete protease inhibitor and 
phosphatase inhibitors (40mM β-Glycerophosphate, 1mM Sodium Orthovanadate and 
25mM Sodium Fluoride). Swollen nuclei and chromatin aggregates were removed by 
centrifugation at 5500 rpm for 10 min and supernatant was filtered through 70 µm mesh. 
To the filtered lysate 9mM Hepes and DNAse I (2 units/ml) were added and left to 
incubate on ice for 30 min. Typically, 4 ml of the lysate was then underlaid with 0,5 ml of 
60% sucrose solution (60% w/w sucrose in 10mM Pipes pH-7.2, 0.1% Triton X-100, 0.1% 
β-Mercaptoethanol) and centrifuged at 12,500 rpm  for 30 min (JA14 rotor, Beckman 
coulter Avanti J-26 XP centrifuge) in order to sediment the centrosomes into sucrose 
cushion . The protocol was continued by discarding the top 3 ml of supernatant and the 
remaining 1,5 ml was loaded into a discontinuous gradient consisting of: 500 µl of 70% 
sucrose, 300 µl of 50% sucrose and 300 µl of 40% sucrose in the above Pipes buffer. 
Tubes (Beckman polyallomer centrifuge tubes, 2.2 ml) were centrifuged at 35,000 rpm for 
30 min (TLS55 rotor, Beckman coulter optima ultracentrifuge). Fractions were collected 
from the top: 500µl for fraction number 8 (top) and the rest of the fractions, named 7-0, 
had 200µl/fraction. Remaining stuff not collected as it was too viscous. Fractions were 
 Methods 
 
115 
 
diluted in 10mM Pipes buffer, pH 7.2 to make each of them upto 1ml. Trichloracetic acid 
(6.5%, final concentration) was added to all the fractions in order to precipitate the protein 
and incubated for 20 min at RMT followed by centrifugation and removal of supernatant. 
Pellets were dissolved in loading buffer (without β-Mercaptoethanol) with the addition of 
Tris pH 8. After boiling the samples, they were loaded into 10% SDS-PAGE and Western 
blotted. 
12. Luciferase assay 
To determine β-catenin transcriptional activation status, luciferase assay was performed 
following transfection of the TOP-Flash plasmid that carries a synthetic promoter 
containing three copies of the TCF-4 binding site upstream of a firefly luciferase reporter 
gene (a kind gift of Dr. Garcia de Herreros, IMIM, Barcelona, Spain). Hek293T cells were 
plated at a density of 100 cells/mm
2
 in 24-well plates and transfected with Lipofectamine 
2000 on the day next to plating. Treatments were given on the following day for 24 h 
(HGF 50 ng/ml; Wnt-3a 100 ng/ml; FH535 8μM and SU11274 2 μM). After 48 h of 
transfection, cells were lysed in lysis buffer 25mM glycylglycine, pH 7.8, 15mM Mg2SO4, 
1% Triton X-100, 5mM EGTA and left for rocking on ice for 15 min. Luciferase activity 
in the lysates was determined in Luciferase Buffer (25 mM glycylglycine, 15 mM KHPO4, 
pH 7,8, 15 mM Mg2SO4, 1% Triton X-100, 5 mM EGTA, 1 mM dithiothreitol, 2mM ATP, 
100 mM acetyl-coenzymeA (Ac CoA), and 100mM luciferine) using a microplate 
luminometer. Luciferase activity was normalized for the total protein concentration 
measured by Lowry method in each well. 
13. Polymerase chain reaction (PCR)  
Chemokine expression was analyzed by semi-quantitative (sq) PCR and real-time PCR 
(qPCR) in hippocampal neurons control or treated with HGF 50 ng/ml; SU11274 2µM; 
FH535 10µM or pervanadate (overnight from 1DIV to 2DIV). 
 
 
13.1 RNA isolation and cDNA synthesis 
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Primarily, Mesenger RNA (mRNA) was extracted using Nucleospin RNA II Kit 
(Macherey-Nagel) as per manufacturer’s instructions. RNA was quantified using nanodrop 
(ND-1000) spectrophotometer. mRNA was reverse-transcribed (RT) to cDNA using 
random hexamers and Superscript II reverse transcriptase (Applied Biosystems) in a PCR 
device  (25°C for 10 min, 42°C for 60 min, and 95°C for 5 min). Negative control RT-
minus reactions were carried out to confirm absence of DNA contamination in RNA.  
13.2 Semi-quantitative PCR (sq-PCR) 
Equal volumes of cDNA were amplified by PCR using a couple of specific primers 
expanding at least two exons within the gene of interest. Sequences of the primers used are 
mentioned in Table3. 10µl aliquots were taken from 25, 30, and 35 PCR cycles (CXCL2 
and CCL7), 30, 34, and 38 PCR cycles (CCL5) or 24 and 28 PCR cycles (CCL20). PCR 
products were analysed in 3% agarose gel. Densitometry of the DNA bands was 
performed using the Scion Image software (Scion Corporation) and comparing 
measurements from non-saturated PCR products. Loading was checked by amplification 
of the GAPDH transcript. Transcript analysis was performed from at least three 
independent samples. 
13.3 Real time PCR (qPCR) 
qPCR amplification was carried out taking cDNA (processed from 1µg of RNA) as the 
template along with gene primers for rat chemokine genes (CXCL2 and CCL5) and an 
endogenous control (GAPDH in an ABI prism 7000 sequence detection system (Applied 
Biosystems). This detection system determines the absolute quantity of a target nucleic 
acid sequence in a test sample by analyzing the cycle to cycle change in fluorescent signal 
as a result of amplification being carried out. Expression of the transcript levels were 
analysed using a FAM-labeled CXCL2 or CCL5 probes and compared to that of GAPDH, 
used as a loading control. The results were obtained in the form of a Ct value (cycle 
threshold) representing the cycle number of the PCR during which the exponential growth 
growth of PCR product starts. Therefore, the higher the expression of the gene in the 
sample, lower will be the Ct value. The relative quantity of mRNA for every gene was 
calculated as: ∆Ct = Ct of the target gene – Ct of GAPDH gene; ∆(∆Ct) = ∆Ct of sample - 
∆Ct of control. Relative mRNA levels were calculated and expressed as fold induction 
over contralateral controls (value = 1.0) using the formula 2
-∆(∆Ct)
. 1µl aliquot of each 
cDNA was used per well and samples were run in triplicate. 
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14. Array processing and Array data analysis 
RNA from control and HGF 50ng/ml treated samples was obtained from 2DIV rat 
hippocampal neurons. Array experiments were performed in collaboration with Drs. A. 
Dopazo and A. Benguria (CNIC, Madrid, Spain). 
 
RNA samples (800 ng) were amplified and labeled with Cy3-CTP using the One-Color 
Microarray-Based Gene Expression Analysis Protocol (Agilent Technologies, Palo Alto, 
CA, USA) and hybridized to Whole Rat Genome Microarray 4 × 44K (G4131F, Agilent 
Technologies). Raw data files from the scanned arrays were extracted using Feature 
Extraction software version 9 (Agilent Technologies). Data files from Feature Extraction 
software were imported into GeneSpring® GX software version 9.0. (Agilent 
Technologies). Quantile normalization was performed (Bolstad et al., 2003) and 
expression values (log2 transformed) were obtained for each probe. Probes were also 
flagged (Present, Marginal, Absent) using GeneSpring® default settings. Probes with 
signal values above the lower percentile (20th) and flagged as Present or Marginal in 
100% of replicates in at least one out of the two conditions under study, were selected for 
further analysis. Paired t-test was performed between conditions to be tested for 
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differential expression analysis. Raw p-values were corrected for false discovery rate 
control using Benjamini–Hochsberg’s method (Benjamini and Hochberg, 1995). The steps 
followed while performing array shown in the flow chart. 
15. Statistical analysis 
Significance was calculated by the Student T test (paired). Asterisk (*) indicates statistical 
significance compared to the corresponding untreated control and hash (#) compared to 
stimulated controls. 
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Chapter 1. 
HGF signaling regulates chemokine expression in 
developing hippocampal neurons 
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1.1  Chemokines of  the CC and CXC families are upregulated in 
hippocampal neurons upon stimulation with HGF. 
To identify the genes regulated downstream to HGF signaling during axon morphogenesis, 
microarray analysis was performed in collaboration with the Genomic Unit of CNIC 
(Madrid, Spain). Total RNA was obtained from rat hippocampal neurons untreated or 
treated with HGF (50 ng/ml for 24h from 1DIV to 2DIV; n=4). RNA was amplified, 
labeled and hybridized to Whole Rat Genome Microarray 4 × 44K (Agilent Technologies) 
representing about 41000 rat genes and transcripts. 
Array data analysis, upon discarding noise signals, provided 27982 probes that were 
statiscally (t-paired test) analyzed. Normalized expression signal for individual genes in 
“Control” and “HGF” was in log2 scale. Fold changes were calculated (HGF vs control 
sample) in lineal scale (1 meaning no change).  p-values and corrected p-values (corrected 
for False Discovery Rate) were calculated. Differentially expressed genes were filtered as 
showing corrected p values <0.25 (showing at this stage 1792 genes of the total genes in 
the array). In addition, among these genes only those showing fold changes >1.5 were 
selected, resulting in a list of 233 genes/probes containing both upregulated and 
downregulated genes in response to treatment with HGF.  
To our surprise, array results pointed to several chemokines of the  CC and CXC families 
as a group of genes upregulated by HGF signaling. In addition, chemokine genes were 
ranked among the genes showing higher fold increase values vs control samples. As 
shown in (Figure 1A), array results indicate that upregulated genes in HGF-treated vs 
control hippocampal neurons include CCL5, CCL7, CCL13, CCL20, CCL19 and CXCL2. 
Colony-stimulating-factor-1 (CSF-1) and Bone Morphogenetic Protein-6 (BMP-6) were 
other secreted molecules identified by the array as upregulated by HGF signaling, with 
fold increases vs. control neurons of 2,07 and 1,78, respectively (p values = 0,002 and 
0,012, respectively). 
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Figure1. Array data analysis revealed the genes upregulated downstream to HGF 
signaling in hippocampal neurons. (A)  Table summarizing the chemokine genes, which 
amongst the other genes (not mentioned) showed a higher fold increase upon HGF 
stimulation (50 ng/ml, 24h, 1DIV to 2 DIV) vs control in hippocampal neurons. (B) 
Graphical representation of the percentage of genes identified downstream to HGF 
signaling categorised as upregulated or downregulated upon 24h treatment with HGF (50 
ng/ml) vs control in hippocampal neurons. Of the total genes, 30% were upregulated and 
70% were downregulated. (C) Pie chart classifying the target genes downstream to HGF 
signaling deduced from the array based upon their function. Of all, 4% were secreted 
molecules, 3.2% referred as cytoskeletal and transport related proteins, 13% included 
plasma membrane proteins and receptors, 2.8% were the Wnt or cadherin/catenin 
signaling components and 17% were transcriptional regulators and nuclear proteins. 
 The majority of the identified genes were downregulated upon HGF signaling (70%) with 
only a 30% of genes being upregulated (Figure 1B). We have attempted a simple 
functional classification of the target genes listed in the array (Figure 1C): 4% of the genes 
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can be classified as secreted molecules (all chemokine genes, BMP6, CSF-1), 3.2% of 
genes refer to cytoskeletal and transport related proteins (Microtubule Associated Protein-
9 and -2, ankyrin2, tubulin β6, kinesin family member 1A), 13% of genes include plasma 
membrane proteins and receptors (Fas, CD83, syntaxin-11, SV2B, ICAM1), 2.8% of 
genes are components of Wnt or cadherin/catenin signaling (APC, TCF12, cadherin-4, 
protocadherin-7, and protein phosphateses like PTPN11, PTPRD, PPP1R9A) and 17% of 
genes refer to transcription regulators and nuclear proteins (including FOSL1, KLF7, 
cyclin-dependent-kinase inhibitor 1 and 2B, splicing factor SFRS2IP, histone 1 family 
member 4, EIF3A, Calcium/Calmodulin kinase 4, REST corepressor 1).  
 
Figure 2. Upregulation of chemokines genes upon HGF stimulation demonstrated by 
sq-PCR. (A) sq-PCR was run for chemokine genes (CCL5, CCL7, CCL20 and CXCL2) 
comparing their expressional levels in control and HGF (50 ng/ml, 24h, 1DIV to 2DIV) 
treated hippocampal neurons. For different genes, PCR was run for different number of 
cycles (as mentioned). GAPDH was used as the loading control (Image corresponds to 30 
pcr cycles). RT- indicates the samples in which reaction was run without RT enzyme. (B) 
Summary table for the quantification of sq-PCR showing the fold change achieved for 
chemokine genes upon treatment with HGF vs control ± sem.  c corresponds to the 
number of pcr cycles 
To confirm the array results, we ran sq-PCR for the chemokine genes upregulated in the 
array (Figure 2A). A summary of the changes in the expression obtained upon 
normalization of the intensity of the product band in HGF vs control sample are shown in 
Figure 2B.  
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In-silico analysis of the region 2 kb upstream of the ATG in the identified chemokine 
genes, confirmed the presence of several copies of TCF binding site A/T CAAAG G/C or 
the reverse and complementary sequence G/C CTTTG A/T (Van de Wetering et al., 
1991; Giese, Amsterdam,& Grosschedl, 1991) (data not shown). The identification of the 
chemokines as molecules regulated by HGF signaling in hippocampal neurons, prompted 
us to investigate their possible role in the regulation of axon morphogenesis.  
1.2  Chemokines promote axon outgrowth in hippocampal 
neurons 
In order to test a possible role of chemokines in the regulation of axon outgrowth as 
suggested by the array data, different concentrations of recombinant chemokines were 
tested (CCL5, CCL7, CCL20, CXCL2 ranging from 10-1000 ng/ml) in cultured 
hippocampal neurons. Treatments were applied to the culture from 1DIV to 2DIV. Upon 
fixation, anti βIII-tubulin immunostaining was used to reveal the neuron morphology. At 
this stage (2DIV) of the hippocampal neuron culture, the longest neurite is unequivocally 
identified as the axon, while the future dendrites remain as short processes. Axon length 
measurements of neurons treated with different concentrations of chemokines indicated 
that CCL7 (1000 ng/ml), CXCL2 (300 and 1000 ng/ml) and CCL20 (10, 300 and 1000 
ng/ml) significantly increase axon length versus untreated control neurons (Figure 3I, J). 
CCL5 showed a tendency to increase axon length, but results were not statistically 
significant.  
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Figure 3. Recombinant chemokines increase axon length. (A-H) Hippocampal neurons 
(2DIV) control and treated with CXCL2, CCL5, CCL7, CCL20 (1000 ng/ml) 
immunostained using anti βIII-tubulin antibody. Immunofluorescence pictures have been 
inverted for a better visualization of the neuron morphology. (A-E) Images acquired at 
10x and (F-H) at 20x. Bars = 30 µm. (I) Graphical representation comparing axon length 
achieved on treating hippocampal neurons with different recombinant chemokines at 
different doses to axon length of control neurons. “All” refers to the cocktail of the four 
chemokines (10ng/ml each). (J) Table summarizing the average axon length of 
hippocampal neurons quantified in µm, following treatment with the corresponding 
chemokine (1000 ng/ml), HGF (50 ng/ml) or a cocktail of chemokines at 10 ng/ml versus 
untreated neurons. *  p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001. n=10.* shows the 
statistical significance versus untreated controls. 
The increase in axon length achieved after treatment with chemokines was in the range of 
the increase produced by HGF stimulation (50 ng/ml, 24h) (David et al., 2008), of around 
a 30-35% over the length of axons of untreated neurons. We reasoned that perhaps the 
simultaneous treatment with a mix of chemokines could produce a bigger increase in axon 
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length. We treated hippocampal neurons with a cocktail of all the same chemokines at 10 
ng/ml, which however promoted axon outgrowth in a similar manner (Figure 3).  
Among the chemokines tested, it was noted that CXCL2 seemed to promote axon 
arborization. Therefore, axon branching was measured by counting Total Axonal Branch 
Tip Number (TABTN) (Yu, & Malenka, 2003). Axon branching measurements confirmed 
that CXCL2 not only promotes axon outgrowth but also significantly increases axon 
branching at all the concentrations tested (10-1000 ng/ml) (Figure 4). The other 
chemokines did not produce significant axon branching at the concentrations used. 
Together, these results demonstrate that chemokines promote axon outgrowth (CCL5, 
CXCL2 and CCL20) as well as axon branching (CXCL2) in developing hippocampal 
neurons. 
 
Figure 4. CXCL2 induces axon branching in hippocampal neurons. (A) Images 
acquired at 20x showing control and cxcl2 treated hippocampal neuron immunostained 
with anti βIII-tubulin. Bars = 30 µm. (B) Graphical representation showing fold increase 
in axon branching in CXCL2-treated neurons (10, 300 and 1000 ng/ml) vs. control. “All” 
represents the cocktail of all the recombinant chemokines (10 ng/ml each). HGF (50 
ng/ml) was used as the positive control. * p ≤ 0.05. 
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Having proven that chemokines can promote axon morphogenesis when added to the 
culture medium in hippocampal neurons, we decided to block chemokine signaling to 
confirm a role of chemokine signaling downstream of the HGF signaling cascade. We 
focused ourselves on CCL20 as this chemokine produced a significant increase in axon 
length at all the tested concentrations and in CXCL2 because of its unique effect on axon 
branching. Thus, we used blocking antibodies against the chemokines (anti-rat CXCL2 
and anti-rat CCL20) and chemokine receptor antagonists (SB225002 and SB328437) 
(Figure 5 and 6). 
 
Figure 5. Chemokine signaling is involved in axon morphogenesis downstream to HGF 
signaling in hippocampal neurons. Neurons were treatments with antibodies against 
chemokines (anti-CXCL2 and anti-CCL20, 40µg/ml) and chemokine receptor antagonists 
(SB225002 1.25 nM and SB328437 20 nM) together with HGF (50 ng/ml) from 1DIV to 
2DIV. Cells were fixed and immunostained using βIII-tubulin antibodies. Bars = 30 µm. 
Images were acquired at 10x (A) for axon length quantification and 20x (B) for better 
visualization of the neuron morphology. 
 In the blocking antibodies experiments, neurons were incubated with HGF together with 
antibodies against CXCL2 or CCL20 (40 µg/ml). Control neurons were treated with the 
same concentration of a non-relevant protein (ovalbumin) added to the culture medium 
together with HGF to confirm the specificity of a possible effect of the antibodies. Axon 
length and branching were measured. As expected, HGF promoted axon length was not 
affected by the presence of ovalbumin. Neurons treated with HGF (50 ng/ml) together 
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with the anti-CCL20 or anti-CXCL2 antibodies (40 µg/ml) from 1DIV to 2DIV displayed 
axons significantly shorter (by 32% and 33% respectively) than those of neurons 
stimulated with HGF alone or with HGF and ovalbumin (40 µg/ml) (Figure 5 and 6). In 
fact, axon length values in the presence of blocking antibodies were below those of control 
untreated neurons (Figure 6).  
On the other hand, we used chemokine receptor antagonists. We chose SB225002 to block 
CXCL2 signaling through its receptor CXCR2 (White et al., 1998) and SB328437 (White 
et al., 2000) that acts on CCR3, the only known receptor for CCL20 that also acts as one 
of the receptors of CCL5. Incubation of hippocampal neurons with HGF (50 ng/ml) and 
SB225002- 1.25 nM or with SB328437- 20 nM from 1DIV to 2DIV inhibited axon 
outgrowth by 72% and 34% respectively, as compared to treatment with HGF alone 
(Figure 6A).  
To evaluate the role of a putative chemokine signaling as downstream of HGF signaling in 
axon arborization, axon branching was measured in HGF stimulation compared to HGF 
treatment together with blocking antibodies or chemokine receptor antagonists. As shown 
in Figure 6B, anti-CXCL2 and CCL20 antibodies inhibited the axon branching induced by 
HGF treatment and reduced to that of control untreated neurons. On the other hand, 
chemokine receptor antagonists SB225002 1.25 nM or SB328437 20 nM significantly 
blocked the axon branching induced upon HGF stimulation and reduced to values below 
those of control neurons (Figure 6B). These results suggest that the chemokines are 
produced and secreted by the hippocampal neurons upon HGF stimulation in order to aid 
for axon outgrowth and branching. Together, these findings indicate that CCL20 and 
CXCL2 signaling is involved in axon morphogenesis downstream of HGF signaling in 
hippocampal neurons, in agreement with data pointed out by the array study. 
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Figure 6. Chemokine signaling is involved in axon morphogenesis promoted by HGF. 
Graphical representation exhibiting the fold change in axon length as well as branching, 
upon treating hippocampal neurons with antibodies against CXCL2 and CCL20 and the 
receptors antagonist of CXCR2 and CCR3, respectively. HGF was taken as the positive 
control. ** p ≤ 0.01 and *** p ≤ 0.001. ## p ≤ 0.01 and ### p ≤ 0.001.  * and # shows the 
statistical significance in comparison to untreated controls and stimulated controls 
respectively. 
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1.3  Met and TCF inhibition reduce the axon outgrowth induced 
by HGF signaling. 
Next, we wanted to investigate the pathway regulating chemokine downstream of HGF 
signaling. We have previous demonstrated that HGF signaling increases PTyr142 β-cat, 
which promotes TCF-4-dependent transcriptional regulation of target genes during the 
axon morphogenesis (David et al., 2008). We used SU11274, which inhibits Met activity 
(Berthou et al., 2004) by targeting the ATP-binding site of Met to block HGF-dependent 
Met activation (Ma et al., 2003; Ma et al., 2005) and FH535, which inhibits TCF/β-catenin 
by blocking the recruitment of  β-catenin to the promoter of the target genes (Handeli, & 
Simon, 2008). 
First, we studied β-catenin transcriptional activation using luciferase assay. We transfected 
Hek293T cells with the TOP-FLASH reporter plasmid that carries a synthetic promoter 
containing three copies of the TCF-4 binding site upstream to the luciferase reporter gene 
(Figure 7A). This is a widely used reporter system to monitor β-catenin transcriptional 
activity in mammalian cells. The bioluminescent reaction catalyzed by luciferase requires 
luciferin (the substrate), ATP, Mg
2+
 and Ac CoA. Mixing these reagents with the cell 
lysates of transfected cells from different experimental conditions results in a flash of 
light, which is detected by a luminometer. Higher the β-catenin transcription, more will be 
the binding to TCF sites resulting in activation of the reporter gene (luciferase) read by 
luminometer.  
Hek293T cells were transfected with the TOP-FLASH reporter plasmid. HGF/Met 
signaling is active in this cell line (Royal, & Park, 1995). Although no stimulation of 
luciferase reporter activity was obtained when treating cells with HGF (50 ng/ml, 24h) vs 
control, treatment with SU11274 and HGF reduced β-catenin transcriptional activation to 
values below of those of untreated cells. This finding suggests a basal activation of 
HGF/Met signaling (probably by an autocrine production of HGF) in Hek293T cells. 
Furthermore, treatment with FH535 (10 μM 24h) together with HGF reduced luciferase 
activity significantly, indicating the involvement of TCF in the HGF/Met signaling 
cascade. Wnt-3a was used as positive control and produced a clear activation of luciferase 
activity that was inhibited by FH535 (Figure 7B). These results confirmed FH535 as an 
effective TCF/β-catenin inhibitor and illustrate that HGF/Met signals through TCF/β-
catenin in Hek293T cells (among other cell systems) (Monga et al., 2002).  
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Figure 7. β-catenin transcriptional activity in transfected HEK293T cells upon 
HGF/Met signaling regulation. (A) Schematic representation of TOP-FLASH reporter 
plasmid carrying synthetic promoter containing three copies of the TCF-4 binding site 
upstream to luciferase reporter gene. (B) Graphical representation of the relative 
luciferase activity quantified in Hek293T cells upon transfection with TOP reporter 
plasmid for 48h and treated for the last 24h with HGF (50 ng/ml), SU11274 (2 µM), Wnt-
3a (100 ng/ml) and FH535 (10 µM). * p ≤ 0.05, ** p ≤ 0.01.  * shows the statistical 
significance in comparosin to untreated controls.  
 
In order to get deeper into the signaling pathway activated by HGF in hippocampal 
neurons in axon outgrowth, neurons were also treated with SU11274 and FH535. Both 
inhibitors inhibited the axon outgrowth induced by HGF signaling (Figure 8A and B). 
Wnt-3a was used as the positive control, which produced an increase in axon outgrowth vs 
untreated neurons that was inhibited by the TCF inhibitor FH535, as expected. 
Interestingly, FH535 treatment also blocked the axon outgrowth promoted by HGF, 
rendering the axon length values below the control neurons. This result confirms that HGF 
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signaling is dependent on TCF-driven transcription in hippocampal neurons (David et al., 
2008). 
 
Figure 8. Met and TCF inhibition reduce axon outgrowth induced by HGF in 
hippocampal neurons. Images acquired at 10x (A) and 20x (B) of 2DIV hippocampal 
neurons demonstrating increased axon outgrowth upon HGF (50 ng/ml 1DIV to 2DIV) 
stimulation, which is lost upon treating them with HGF and TCF inhibitor (FH535 10 µM) 
or Met inhibitor (SU11274 2 µM). Wnt-3a (100 ng/ml), used as the positive control, 
promoted axon outgrowth, which was reduced by treatment with FH535 10 µM. Neurons 
were immunostained using anti βIII-tubulin antibodies and axon length was measured. 
Images are inverted for the better visualization of the neuron morphology. Bars = 30 µm. 
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1.4  CXCL2 and CCL5 expression is regulated by HGF signaling 
through TCF/β-catenin signaling 
We next asked whether chemokine expression is controlled by TCF/ β-catenin 
downstream of HGF/Met signaling. For this we chose two chemokines, CXCL2 (as it was 
involved in both axon outgrowth as well as axon branching) and CCL5 (as a member of 
CC family of chemokines). The expression of both chemokines was analyzed by real time 
qPCR in control neurons or in neurons treated with HGF alone or together with SU11274 
2 μM or with FH535 10 μM (overnight from 1DIV to 2DIV). Expression of CXCL2 was 
increased by 1.6 fold in HGF-treated vs untreated neurons, and was reduced to below 
control values in neurons treated HGF plus SU11274. HGF together with FH535 also 
decreased CXCL2 expression in comparison to that in neurons treated only with HGF, 
suggesting that it is mediated through TCF/β-catenin pathway (Figure 9A). Pervanadate (a 
tyrosine phosphatase inhibitor) was used previously to stabilize the PTyr142 form of β-
catenin (David et al., 2008) and we reasoned that perhaps could promote a larger increase 
in the upregulation of CXCL2. However, the increase of CXCL2 expression in neurons 
treated with HGF and pervanadate was similar to that obtained in neurons treated with 
HGF alone (Figure 9B). In addition, CXCL2 expression was also analysed in hippocampal 
neurons transduced with lentiviruses carrying shRNA against β-catenin. The silencing of 
β-catenin achieved on transducing neurons with lentiviruses from day of plating up to 
4DIV was around 40-50% as reported earlier and detected by Western-blot (David et al., 
2008) (Figure 9E). Of note, some authors have shown that silencing of β-catenin seems to 
impact significantly the nuclear pool of β-catenin, whereas cytoplasmic levels remain 
largely unaltered (Eichhoff et al., 2011). Treating neurons with HGF (50 ng/ml overnight 
from 3DIV to 4DIV), increased CXCL2 mRNA levels in neurons expressing scrambled 
shRNA. However, the increase in CXCL2 mRNA levels was lost when neurons 
transduced with shRNA against β-catenin were treated with HGF (Figure 9D).  
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Figure 9. CXCL2 and CCL5 expression is regulated by HGF signaling via TCF/β-
catenin pathway. (A) Graphical representation of relative CXCL2 levels (2DIV) in 
hippocampal neurons showing increase in CXCL2 expression achieved upon treatment 
with HGF (50 ng/ml) overnight, which was decreased below the control when HGF was 
accompanied with FH535 (10µM) or SU11274 (2µM). (B) CXCL2 relative levels in 
control neuron vs HGF (50 ng/ml overninght) plus pervanadate (Perv) (last 2h) treated 
neurons. (C) CCL5 relative levels (4DIV) increased upon stimulation with HGF and were 
significantly reduced upon co-treatment with HGF and FH535. (D) CXCL2 relative levels 
at 4DIV in hippocampal neurons transduced with lentiviral vectors driving the expression 
of scrambled or β-catenin shRNAs. Upon treatment with HGF, scrambled (scr) shRNA 
transduced hippocampal neurons show an increase in CXCL2 levels, which is lost in the 
case of shRNA β-catenin transduced neurons. (E) Western-blot showing the β-catenin 
silencing achieved on transducing hippocampal neurons with shRNA against β-catenin 
from 0DIV-4DIV. β-actin (β-act) was used as the loading control and silencing efficiency 
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was quantified with the help of Scion image software. * and # shows the statistical 
significance in comparison to untreated controls and stimulated controls respectively. *  p 
≤ 0.05,** p ≤ 0.01, #  p ≤ 0.05, ## p ≤ 0.01.   
Furthermore, CCL5 expression was also analysed by real time qPCR in neurons treated 
with HGF with or without FH535. HGF treatement increased by nearly 2 fold the 
expression of CCL5, which was reduced by ~ half in the presence of FH535 (Figure 9C). 
In summary, these results confirmed the initial findings of the array and indicate that 
CCL5 and CXCL2 are, at least in part, regulated by TCF/β-catenin downstream of HGF 
signaling.  
1.5 CXCL2 promotes neurite outgrowth in DRG explants. 
Upon revealing the role of chemokines in axon morphogenesis in hippocampal neurons, 
we investigated a putative effect of the chemokines in the regulation of neurite outgrowth 
in the PNS. We focused these experiments on CXCL2. To address this possibility we 
prepared DRG explants from newborn rat pups (P1-P2), which were grown on collagen in 
the presence of  NT-3 and NGF (50ng/ml) required for sensory neuron survival (Figure 
10A and 10B). Neurite extension from DRG sensory neurons was evaluated in control 
untreated conditions, CXCL2 (1000 ng/ml), and CXCL2 (1000 ng/ml) + SB225002 
(1.25nM). Phase contrast images (4x) were taken after 48h and 96h of treatments (Figure 
10). 
Even though the neurites did show some outgrowth from the untreated explant, outgrowth 
of the neurites was prominent in CXCL2-treated DRG explants in comparison to untreated 
control explanted. This was consistent in both NT-3 as well as NGF conditions. 
Furthermore, cells coming out of the explants were observed already in control explants, 
which increased in CXCL2-treated DRG explants and were significantly reduced in 
number when SB225002 was added together with CXCL2 (again observed in both NT-3 
and NGF-treated explants; Figure 10). These observations were accounted for both the 
time points: 48h as well as 96h of treatment.  
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Figure 10. CXCL2 promotes neurite outgrowth of DRG sensory neurons, which is 
inhibited by a CXCR2 antagonist. Figure shows the phase contrast images taken at 4x at 
48h and 96h following the treatments in the presence of NT-3 (A) or NGF (B) to support 
neuron survival. An enhancement in the outgrowth of neurites coming out of the DRG 
explants was seen in both NT3- and NGF-treated explants, upon addition of CXCL2 (1000 
ng/ml) vs control that  was reduced following the addition of CXCL2 (1000 ng/ml) plus 
SB225002 (1.25nM). Bars = 8 µm. 
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To support the observations made by Phase contrast microscopy, we immunostained the 
DRG explants with an antibody specific for βIII-tubulin and costained them with Hoescht 
to visualize the individual cells coming out of the explants (Figure 11). 
 
Figure 11. βIII-tubulin immunostaining reveals that CXCL2 increases neurite 
outgrowth, which is reduced by SB225002, in DRG explants. Figure is demonstrating the 
immunofluorescence images taken at 4x after 96h of treatment, in both NT-3 and NGF-
treated explants. Although control explants show neurite outgrowth, upon CXCL2 (1000 
ng/ml) a denser mesh of neurites is observed coming out from the explants, which is 
significantly inhibited by the addition of SB225002 (1.25 nM), in both NT-3 (top) as well 
as NGF- treated (bottom) explants. Neurites are shown immunostained with βIII- tubulin 
(in green) and nuclear staining by Hoechst in blue. Bars = 8 µm. 
Images captured at 4x using a fluorescence microcope exhibited βIII-tubulin 
immunostaining to all the neurites coming out of the explants that helped visualizing the 
neurite outgrowth effect promoted by CXCL2 (Figures 11). This was further strengthened 
by the results obtained upon co-treatment with CXCL2 and SB225002, showing inhibition 
of the outgrowth observed upon treatment with CXCL2 alone. Together, these findings 
suggest that CXCL2 promotes neurite outgrowth of regenerating sensory axons, which is 
inhibited upon the addition of its receptor antagonist.  
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We aimed at getting further understanding about the cells coming out from the explants, 
which we thought could be SGCs. To visualize SGCs we immunostained the explants with 
anti-GFAP antibody (as described by Garrison et al., 1991; Souza et al., 2013) . 
Chemokines have been demonstrated to actívate SGCs by enhancing GFAP expression 
during the sensitivity towards neuropathic pain (Souza et al., 2013). DRG explants 
immunostained for GFAP and counterstained by Hoechst after 96h of treatment confirmed 
that the cells coming out of the explants were GFAP, and likely SGCs (Figure 12).  
 
Figure 12. CXCL2 promotes SGCs to proliferate and/or migrate out of the explant, 
which may support neurite outgrowth of sensory neurons. The figure is showing 
immunofluorescence images captured at 10x (A) and 20x (B) for the DRG explants, 
immunostained by an antibody against GFAP (red) following 96h of treatments. The 
number of SGCs expressing GFAP, increases upon the treatment with CXCL2 (1000 
ng/ml) in comparison to untreated explants and this effect of CXCL2 is lost upon the co-
treatment with SB225002 (1.25nM). Note in the panels in B (control and CXCL2) that 
SGCs appeared aligned on top of the neurites.  GFAP antibody seems to induce some 
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background staining at the explant and on neurites. Hoechst staining is in blue. Bars = 11 
µm. 
Immunofluorescence images captured at 10x and 20x showed the presence of SGCs 
(confirmed by immunostaining with anti-GFAP antibodies) out from the explants (Figure 
12), consistent with the Phase contrast images (Figure 10). Although SGCs were present in 
both untreated as well as CXCL2-treated explants, sitting on top or around the neurites, 
their numbers clearly increased by treatment with CXCL2 and decreased by the 
cotreatment with CXCL2 and SB225002 (Figure 12) (as observed before). These findings 
suggest that CXCL2 promotes neurite outgrowth in DRG explants at least in part by 
inducing the proliferation or migration of SGCs. These observations raise the question as 
to whether the effect of CXCL2 in neurite outgrowth is by directly acting on the neurite 
and/or by regulating the number of SGCs, which give support to neurite and could release 
trophic factors promoting more outgrowth (see Discussion).  
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Chapter 2. 
Role of β-catenin and the phosphorylation of its Tyrosine 
residue 142 at centrosome 
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2.1 PhosphoTyrosine142 β-catenin (PTyr142 β-cat) localizes to 
the centrosome in different cell types and cofractionates with γ-
tubulin.  
We studied the subcellular localization of PTyr142 β-cat by immunocytochemistry using 
the antibody specific for it in Hek293T (epithelial kidney cell line), primary striatal 
astrocytes and glioma (U87MG and U251MG) cell lines (Figure 13).  
 
Figure 13. Centrosomal localization of PTyr142 β-cat in different cell types. Figure 
shows PTyr142 β-cat localization at centrosome in primary striatal astrocytes (A), 
U251MG (B), U87MG (C) and Hek293T cells (D), confirmed by colocalization with γ-tub 
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immunostaining (arrows). Insets are showing the enlargements of a single cell showing 
specific immunostainings (as mentioned). Images were captured using a fluorescence 
microscope (20x, 0.4NA). Abbreviations used: γ-tub (in green) stands for γ-tubulin; H (in 
blue) stands for Hoechst. Bars for A, B, C, D are 16 µm, 11 µm, 15µm and 21 µm 
respectively. 
PTyr142 β-cat was present at the centrosome in all the studied cell types. This was 
confirmed by its colocalization with γ-tubulin, a crucial component of the pericentriolar 
material responsible for the nucleation of MTs, in a dot pattern observed at the proximity 
of the nucleus (depicted by Hoechst staining). 
Next, different fixation protocols were tried to try to identify fixation conditions that 
would provide us with the best centrosomal immunostainings, because different fixation 
methods have been developed for it (Ciani, & Salinas, 2007) for which striatal astrocytes 
were fixed either with 100% methanol, PFA (4%) or by the “detergent fixation” protocol 
(Figure 14) (see Methods). The latter method has been described to provide best 
immunostainings for cytoskeletal proteins. PFA fixation showed brighter and nitid 
PTyr142 β-cat immunostaining at the centrosome (as addressed by colocalization with γ-
tubulin immunostaining). Methanol and detergent fixation produced weaker PTyr142 β-cat 
immunostainings at the centrosome, in agreement with weaker γ-tubulin immunostaining, 
suggesting the partial extraction of centrosomal components upon methanol or detergent 
fixation of the cells. Therefore, PFA fixation provided the best results (Figure 14) and was 
used in all the PTyr142 β-cat immunostainings except  where co-immunostainings with 
Syk was fixed by methanol as recommended (Zyss et al., 2005). 
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Figure 14. PTyr142 β-cat centrosomal immunostaining upon different fixation 
protocols. The panel shows PTyr142 β-cat immunostaining results obtained following the 
three fixation methods in striatal astrocytes. PFA fixed cells showed more intense and 
nitid PTyr142 β-cat and γ-tub immunostainings at centrosome. Instead, detergent fixed 
and especially methanol fixed cells showed weaker, more diffuse PTyr142 β-cat and γ-tub 
immunostainings and higher background. Insets are showing the enlargements of cells 
showing immunostaining at centrosomes. Images were captured using a fluorescence 
microscope (32x, 0.4NA) showing PTyr142 β-cat in red, γ-tub in green and H  in blue. 
Bars = 25 µm. 
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Since immunocytochemical results strongly suggested that PTyr142 β-cat accumulates at 
the centrosome, next we aimed to confirm these findings by biochemical means, using 
sucrose gradients to separate centrosomal fractions. Centrosomal fractions were isolated 
from exponentially growing unsynchronized U251MG cells and striatal astrocytes, using 
discontinuous sucrose gradient centrifugation method (Hsu, & White, 1998) and subjected 
to SDS-PAGE and Western blot (WB) analysis. For these procedues, cells were harvested 
after a brief treatment with nocodazole and cytochalasin D to disrupt MTs and actin 
cytoskeleton. Fractions were collected from the top, with top fraction being named as 8 
and the lowest fraction as 0 (Figure 15). In the same figure, the stage at which a sample of 
the lysates was collected (as control) is also shown. 
 
 
Figure 15. Scheme depicting the centrosome isolation protocol and the different stages 
of collection of lysates. 
 
Fraction number 2 and 3 were considered centrosomal fractions, corresponding to ~ 50-
60% sucrose fractions (Hsu, & White, 1998), as identified by a peak of γ-tubulin. Co-
fractionation of PTyr142 β-cat as well as total β-catenin was detected by WB in the γ-
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tubulin-positive centrosomal fractions in striatal rat astrocytes as well as U251MG glioma 
cells. Together with the immunostaining results, these results thus confirmed the finding 
of PTyr142 β-cat being localized at the centrosome (Figure 16). Other centrosomal 
components that co-fractioned with γ-tubulin and β-catenin were APC (in striatal 
astrocytes) (Louie et al., 2004) and Syk (Zyss et al., 2005) (Figure 16).  
 
Figure 16. Centrosome fractionation shows cofractionation of PTyr142 β-cat in the 
centrosome-enriched fractions. Cell lysates of rat striatal astrocytes (A) and U251MG 
cells (B) treated with cytochalysin D and nocodazole (see Methods) were processed for 
sucrose gradient subfractionation to isolate centrosomal-enriched fractions. Upon 
collection, gradient fractions (0-8) were subjected to SDS-PAGE and WB using specific 
antibodies (as indicated). WB for γ-tub identifies fractions 2-3 (50-60% sucrose) as 
centrosomal-enriched fractions. Nevertheless, γ-tub can also be found in other fractions as 
similarly described by other authors (Fumoto et al., 2009). PTyr142 β-cat and total β-
catenin (β-cat) cofractionate in these fractions in both cell types. Centrosomal fractions 
also show cofractionation of APC in astrocytes and Syk. On the left, samples of the total 
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lysates (1
st
 and 2
n 
lysates) are shown. Levels of PTyr142 β-cat and total β-cat in the 
lysates are higher in U251MG glioma cells that in rat astrocytes.   
 
To try to confirm the specificity of the PTyr142 β-cat immunostaining at the centrosome, 
we also performed an immunocytochemical study using a pan anti-PhosphoTyrosine 
(PTyr) antibody in Hek293T, U251MG and U87MG cell lines (Figure 17).  
 
Figure 17. Differential subcellular localization of PTyr142 β-cat and pan-PTyr 
immunostainings. The figure shows the immunolocalization of PTyr142 β-cat and PTyr in 
Hek293T, U251MG and U87MG cells. Whereas PTyr142 β-cat localization can be seen in 
the cytosol, nucleus and centrosome (arrows) of U251MG and U87MG and Hek293T cells 
(costained by Hoechst), PTyr was seen mainly at cell to substrate contacts (arrow head). 
Apparent colocalization between the two immunostainings is observed in the nucleus of 
glioma cell lines and some PTyr142 β-cat immunostaining at lamella on the plasma 
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membrane of U87MG cells (asterisks). Images were taken in a fluorescence microscope 
(32x, 0.4NA) staining PTyr in green, H in blue and PTyr142 β-cat in red. Bars for 
Hek293T and U251MG are 17 µm and; for U87MG is 23 µm.  
 
However, we found that PTyr142 β-cat and PTyr immunostainings differentially localized 
at different cell compartments. Whereas PTyr immunostaining was found more on the 
plasma membrane and cell-substrate contacts and less in the cytoplasm and nucleus, 
PTyr142 β-cat immunostaining decorated only some lamella in U87MG cells and 
immunostained the cytoplasm, nucleus and putative centrosome in all the three cell types. 
The unability to address the double immunocytochemistry, using anti-PTyr and γ-tubulin 
antibodies, due to the fact that both are mouse monoclonals, made it difficult to 
unequivocally identify whether PTyr immunostaining is found at the centrosome. 
Nevertheless, these findings highlight that PTyr142 β-cat, unlike other PTyr-proteins, 
mainly signals away from the adhesion and cell-substrate contacts. 
 
Considering the presence of PTyr142 β-cat at the centrosome, we next asked if it was 
regulated during mitosis. To this aim, we used U251MG cells because they are bigger in 
size and the centrosome is easier to visualize. Cells plated on coverslips were cell cycle-
arrested by serum deprivation for 20h followed by a period of 16-20h of release in 
complete media (period in which mitotic figures are easily observed). Using 
immunocytochemistry, variations in PTyr142 β-cat levels and its localization at the 
centrosome during different mitotic phases (M-phases) were detected by the antibody 
against PTyr142 β-cat. The different M-Phases were identified using Hoechst dye (to 
monitor the DNA condensation status) and α-tubulin (α-tub, to reveal the MT 
reorganization) (Figure 18). Although PTyr142 β-cat appeared intensely centrosomal in 
cells in interphase (shown by arrows in Figure 18), its levels at centrosome decreased 
abruptly in metaphase and continued to be absent from centrosomes till the end of 
telophase. PTyr142 β-cat levels in the neighbouring interphase cells were compared to 
those observed in the cells found in mitosis and used as internal standards (Figure 18).  
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Figure 18. Variation in centrosomal levels of PTyr142 β-cat during mitosis. Figure 
demonstrates the absence of PTyr142 β-cat from the centrosomes during all the stages of 
mitosis in U251MG cells. Images correspond to confocal sections taken at 60X showing 
PTyr142 β-cat  in red, α-tub (α-tubulin) in green, and H  in blue. Bars = 16 µm. 
 
These observations suggest that PTyr142 β-cat at the centrosome possibly imposes a break 
for mitosis progression. 
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2.2 β-catenin and its phosphorylation at Tyr142 residue are 
involved downstream to HGF signaling during cell migration and 
polarization. 
The establishment and maintenance of cell polarity is a characteristic feature of all 
eukaryotic cells. Upon establishing the presence of  PTyr142 β-cat at centrosome, we 
moved our study to the direction of cell polarity because the centrosome is the major 
organizer of MTs and of  crucial relevance importance in determining cell shape, polarity 
and motility (reviewed in Tang, & Marshall, 2012). Two approaches have been used to 
address it. On one hand, we performed wound-healing  assay  on  monolayers of rat 
primary astrocytes, which has been described and used as a simple model to study cell 
migration (Etienne-Manneville, & Hall, 2001) and Hek293T cells, kidney epithelial cells 
which are easy grow and manipulate. On the other hand, we also analyzed orientation of 
the centrosome (MTOC) during cell migration.  
Since published work demonstrates that Met RTK phosphorylates β-catenin at Tyr142 
(Brembeck  et al., 2004; David et al., 2008), we wanted to address the connection between 
HGF/Met signaling and β-catenin signaling in cell migration. Met expression has already 
been reported in astrocytes (Shimazaki et al., 2003). First, we studied cell migration in 
astrocytes upon formation of a scratch, which stimulates its migration in the direction 
perpendicular to the wound. We investigated the involvement of Met signaling in astrocyte 
migration by treating astrocytes with HGF (50 ng/ml, 24h) and/or a Met inhibitor 
(SU11274; 2 µM, 24h), after creating an artificial “scratch” or “wound”.  Phase-contrast 
images of the scratch at the time of creating it (0h) and after 24h were taken. Width of the 
scratch was measured. For each treatment condition, duplicates were taken and in each 
wound image, three readings were taken (to avoid the discrepancies because of the 
variation in the width of scratch). As expected, HGF treatment stimulated cell migration in 
comparison to control untreated cells, demonstrated by a reduction of ~28% of the width 
of the wound after 24h (Figure 19). In contrast, co-treatment of HGF and SU11274 
blocked cell migration, as demonstrated by a width of the scratch after 24h similar to that 
of control cells (18% wider, suggesting the retraction of the monolayer; Figure 19). These 
results clearly indicate that HGF signaling promotes cell migration in rat astrocytes, which 
is inhibited by the Met inhibitor SU11274.  
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Figure 19. Quantification of cell migration in rat primary striatal astrocytes upon Met 
stimulation or inhibition utilizing in vitro scratch assay. (A) Phase contrast images of the 
striatal astrocytes monolayer, were compared from 0h (Red line, when the scratch was 
given, top images) to 24h (Yellow line, scratch after 24h of cell migration, lower images) 
in different conditions (control, HGF 50 ng/ml, HGF 50 ng/ml + SU11274 2µM). Images 
were captured at 4x. (B) Graphical representation showing the width of the scratch  in μm 
after 24h of treatments in comparison to the scratch at 0h. Width of the scratch was 
measured with the help of image J software. Results are normalized versus control and 
shown as fold change. Minimum three expreriments were taken and the width of the space 
created by scratch in each image was measured  in triplicates. ** p ≤ 0.01 and *** p ≤ 
0.001, where * shows the statistical significance versus untreated control. Bars = 15 µm 
In order to study the role of β-catenin Tyr142 residue downstream to HGF signaling while 
promoting cell migration, Hek293T cells were used for transfection experiments. For this, 
Wild Type (WT) or mutant Tyr142Phe β-cat (β-catenin non-phosphorytable at Tyr142) 
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(kind gifts from Dr. Mireia Duñach) were expressed together with GFP. Considering the 
time 0 (T0) as the time when scratch was given to the cell monolayer followed by 
treatments, images were taken in the fluorescent microscope using 4x objective (Figure 
20). At this time 40-50% of cells showed GFP expression, which increases upto more than 
90% by 24h (T24). Scratch images from T0 and T24 were measured and compared for the 
wound left after 24h of scratch in different conditions.  
 
Figure 20. Cell migration induced by HGF signaling is inhibited in Hek293T cells 
expressing Tyr142Phe β-cat. (A)  Images of GFP fluorescence captured at 4x, from 
monolayers of cells expressing GFP+WT β-cat (untreated – or treated with HGF 50 
ng/ml) or expressing GFP+Tyr142Phe β-cat (untreated – or treated with HGF 50 ng/ml). 
Following transfection of WT or mutant β-cat, cells were left untreatred or treated with 
HGF and the width of the scratch was quantified at 0h (red line, when the scratch was 
created) and 24h (yellow line, scratch after 24h)  (B) Plot is showing the graphical 
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representation of the wound width values (in μm) at 24h in the different conditions. Values 
are normalized versus WT β-cat (fold change). Plot includes results of  three experiments 
in each condition, performed in duplicates. ** p ≤ 0.01, where * shows the statistical 
significance versus untreated control. Differences between Tyr142Phe β-cat-expressing 
cells treated with HGF vs untreated cells were not significant (n.s.). Bars = 13 µm. 
In cells overexpressing WT β-cat, HGF stimulation promoted cell migration and 
significantly reduced the width of the wound left after 24h by 20% in comparison to 
untreated WT β-cat-expressing cells (Figure 20). However, there was no reduction in the 
width of the wound when Tyr142Phe β-cat-expressing cells were treated with HGF, as 
compared to Tyr142Phe β-cat control cells (Figure 21). These results indicate that 
PTyr142 β-cat is required for the promotion of cell migration induced by HGF/Met 
signaling in Hek293T cells. 
Next, we aimed at investigating the role of β-catenin in centrosome reorientation during 
cell migration. To this end, we used primary rat striatal astrocytes. It has already been 
shown that in migrating astrocytes centrosome localizes in front of the nucleus in the 
direction of migration (Etienne-Manneville, & Hall, 2001; Etienne-Manneville, 2006) 
(Figure 21A). In addition, the correct position of the centrosome during migration controls 
the direction of migration in astrocytes, a process in which N-cadherin is involved 
(Camand et al., 2012) Thus, silencing of N-cadherin in glioma cells resulted in a higher 
percentage of cells presenting incorrectly positioned centrosomes and erratic movement 
(with cells constantly changing the direction of migration) (Camand et al., 2012). To 
elucidate the role of β-catenin in this process, lentiviral infection allowing the expression 
of shRNA directed towards β-catenin was used (as previously described in David et al., 
2008). Non-Infected (NI) astrocytes and those expressing Scrambled (Scr) or shRNA 
against β-catenin (shRNA β-cat) were compared (Figure 21B). γ-tubulin immunostaining 
was used to reveal the position of centrosome in response to scratch and Hoechst to stain 
the nucleus. The efficiency of silencing of β-catenin achieved by transducing rat primary 
astrocytes with shRNA β-cat was around 30% (as similarly reported in neurons; David et 
al., 2008; David et al. 2010). To evaluate the centrosome reorientation upon wound, cells 
of first and second rows were only selected as the ones beyond this will not be affected by 
the wound (as described in Etienne-Manneville, 2006). Duplicates for each condition were 
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taken and counted for centrosome reorientation (as described in Etienne-Manneville, 
2006).   
 
Figure 21. Centrosome reorientation in striatal astrocytes is altered by β-catenin 
silencing. (A) The scheme illustrates that the centrosome (in green) is considered as 
correctly positioned if it lies within the quadrant (black line) of the nucleus (in blue) 
facing the scratch (black, dotted line). (B) Immunofluorescence images showing the 
centrosome (immunostained by γ-tub antibody) position versus the scratch (white dotted 
lines) in NI or Scr and sh β-cat-expressing striatal astrocytes. Images were taken at 40x 
using a fluorescence microscope. Note that the cells shown in shRNAβ-cat 
displaycentrosomes incorrectly positioned vs the scratch according to A.  (C) Graphical 
representation showing the % of cells displaying correctly positioned centrosomes in the 
different experimental conditions. Minimum three experiments were included and 25-30 
images were counted per condition. * p ≤ 0.05, where * shows the statistical significance 
versus untreated control. Bars = 22 µm. 
 
Whereas NI showed 49,22 % of cells showing correctly positioned centrosomes towards 
the direction of the scratch, Scr showed values similar to NI with 47,22 % of cells showing 
correctly positioned centrosomes. In contrast, in cells expressing shRNA against β-cat, the 
percentage of cells displaying correctly positioned centrosome was significantly reduced 
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(by ~15%) in comparison to the values in NI and Scr expressing cells (Figure 21C). This 
finding demonstrates that β-catenin is involved in regulating the position of the 
centrosome during cell migration, although it is not the only parameter. 
  
2.3 Met and Syk as possible tyrosine kinases involved in the 
phosphorylation of Tyr142 β-cat at the centrosome. 
Having demonstrated that PTyr142 β-cat is found at centrosomes in interphase cells and 
the involvement of β-catenin in cell polarization , we aimed at identifying the Tyr kinase 
responsible for maintaining the phosphorylation of Tyr142 at centrosomes, which may be 
putatively involved in the control of centrosome cycle and/or cell migration. Our previous 
work demonstrated that Met directly phosphorylates PTyr142 β-cat (David et al., 2008). 
Therefore, Met was a strong candidate kinase that could regulate centrosomal PTyr142 β-
cat. Moreover, although Met has not been previously localized to the centrosome, recent 
reports demonstrated that overexpression of Met leads to supernumerary centrosomes 
(Nam et al., 2010), implying a connection between Met and centrosomal regulation. We 
investigated whether phosphorylated Met could be found in centrosomes. We checked 
various anti-PhosphoMet antibodies: a rabbit polyclonal and a rabbit monoclonal, D26, 
antibodies recognizing phosphorylated tyrosines (PTyr)1234/1235 (in the catalytic region 
of Met) and a rabbit polyclonal antibody against PTyr1349 Met (in the multifunctional 
docking site). U87MG cells were fixed with methanol (15 min, -20°C), which maintains 
good centrosomal immunostainings, and doubly immunostained using the corresponding 
Met antibody and a mouse antibody against γ-tubulin (to confirm the immunolocalization 
to the centrosomes). Interestingly, immunostaining results clearly revealed the presence of 
PTyr1234/1235 Met (detected by the D26 antibody), active Met, at the centrosome 
(overlapping with γ-tubulin immunostaining) (Figure 22B). A weaker PTyr1234/35 Met 
immunostaining at centrosome was also observed when using the rabbit polyclonal against 
PTyr1234/1235 Met (Figure 22A). However, immunostaining obtained using anti-
PTyr1349 Met did not label the centrosomes (Figure 22C). Cells incubated with secondary 
antibodies only were used as a negative control (Figure 22D). These results indicate the 
presence of active Met at centrosomes.  
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Figure 22. PTyr1234/1235 Met localizes at the centrosome in U87MG cells. 
Immunofluorescence images (20x) comparing the immunostainings obtained using 
different anti-PMet antibodies: rabbit polyclonal against PTyr1234/1235 Met (B), rabbit 
monoclonal against PTyr1234/1235 Met, D26 (B), and rabbit polyclonal against 
PTyr1349 Met (C). Results with D26 antibody showed a bright PTyr1234/1235 Met 
immunostaining at the centrosome, colocalizing with γ-tub. In contrast, a polyclonal 
antibody against PTyr1234/1235 Met showed only weak centrosomal immunostaining. 
Immunostaining using anti-PTyr1349 Met antibodies does not localize to the centrosome. 
Images obtained from cells incubated with secondary antibodies only (no primary 
antibody; Sec Ab) (D) are shown as negative control. Insets show the enlarged views of 
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cells displaying the immunostainings at centrosome. Positive centrosome stainings are 
marked with arrows (→) and its absence is marked as (X). H stands for Hoechst. 
Phospho-Met immunostainings are visualized in red, γ-tub in green and H in blue. Bars = 
15 µm. 
Having observed the presence of PTyr1234/1235 Met at centrosome, we wanted to 
investigate the effect of a Met inhibitor, SU11274 (that inhibits ATP binding to Met) on 
the centrosomal levels of PTyr1234/1235 Met and of PTyr142 β-cat. U87MG cells were 
treated with SU11274 (2µM, overnight) and then routine immunostaining was performed. 
However, we could not detect any change in the levels of PTyr1234/1235 Met at 
centrosomes in SU11274 treated cells compared to control cells (Figure 23).  
 
Figure 23. Met inhibitor, SU11274, does not alter centrosomal PTyr1234/1235 Met 
levels in U87MG cells. Immunofluorescence images (20x) demonstrate that there is no 
change on the centrosomal levels of PMet Tyr1234/1235 upon inhibition of Met by 
SU11274 (2µM , overnight) compared to control cells. Insets are showing the enlarged 
view of centrosomal immunostainings. PMet 1234/1235 is visualized is red, γ-tub in green 
and H in blue. Bars = 15 µm. 
Effective inhibition of Met by SU11274, immunodetected by a significant reduction of 
PTyr1234/1235 Met levels was confirmed in U87MG total cell lysates (results not shown). 
These results localize for the first time active Met (PTyr1234/1235 Met) at centrosomes. 
However, centrosomal active Met could not be inhibited by SU11274. These results 
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correlated with levels of centrosomal PTyr142 β-cat being unaffected upon treatment with 
SU11274 (Figure 24). 
 
Figure 24. PTyr142 β-cat levels are not altered upon Met inhibition. Consistent with the 
Met inhibitor (SU11274 2 µM) not altering PTyr1234/35 Met at centrosome (in the 
previous figure), PTyr142 β-cat centrosomal levels in U87MG were also unaffected upon 
treatment with SU11274 (2µM). Images were captured at 20x, showing PTyr142 β-cat 
immunostained in red and γ-tub in green. Bars = 15 µm. 
Another candidate Tyr kinase was Syk, which was found in centrosomal fractions also 
(Figure 17). Syk is known to localize at the centrosome affecting mitosis progression, 
which levels drop in mitosis (Zyss et al., 2005) as similarly observed for PTyr142 β-cat 
(Figure 19). To investigate the connection between PTyr142 β-cat and Syk at the 
centrosome, we transfected glioma cell lines (U251MG and U87MG) with WT and mutant 
(Tyr130Glu and Lys402Arg) Syk plasmids fused to Discosoma Red (Ds Red) fluorescent 
protein (a kind gift from P. Coopman, Montpellier, France). The two mutant forms were: 
a) a kinase-dead mutant in which the ATP-binding domain was inactivated (Lys402Arg) 
and absent from centrosomes, but present at membrane and b) a mutant possessing 
increased intrinsic kinase activity (Tyr130Glu) that basally localizes to the centrosome . 
The altered catalytic activities of these mutants was verified by evaluating their 
phosphorylation capacity, hence as expected Lys402Arg mutant lacked any detectable 
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kinase activity, whereas Tyr130Glu mutant showed an increased capacity to phosphorylate 
itself and other proteins (Zyss et al., 2005).   
Syk-transfected cells were fixed with methanol (15 min, -20°C; which allows a good 
visualization of the DsRed fluorescence reporting Syk expression), followed by 
immunostaining against PTyr142 β-cat. Expression of WT and mutant Syk in glioma cell 
lines showed a pattern consistent with the distribution of Syk in different subcellular 
compartments in a breast cancer cell line (Zyss et al., 2005). WT Syk was present at both 
plasma membrane extensions and centrosomes; Lys402Arg (kinase-dead mutant) was 
present exclusively at membrane but no longer present at centrosomes; and the 
constitutively active mutant (Tyr130Glu) was predominantly present at the centrosomes 
(Figure 25, 26). 
We reasoned that if Syk was responsible for phosphorylating PTyr142 β-cat, 
overexpression of basally active or inactive Syk mutants would increase or reduce, 
respectively, PTyr142 β-cat levels at the centrosome. Images taken under a fluorescence 
microscope revealed the colocalization of Tyr130Glu Syk and PTyr142 β-cat at 
centrosome in U87MG cell line, which was absent in the mutant Lys402Arg (Figure 25) 
(as described). However, there was no apparent change in the centrosomal of PTyr142 β-
cat when overactive Tyr130Glu Syk was expressed (Figure 25). 
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Figure 25. Overexpression of hyperactive or inactive Syk mutants does not seem to 
affect centrosomal PTyr142 β-cat in U87MG cells. DsRed fluorescence or 
immunofluorescence images acquired at 20x show the localization of DsRed-Syk 
constitutive active (Tyr130Glu, A) or kinase-dead (Lys402Arg, B) mutants. Whereas 
Tyr130Glu is found almost exclusively at the centrosome (where it colocalizes with 
PTyr142 β-cat), kinase-dead Lys402Arg Syk localizes to the plasma membrane and 
cytoplasm, and it is absent from the centrosome. PTyr142 β-cat localizes to centrosome 
(arrows) also in kinase-dead syk mutant-expressing cells. PTyr142 β-cat is visualized in 
green and H in blue. Bars = 15 µm. 
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Similarly, in U251MG cells, WT and Tyr130Glu Syk (Figure 26A and B) localized to the 
centrosomes together with PTyr142 β-cat. However, when inactive Syk was found at the 
centrosome, PTyr142 β-cat was still observed at centrosomes in both glioma cell lines 
(Figure 25B and 26C).  
 
Figure 26. Overexpression of WT, active or inactive Syk does not affect PTyr142 β-cat 
at the centrosome in U251MG cells. DsRed fluorescence or imunofluorescence images 
acquired at 20x  demonstrate the presence of WT Syk at plasma membrane as well as 
centrosome (A), preferential expression in the  centrosome of constitutive active mutant 
Tyr130Glu (B) and expression restricted to the plasma membrane of the kinase-dead 
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mutant Lys402Arg (C). However, expression of the different Syk mutants does not affect 
the localization of PTyr142 β-cat to the centrosome. Arrows point to centrosomal 
localization and (X) to the absence of Syk expression at the centrosome. PTyr142 β-cat is 
visualized in green and H in blue. Bars = 11 µm. 
These results indicate that modulating Syk activity by expression of mutant Syk forms at 
the centrosome does not affect in a significant manner the levels of PTyr142 β-cat, 
suggesting that Syk may not be the kinase responsible for this phosphorylation. However, 
endogenous Syk expressed by glioma cells could explain why we were not able to see 
changes in the levels of centrosomal PTyr142 β-cat upon overexpression of Syk forms.  
Thus, we took as an alternative approach the use of Piceatannol (Pic) to specifically inhibit 
Syk  (Larive et al., 2009; Seow, Chue, & Wong, 2002) and then investigate the possible 
changes in the centrosomal levels of PTyr142 β-cat. For these set of immunostainings, a 
short methanol fixation (5 min, -20°C) was performed, which provides good PTyr142 β-
cat and γ-tubulin results (similar to PFA fixation). In addition to treatments with Pic 
(200µM, 6h at 37°C), we also treated glioma cells with the Tyr phosphatase inhibitor 
sodium pervanadate (1mM, 15 min at 37°C prior fixation), to try to potentiate centrosomal 
PTyr142 β-cat levels. In pervanadate-treated U87MG cells, PTyr142 β-cat was dominantly 
defined at centrosome (colocalizing with γ-tubulin; Figure 27). Interestingly, upon cell 
treatment with Pic, centrosomal PTyr142 β-cat levels decreased and colocalization with γ-
tub diminished in most of the cells (Figure 27). 
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Figure 27. Syk inhibition decreases centrosomal PTyr142 β-cat in U87MG cells. The 
figure shows the immunofluorescence images acquired at 60x (confocal microscope), 
demonstrating the decrease of PTyr142 β-cat from the centrosome (immunostained by γ-
tub antibody in green) in Pic-treated (200 µM) cells in comparison to the cells treated 
with pervanadate (1mM). Arrows indicate either the colocalization or no colocalization 
(X) of PTyr142 β-cat with γ-tub at centrosome. Insets are showing detailed views of cells 
displaying centrosomal immunostainings. H is in blue. Bars = 15 µm 
Similar results were obtained in U251MG cells (Figure 28). Whereas control untreated and 
pervanadate-treated cells did show centrosomal immunostaining for PTyr142 β-cat, 
centrosomal PTyr142 β-cat was reduced or completely absent in the majority of Pic-
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treated cells, suggesting that Syk may be playing a role in regulating centrosomal levels of 
PTyr142 β-cat. 
 
Figure 28. Centrosomal levels of PTyr142 β-cat decrease upon treatment with Pic in 
U251MG cells. Figure shows immunofluorescence images acquired at 60X (confocal 
microscope), showing centrosomal PTyr142 β-cat immunostaining (in red) in control, 
pervanadate- (1mM) or Pic-treated (200 µM) cells.  Centrosomal PTyr142 β-cat 
immunostaining diminishes upon treatment with Pic compared to control untreated cells. 
γ-tub is immunostained in green and H in blue. Bars = 16 µm. 
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Apart from this, we also noticed some pervanadate-treated cells showing apparently bigger 
centrosomes compared to control cells (as reported by larger intense dotted PTyr142 β-cat 
and γ-tubulin immunostainings).  
To support our obervations, we quantified immunofluorescence intensities of centrosomal 
PTyr142 β-cat and γ-tubulin obtained under different treatment conditions in U87MG and 
U251MG cells (Figure 29). 
 
Figure 29. Immunofluorescence intensity quantification confirms the reduction of 
PTyr142 β-cat levels at centrosome following treatment with Pic in glioma cell lines. 
Immunofluorescence intensities of PTyr142 β-cat and γ-tub at centrosome were measured 
using the RGB plugin of ImageJ (available online) in U251MG (A, B and D) and U87MG 
(C) cells. Plots in A and C represent the intensity values obtained for centrosomal 
PTyr142 β-cat, which is significantly reducted in Pic-treated cells (200 µM,  6h) 
compared to control or Pervanadate-treated (Perv; 1mM, 15 mins) cells. Differences 
between control and Pervanadate were not significant (N.S.). *** p ≤ 0.001 indicates 
statistical significance versus control. Plot in C represents the values for the 
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“colocalization ratio” (PTyr142 β-cat/γ-tub) at centrosome) in each cell, which is also 
significantly reduced in Pic-treated cells versus control cells (*** p ≤ 0.001). Plot in D 
summarizes graphically the correlation between PTyr142 β-cat and γ-tub intensity values 
in untreated and Pic-treated U251MG cells. The linearizations obtained for control (grey 
squares) and Pic-treated (black triangles) cells illustrate the dispersion, with lower 
PTyr142 β-cat values in Pic-treated cells (p ≤ 0.001). A.U., arbitrary units.  
The immunofluorescence intensity quantifications revealed a siginificant reduction in 
PTyr142 β-cat levels at centrosome following treatment with Pic with respect to control in 
U251MG and U87MG cell lines. In contrast, γ-tubulin intensive values were not affected 
by treatment with Pic. The ratio depicting the immunofluorescence intensity of PTyr142 
β-cat to γ-tubulin in each cell was also reduced significantly in U251MG cells treated with 
Pic versus untreated cells (Figure 29).  
The immunostainings revealing the regulation of centrosomal PTyr142 β-cat by Pic, were 
further supported by confirming the centrosomal localization of endogenous Syk in glioma 
cells. Double immunocytochemistry was performed using anti-Syk antibodies together 
with PTyr142 β-cat antibodies in both U87MG and U251MG cells lines. In U87MG 
control cells, PTyr142 β-cat and Syk colocalize at the centrosomes (Figure 30). In 
contrast, in Pic-treated cells PTyr142 β-cat was absent from the centrosomes as described 
above, while total Syk levels at the centrosome remain as in control cells as expected. This 
finding is illustrated by the merge pictures depicting either “yellow” (colocalization of 
PTyr142 β-cat and Syk) or “green” (displaying only Syk immunostaining) centrosomes in 
control and Pic-treated cells, respectively (Figure 30)  
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Figure 30. Centrosomal localization of endogenous Syk in U87MG cells. 
Immunofluorescence images acquired at 20X demonstrate the colocalization of both 
PTyr142 β-cat (in red) and Syk (in green) in control cells and Pic-treated cells. In cells 
treated with Pic, PTyr142 β-cat levels diminish but centrosomal Syk levels remain similar 
to control. Positive centrosomal stainings are illustrated by arrows, whereas absence or 
reduction in the centrosomal levels are marked as (X). H is immunostained in blue. Bars = 
15 µm. 
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In U251MG cells, whereas centrosomal expression of both Syk and PTyr142 β-cat was 
observed upon treatment with pervanadate, Syk persisted at centrosomes upon treatment 
with Pic. However, again, centrosomal PTyr142 β-cat was decreased by Pic (Figure 31). 
 
Figure 31. Comparison of centrosomal levels of PTyr142 β-cat and Syk upon 
pervanadate (1mM) and Pic (200 µM) treatments to U251MG cells. Immunofluorescence 
images acquired at 20x demonstrate the colocalization of PTyr142 β-cat and Syk at 
centrosome in control conditions. Treatment with Pic diminishes PTyr142 β-cat 
centrosomal levels. Positive PTyr142 β-cat centrosomal staining is illustrated with the 
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help of arrows, whereas its absence is marked with (X). H is immunostained in blue. Bars 
= 11 µm. 
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β-catenin plays essential and well-established roles in cell–cell adhesion and Wnt 
canonical signaling (Nelson, & Nusse, 2004). Moreover, β-catenin’s implication in bipolar 
spindle formation and centrosomal functions came into light recently (Kaplan et al., 2004; 
Huang et al., 2007; Bahmanyar et al., 2008). Of note, phosphorylation of β-catenin by 
different kinases plays key roles in regulating the level, localization, and signaling 
function of β-catenin in different cellular processes. 
β-catenin plays an important role in the structural and functional organization of adherens 
junctions in cell–cell adhesion. It binds tightly to the cytoplasmic domain of type I 
cadherins and to the actin-binding protein α-catenin (Weis, & Nelson, 2006). The catenin–
cadherin complex is regulated by Ser/Thr phosphorylation of β-catenin (Bek, & Kemler, 
2002) and E-cadherin (Aberle et al., 1994). In axon outgrowth, synapse development and 
pathological states, Tyr phosphorylation of β-catenin disrupts the cadherin–catenin 
complex, causing reduction of cell–cell adhesion and increasing cytoplasmic β-catenin 
(Roura et al., 1999; Piedra et al., 2003; David et al., 2008, Brembeck et al., 2004; Murase, 
Mosser, & Schuman, 2002). In the case of β-catenin phosphorylated at Tyr142, this 
signaling form is induced by HGF in neurons (David et al., 2008). PTyr142 β-cat 
translocates to the nucleus and regulates expression of target genes in a TCF-dependent 
manner. Here we identified several chemokines as novel targets of HGF/Met/β-
catenin/TCF signaling. In addition, we showed the involvement of chemokine signaling in 
the definition of the morphology of axon arbours during the establishment of neuronal 
connectivity in brain development.   
β-catenin also plays a key role in the canonical Wnt signaling pathway (Nelson, & Nusse, 
2004), in which regulation of the level of cytoplasmic β-catenin is the central element. In 
addition to its roles in Wnt signaling and cell–cell contact, β-catenin is a component of the 
centrosome (Kaplan et al., 2004). During interphase, the centrosome coordinates an astral 
array of MTs that participates in intracellular trafficking, cell motility, adhesion and 
polarity (Azimzadeh, & Bornens, 2007). β-catenin localizes to centrosomes in interphase 
and in mitosis and controls centrosome separation and bipolar spindle formation (Kaplan 
et al., 2004; Bahmanyar et al., 2008). Depletion of β-catenin leads to an increase in 
monopolar spindles and impaired centrosome separation (Kaplan et al., 2004; Huang, 
Senga, & Hamaguchi, 2007). On the contrary, stabilized β-catenin (with alanine 
substitutions of GSK-3β/CK1 phosphorylation sites Ser33/Ser37/Thr41 and Ser45) also 
localizes to centrosomes (Bahmanyar et al., 2008, 2010). Stabilization of β-catenin results 
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in premature centrosome separation (Bahmanyar et al., 2008), an effect also proposed for 
β-catenin dephosphorylated at Ser/Thr (“Wnt-active”) (Hadjihannas, Brückner, & 
Behrens, 2010). Here we demonstrate that PTyr142 β-cat localizes to centrosome both in 
cancerous and non-cancerous cells. We also propose that Syk regulates centrosomal 
PTyr142 β-cat. Centrosomal aberrations are common in cancer, including centrosome 
amplification (extranumerary centrosomes), leading to monopolar or multipolar spindles 
and chromosome instability. As Wnt/β-catenin signaling is widely implicated in cancer, 
the localization of this novel β-catenin signaling form at the centrosome points at new 
functional implications of β-catenin (in addition to regulation of transcriptional targets, 
self-renewal, proliferation and migration) that may clearly contribute to its oncogenic 
roles.  
Chemokines in axon morphogenesis 
Chemokine signaling during neurogenesis and neuronal migration 
Our cDNA array data identified several chemokines as target genes of HGF signaling in 
developing hippocampal neurons (Bhardwaj et al., 2013). Chemokines,  were initially 
recognized as the proteins engaged in diverse functions in the immune system (Rossi, & 
Zlotnik, 2000) including regulating leukocyte migration and neuroinflammation 
(Hesselgesser, & Horuk, 1999; Ransohoff, & Tani, 1998). The insights into their functions 
were thought to be obtained through their evolutionary ancestry with the immune system. 
However, it is now clear that the rapid expansion of the chemokine family only 
accompanied the evolution of immune system, proven by their roles in nervous system 
(discovered later). In the recent years, numerous studies have demonstrated the expression 
of chemokines as well as their receptors in the CNS, where they have been shown crucial 
in physiological and pathological conditions such as neuronal development, synaptic 
transmission, brain homeostasis, injury and disease-associated neuroinflammation 
(reviewed in de Haas et al., 2007). Phenotypic inspection of CXCL12 and CXCR4 knock-
out mice indicated the original function of chemokines in regulating migration of stem 
cells (Miller, Banisadr, & Bhattacharyya, 2008). Both α chemokines (CXCL1, CXCL6 
and CXCL8 and their receptors CXCR1 and CXCR2) and β-chemokines (CCL2 and 
CCL7) have been studied for their the task in regulating proliferation, neurogenesis and 
differentiation of dopaminergic precursors in the midbrain  (Edman et al., 2008; Edman, 
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Mira, & Arenas, 2008). An age dependent role of CCL2, CCL3 and CXCL1 have been 
shown to influence both migration rate and fate of SVZ-derived neural precursor cells 
(Gordon et al., 2012). But the role of chemokines is not only restricted to developmental 
stages, as chemokines like CXCL12, CCL2, CCL3 and CXCL1 acts as chemoattractant 
and guide adult neuronal precursors during migration (Gordon, McGregor, & Connor, 
2009; Tran et al., 2004, 2007). CXCL12/CXCR4 signaling is involved in the guidance of 
motoneuron axons (Lieberam et al., 2005) and downstream of Sonic Hedgehog signaling 
in retinal ganglion cell axon path finding (Stacher Hörndli & Chien, 2012). In agreement 
with our array data, in situ hybridization data (freely available online) reveal the 
expression of chemokines in the mouse hippocampus during embryonic and adult life 
(Genepaint and Allen Brain Atlas webpages). Further strengthening the role of 
chemokines during development in hippocampus, CXCL12/CXCR4 was shown to 
promote the extension of perforant-fibres from the entorhinal cortex to DG (Ohshima et 
al., 2008), which was further complemented by demonstrating the CXCR4-knockout mice 
exhibiting the defect in the structure of DG for the poor migration of the granule cells 
(Bagri et al., 2002; Lu, Grove, & Miller, 2002). Interestingly, CXCL12 has also been 
involved in the modulation of branching for the leading process of interneurons, which 
inversely affects the speed of migration of interneurons during their travel from the 
ganglionic eminescence towards the cortical plate (Lysko, Putt, & Golden, 2011).  
CXCL12 either produces growth cone repulsion or attraction depending on the levels of 
cGMP (Xiang et al., 2002). Remarkably, CXCL12 signaling regulates the migration of a 
variety of neuron and neuronal progenitor populations: gonadotropin-releasing hormone-1 
neurons emerging from the nasal placode (Casoni et al., 2012), interneurons moving from 
the medial ganglionic eminence towards the cortical plate (Lopez- Bendito et al., 2008; 
Lysko, Putt, & Golden, 2011), cerebellar progenitors (Zou et al.,1998; Vilz et al., 2005) 
and sensory neuron progenitors towards the DRGs (Belmadani et al., 2005).  
 
Involvement of chemokine signaling in neurite outgrowth 
As opposed to the well established role of some chemokines in the regulation of neuronal 
progenitor or neuronal migration, not many research reports were available demonstrating 
their involvement in neurite outgrowth. Nevertheless, CXCL12/SDF-1 is one of the best 
studied in this new role also. CXCL12 signaling via its receptor CXCR4 has been involved 
in axon morphogenesis, where it reduces axon elongation while increasing branching, such 
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that it reduces growth cone number in hippocampal neurons (an effect restricted to the 
axon) (Pujol, Kitabgi, & Boudin, 2005). CC chemokines including CCL2 and CCL7 via 
their receptors CCR1 and CCR2,  have been identified as the factors promoting the 
differentiation and neuritogenesis of midbrain dopaminergic neurons (Edman, Mira, & 
Arenas, 2008). Another CC chemokine, CCL5 is secreted by astrocytes and regulates 
neurite morphogenesis in cortical neurons (Chou et al., 2008). Furthermore, decreased 
secretion of CCL5 by astrocytes expressing mutant Huntingtin protein contributes to the 
neuronal dysfunction in Huntington’s disease (Chou et al., 2008 ), 
To our knowledge, our work is the first one reporting the induction of axon morphogenesis 
by several CC chemokines and CXCL2 in hippocampal neurons (Bhardwaj et al., 2013). 
We identified several chemokines in a cDNA array comparing the expression pattern of 
control and HGF-treated developing rat hippocampal neurons (at 2DIV). Similar to the 
role of CXCL12 in promoting axon branching in dissociated hippocampal neurons (Pujol, 
Kitabgi, & Boudin, 2005), we found that CXCL2 enhances neurite morphogenesis by 
increasing axon length and remarkably axon branching, suggesting that the CXC family of 
chemokines induce branch formation. Further supporting the evidence in favour of 
chemokines regulating axon development, mice lacking chemokine receptor CX3CR1 
showed impairments in hippocampal cognitive function and synaptic plasticity (Rogers et 
al., 2011).  
The above summarized observations in the CNS have been paralleled by the important 
roles identified for the chemokines in the PNS too, where effort has been put to investigate  
chemokine signaling in different chronic pain syndromes resulting from damage to the 
nervous system or infections from agents such as HIV-1 (Wallace et al., 2007; White, 
Jung, & Miller, 2007). Generally, two distinct targets in PNS are chosen to study the 
actions of chemokines: nociceptive sensory (DRG) neurons and microglia within the 
dorsal horn of the spinal cord (SC) (reviewed in Miller et al., 2008). The best studied 
example amongst all the chemokines in this field is CCL2/CCR2 (reviewed in Miller et 
al., 2008), followed by CX3CL1 and CCL1, the attenuation of which has been proposed as 
an important target for the drug development against neuropathic pain (Zhu et al., 2014; 
Solinski et al., 2013 ; Akimoto et al., 2013; Zhu et al., 2013) and; CXCL1/CXCR2 
signaling (Zhang et al., 2013). These molecules do not exhibit high levels in the DRG or 
SC, but are strongly upregulated in in the state of chronic pain (White et al., 2005; Sun et 
al., 2006). Upregulation of CXCL12/CXCR4 as well as CCL2/CCR2 signaling has been 
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seen upregulated upon chronic morphine treatment and in a state of chronic pain (Wilson 
et al., 2008; White et al., 2005; Sun et al., 2006). To our knowledge, from the CXC family 
of chemokines only CXCL12 have been demonstrated in promoting neurite outgrowth 
from DRG neurons (PNS) on inhibitory CNS myelin (Opatz et al., 2009), followed by 
CXCL2 (this work). In this study, CXCL2/CXCR2 signaling has been suggested as 
promoting axon outgrowth in neurite outgrowth developed by DRG explants, which was 
reduced upon the addition of an inhibitor of the CXCR2 receptor (SB225002). Neurite 
outgrowth from DRG explants (plated on collagen) was promoted by CXCL2 treatment 
compared to control, both in the presence of NT-3 or NGF (allowing survival of 
propioceptive or nocioceptive sensory neurons, respectively). As DRG explants were 
prepared from neonatal DRGs whose sensory axons are broken in the process of 
extraction, this finding suggests that CXCL2 may promote of axon outgrowth of injured 
“regenerating” axons. In addition, some cells (presumably SGCs) were observed migrating 
out of the control DRG explants, but their number out of the explant increased in the 
presence of CXCL2. We were not able to distinguish whether exogenously added CXCL2 
promoted the neurite outgrowth or this chemokine was also responsible for the 
proliferation/migration of SGCs and subsequently these SGCs secreted molecules 
responsible for the outgrowth. SGCs are the most important cell type of glial cells in 
sensory ganglions that respond to sensory damage or inflammation by proliferating and 
expressing GFAP (Souza et al., 2013). CX3CL1 and CXCL12 have been  shown to 
enhance sensitivity towards pain by the activation of SGCs (Souza et al., 2013; Bhangoo 
et al., 2007). Chemokine receptors like CXCR4 are expressed by the DRG SGCs 
(Bhangoo et al., 2007). Nonetheless, the expression of CXCR2 in sensory neurons of DRG 
has also been demonstrated previously, while showing it to have important pro-
nociceptive effects on neurons (Wang et al., 2008). Co-immunostainings with GFAP and 
βIII tubulin in DRG explants showed that SGCs are immunostained for GFAP and already 
out of the explant in control conditions. However, upon CXCL2 treatment the number of 
SGCs out of the explant significantly increases (possibly by CXCL2 regulating the 
proliferation/migration of SGCs) and this correlates with increased neurite outgrowth (as 
confirmed by βIII tubulin immunostaining). Interestingly, GFAP-immunostained SGCs 
appeared aligned on top of the neurites, suggesting that SGCs support neurite outgrowth. 
Alternatively, SGCs could provide also some trophic suppot (by secreting cytokines or 
other molecules) that could regulate neurite outgrowth. Indeed, inhibition of CXCR2 (the 
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only receptor for CXCL2) by SB225002 significantly inhibited neurite outgrowth, and 
only few SGCs exhibiting GFAP immunostaining were seen.  
In sum, our work reveals that chemokine signaling plays a role in axon morphogenesis in 
developing hippocampal neurons and in the outgrowth of regenerating sensory axons. 
HGF and β-catenin signaling in chemokine expression 
This study has established a relationship between HGF and chemokine signaling in 
hippocampal neurons during axon morphogenesis (Bhardwaj et al., 2013). In agreement 
with our cDNA array study, HGF-treated neurons exhibited enhanced chemokine 
expression, especially CCL5, CCL7, CCL20 and CXCL2. Antibodies directed against 
CCL20 and CXCL2, and CXCR3 and CXCR2 antagonists SB328437 and SB225002 both 
displayed reduction in axon outgrowth and branching promoted by HGF, which indicates 
that chemokine signaling acts downstream to HGF signaling. Furthermore, SB225002 and 
SB328437 treatment resulted in reduction of axon length values below those of untreated 
neurons indicating that endogenous chemokine production by hippocampal neurons also 
affects axon development. Nonetheless, antibodies against CCL20 or the treatment with 
SB328437 decreased axon branching in the presence of HGF. However, CCL20 at the 
tested concentrations (10-1000 ng/ml) did not promote significant axon branching, 
suggesting that promotion or inhibition of axon branching exhibit different EC50/IC50  
(Half maximal effective concentration/Half maximal inhibitory concentration) values. 
Perhaps CCL20 concentrations lower than tested may induce axon branching. It is 
noteworthy that our array study on HGF-treated neurons identified other secreted proteins, 
in addition to chemokines, putatively involved in axon morphogenesis including CSF-1 
and BMP-6. 
β-catenin is a central component of Wnt signaling cascade which promotes transcription of 
Wnt targets upon binding to Lef/TCF (reviewed in Valenta, Hausmann, & Basler, 2012). 
Both HGF and β-catenin have been reported to be critically involved in axon 
morphogenesis and dendritic development in hippocampal neurons (reviewed in Akamura 
& Izuno, 2010; David et al., 2008). Apart from this, the interaction between Met and β-
catenin has been demonstrated (Purcell et al., 2011; David et al., 2008; Monga, 2002) that 
results in the phosphorylation of β-catenin at Tyr142, leading to PTyr142 β-cat 
translocation to the nucleus and regulating axon morphogenesis through TCF4-dependent 
transcriptional activation (David et al., 2008). In cancer cells, β-catenin and α-catenin 
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phosphorylation downstream of RTKs and/or Src is also emerging as a Wnt independent 
mechanism that promotes β-catenin transcriptional activation (Ji et al., 2009; Xi et al., 
2013). In this work, chemokines were indentified as transcriptional targets of HGF 
signaling in developing hippocampal neurons. CXCL2 and CCL5 expression analysis 
confirmed that these chemokines are upregulated by HGF signaling. Furthermore, TCF 
inhibition or silencing of β-catenin blocked the upregulation of CXCL2 by HGF, 
suggesting that chemokines are at least in part responsible for the axon morphogenesis 
promoted by HGF/Met/β-catenin signaling (Bhardwaj et al., 2013). In support of this, a 
previous paper reported upregulation of cytokines and chemokines including CXCL2 by 
Wnt-3a and β-catenin signaling in activated microglia (Halleskog et al., 2011). Moreover, 
Wnt/β-catenin and Met signaling synergistically activate CXCL12 expression in breast 
cancer cells, further highlighting the connection between β-catenin, Met and chemokine 
signaling in cancer (Holland et al., 2013). Real time PCR analysis also showed that TCF 
inhibition reduced the expression of CCL5 promoted by HGF (by ~30% compared to HGF 
treated neurons) indicating in part regulation of CCL5 through TCF/β-catenin downstream 
of HGF signaling. HGF signaling could be activating another pathway, e.g. NFκB 
pathway, which has been shown to regulate CCL5 expression in a Huntington’s disease 
model (Chou et al., 2008). 
Hence, our findings add the chemokines to the growing list of secreted molecules that 
modulate axon outgrowth in CNS and PNS. Chemoattractive cytokines are widely 
involved in brain injury and post-ischemic repair (Wang et al., 2012), orchestrating the 
recruitment of inflamatory cells. In addition, chemokines promote stem cell attraction, 
survival and differentiation. Chemokines might thus indirectly participate in 
remyelination, neovascularization and neuroprotection that are important for CNS repair 
after trauma (reviewed in Miller et al., 2008; Jaerve, & Müller, 2012). CXCL12 was 
demonstrated to regulate neurite outgrowth in the presence of growth inhibitory CNS 
myelin and to enhance axonal sprouting after spinal cord injury (Jaerve, Schira, & Müller, 
2012). Our work opens the possibility that other chemokines of CC and CXC families 
regulate axon outgrowth in a general manner, outside of the hippocampus and in adult life. 
As proposed for CXCL12, it will be exciting to investigate whether other chemokines 
could improve nerve regeneration in vivo. 
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Phosphorylated Tyrosine142 residue of β-catenin at 
centrosomes 
Involvement of β-catenin and its phosphorylation at Tyr142 in 
cell polarization and migration 
Evidence in favour of HGF/Met/β-catenin signaling in axon outgrowth, cell migration and 
invasion (David et al. 2008; Monga et al., 2002; Brembeck et al., 2004) took us to 
investigate this signaling axis in migrating astrocytes and glioma cells. We performed 
wound-healing assays in rat astrocytes treated with HGF or with HGF and the Met 
inhibitor, SU11274. From these experiments, we concluded that HGF works as a 
migratory factor, as the width of the wound in astrocytes treated with HGF was smaller 
that in controls after 24h of treatment. In contrast, in astrocyte monolayers treated with 
HGF and the Met inhibitor, the width of the wound remained similar or wider than in 
controls. Hence, we show that HGF/Met signaling operates in vitro in astrocyte migration 
induced by the artificial formation of a wound to the astrocyte monolayer. 
Further, to address the role of β-catenin downstream to HGF signaling in cell migration, 
we performed in vitro wound-healing assays on Hek293T cells expressing WT or 
Tyr142Phe β-cat. The addition of HGF to cells expressing WT β-cat increased cell 
migration versus untreated cells overexpressing WT β-cat. However, cell migration 
(measured as the reduction in the width of the wound) was similar in cells expressing 
Tyr142Phe β-cat untreated or treated with HGF, indicating the requirement for PTyr142 β-
cat downstream to HGF/Met signaling during cell migration in Hek293T cells. Similar to 
our work, phosphorylation of β-catenin at Ser675 (causing the dissociation of β-catenin 
from adherens complex) has been proposed to be involved in the promotion of astrocyte 
activation, migration and acquisition of an astrocytoma phenotype upon astrocyte injury 
(Yang et al., 2012). Since β-catenin signaling appears to operate downstream of HGF 
signaling in astrocytes, manipulation of this pathway could be helpful in brain injury to 
modulate migration and repopulation of the site of injury by astrocytes. 
We also investigated the role of β-catenin in centrosome positioning during cell migration 
in primary astrocytes. It is well known that during migration, astrocytes localize the 
centrosome in front of the nucleus, in the direction of migration (Etienne-Manneville, & 
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Hall, 2001; Etienne-Manneville, 2006). Here we showed the effect of silencing β-catenin 
in rat astrocytes, where shRNA against β-catenin reduced the percentage of cells bearing 
correctly positioned centrosomes in the direction of wound. In contrast, the percentage of 
cells with correctly positioned centrosomes was similar in non-infected as well as in 
scrambled shRNA conditions, which highlights the specificity of the shRNA β-catenin. In 
line with our results, other cell adhesion molecules like N-cadherin have also been 
recognized important for the correct positioning of centrosome in migrating astrocytes 
(Camand et al., 2012). Thus, silencing of N-cadherin increases the percentage of cells with 
incorrectly positioned centrosomes and promotes erratic movement, a condition that 
resembles the situation of GBM cells (expressing low levels of N-cadherin and typically 
showing non-directed migration; Camand et al., 2012). Although, β-catenin’s presence at 
centrosome has been previously demonstrated by immunocytochemical as well as 
biochemical approaches (Kaplan et al., 2004; Olmeda, Castel, & Cano, 2003; see below), 
its role in centrosome reorientation during migration was not described. Thus, this work 
shows β-catenin’s involvement in cell polarity by guiding the correct positioning of 
centrosomes to regulate directionality during cell migration, possibly through interaction 
with the MTs. β-catenin is overexpressed in GBM (Sareddy et al., 2009; Liu et al., 2010, 
2011; Ji et al., 2009),  where centrosomal PTyr142 β-cat has been observed (this work). 
Further work is needed to address whether centrosomal PTyr142 β-cat signaling could be 
related to centrosome reorientation in astrocyte and astrocytoma cell migration. 
Total, PSer/Thr and PTyr142 β-cat localize to centrosomes. 
β-catenin, a multifaceted protein with critical structural and signaling functions in 
adhesion and Wnt pathway, extends its arms into cell-cell contacts, nucleus, cytosol and, 
lately, centrosomes (reviewed in Mbom, Nelson, & Barth, 2013). β-catenin cytoplasmic 
and nuclear levels were demonstrated to increase in S phase, reaching maximum at late 
G2/M followed by the abrupt reduction as cells re-enter G1 after mitosis (Olmeda, Castel, 
& Cano, 2003) in transformed keratinocytes. Another report, however, showed unchanged 
total β-catenin levels in synchronized colorectal cell lines in G2/M phase (Hadjihannas et 
al., 2012). One of the first evidences in favour of  β-catenin’s role in regulating 
centrosomal functions, came up with the demonstration that overexpression of β-catenin 
leads to centrosome and MT array disorganization (Ligon et al., 2001), while β-catenin 
silencing inhibits MT nucleation from centrosomes (Huang, Senga, & Hamaguchi, 2007). 
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Later, β-catenin was recognized for its role in recruiting centrosomal proteins and 
contributing to centrosome maturation, bipolar spindle formation and centrosome 
separation (reviewed in Mbom, Nelson, & Barth, 2013). β-catenin localization to 
intherphase centrosomes is mediated by centrosomal linker proteins (Rootletin and C-
Nap), which become phophorylated by Nek2 at the onset of mitosis thus providing means 
for centrosome separation. In mitosis, β-catenin localizes at spindle poles independent of 
these linker proteins (Bahmanyar et al., 2008). We observed total β-catenin co-
fractionating with γ-tubulin in centrosomal fractions isolated both from striatal astrocytes 
as well as U251MG glioma cell line, which was accompanied by the Wnt pathway 
component APC in striatal astrocytes as reported (Louie et al., 2004; Lui et al., 2012, 
Olmeda, Castel, & Cano, 2003;  Hadjihannas et al., 2012). 
Not only total β-catenin, but also phosphorylated β-catenin forms has been localized at 
centrosome, with different roles to play. Immunofluorescence studies using the antibody 
recognizing β-catenin phosphorylated at Ser33/Ser37/Thr41 (PSer/Thr) localized this form 
to the centrosome (Chilov et al., 2011), with preferential localization at mother centrosome 
in interphase and to daughter centrosome during cell division (Fuentealba et al., 2008). 
Increased PSer/Thr β-catenin and conductin (also known as Axin2; a negative regulator 
and target of Wnt signaling) levels accumulate in G2/M phases in synchronized colorectal 
cells (Hadjihannas et al., 2012). Reduced levels of PSer/Thr β-catenin have been linked to 
mitotic spindle defects and, centrosomal and MT defects could be rescued upon expressing 
a phospho-mimetic mutant (Chilov et al., 2011). These results were obtained in neuronal 
progenitor cells, and mice expressing mutant β-catenin (mutated at Ser33/Ser34/Thr41) 
displayed defects in MTs and polarity (Chilov et al., 2011). Importantly, PSer/Thr β-
catenin is found at bipolar spindle in mitosis (Bahmanyar et al., 2008; Mbom et al., 2014). 
Interestingly, Nek2 appears as the the main kinase regulating PSer/Thr β-catenin at 
centrosome and GSK-3β inhibitors do not affect centrosomal PSer/Thr β-catenin (Mbom 
et al., 2014). These authors propose that Nek2 binding to β-catenin (observed both for 
active and kinase-dead Nek2) interferes with binding of the E3 ligase to β-catenin and 
therefore with its ubiquitination and degradation (Mbom et al., 2014). This explains the 
apparent contradiction that PSer/Thr β-catenin (usually targeted for degradation in the Wnt 
pathway) is stable at centrosomes. In addition, a role for PSer/Thr β-catenin with regards 
to centrosome separation has also been proposed, where during mitosis Plk-1 activates 
Nek2 and Nek2-mediated β-catenin binding to centrosomes is needed for centrosome 
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separation (Bahmanyar et al., 2008) through the modulation of β-catenin interaction with 
the centrosomal linker Rootletin. Centrosomal PSer/Thr β-catenin is retained during 
mitosis and centrosomal disjunction (Mbom et al., 2014). On the other hand, it was shown 
that expression of a stabilized form of β-catenin (with impaired N-terminal-regulated 
degradation) leads to increasing distance between centrosomes, suggesting that β-catenin 
acts as a negative regulator of centrosome cohesion (Bahmanyar et al., 2008). In 
agreement with this, it was proposed that Wnt signaling or inhibition of GSK-3β promotes 
centrosome splitting by altering the phosphorylation status of β-catenin to dephospho 
Ser/Thr β-catenin (Hadjihannas, Brückner, & Behrens, 2010). The mechanisms by which 
β-catenin promotes centrosome disjunction remain therefore nowadays unclear. β-catenin 
may regulate centrosomal disjunction through different mechanisms involving interactions 
with different partners. 
In addition to the described presence of centrosomal PSer/Thr β-catenin, our work 
demonstrates for the first time the centrosomal localization of β-catenin phosphorylated at 
a tyrosine residue. Here we show, using different types of cell fixation and a 
phosphospecific antibody, that β-catenin phosphorylated at Tyr142 (PTyr142 β-cat) 
localizes to centrosome in different cell types, including Hek293T kidney cells, striatal 
astrocytes and glioma cell lines. PTyr142 β-cat appears to be “stable” at centrosomes as it 
was immunodetected under basal conditions. Centrosome fractionation further confirmed 
our immunofluorescence results, showing the presence of PTyr142 β-cat (co-fractionating 
with γ-tubulin) in centrosomal fractions. PTyr142 β-cat levels were higher in the U251MG 
glioma cell line than in striatal astrocytes, in agreement with a role for this phosphorylated 
form of β-catenin in GBM invasion (Nager et al., unpublished results). We also found that 
the immunostainings obtained using anti-PTyr142 β-cat or pan-PTyr antibodies were 
different. PTyr142 β-cat immunostaining concentrated in the cytosol and nucleus (as 
similarly found in neurons; David et al., 2008), whereas pan-PTyr immunostaining 
localized preferentially to the plasma membrane in lamella in glioma cells.  
Our study of PTyr142 β-cat levels at the centrosomes in glioma cells synchronized by 
serum-deprivation and subsequent release in serum-containing media allowed us to 
investigate the changes in centrosomal PTyr142 β-cat during mitotis. We observed that 
PTyr142 β-cat levels significantly drop from centrosomes during mitosis, in contrast to 
what was described for total and PSer/Thr β-catenin (Kaplan et al., 2004; Huang, Senga, & 
Hamaguchi, 2007; Mbom et al., 2014). This suggests that centrosomal PTyr142 β-cat 
 Discussion 
 
186 
 
might be affecting cell division in a negative manner, such that decline in its levels (or  
dephosphorylation) is needed for cell division. Hence, our results show that PTyr142 β-cat 
is present in interphase centrosomes and is downregulated during cell division. 
Furthermore, PTyr142 β-cat was absent from mitotic spindles, suggesting that this β-
catenin form would be in principle not necessary for spindle functions. 
A balance between the activities of centrosomal kinases and phosphatases determines 
centrosome dynamics during cell cycle. Generally, phosphorylation of centrosome linker 
proteins (e.g., C-Nap1) leading to disruption of centrosome linking, will be a result of 
either activation of kinase or the inhibition of a phosphatase. One such phosphatase is 
Protein Phosphatase 1α (PP1α), known to suppress Nek2 activity as well as to 
dephosphorylate C-Nap1 thus suppressing centrosome splitting (Cohen, Holmes, & 
Tsukitani, 1990). In addition, PP1α is inhibited at the onset of mitosis, when Nek2 is 
activated (Puntoni, & Villa-Moruzzi, 1997). We could not clarify the mechanism by which 
PTyr142 β-cat was degraded or dephosphorylated during mitosis. Little is known about 
the implication of tyrosine kinases (in contrast to Ser/Thr mitotic kinases; Wang, Jiang, & 
Zhang, 2014) in the coupling of the centrosome and the cell cycles that ensures bipolar 
mitotic spindle fidelity. Intriguingly, a decline in centrosomal Syk tyrosine kinase during 
mitosis has been described, through its regulation by the ubiquitin-proteasome system 
(Zyss et al., 2005). On the other hand, Cell division cycle 25 (CDC25) phosphatases 
dephosphorylate Thr and Tyr residues and activate cyclin-dependent kinase (CDK) cyclin 
complexes. CDC25A, B and C are activated by mitotic kinases like Plk and Aur A 
(Boutros, Lobjois, & Ducommun, 2007) and control entry and progression into mitosis. 
CDC25B is thought to be responsible for the initial activation of CDK1–cyclin B at the 
centrosome that contributes to MT network reorganization and mitotic spindle assembly. 
CDC25C localizes to the centrosome in a cell cycle-dependent manner (late S phase, G2 
and mitosis) (Bonnet, Coopman, & Morris, 2008). CDC25B localizes asymmetrically to 
mother centrosome during interphase, becomes evenly distributed by G2 and is required 
for centriole duplication (Boutros, & Ducommun, 2008). CDC25s could be candidate 
phosphatases that dephosphorylate PTyr142 β-catenin in mitosis. Alternatively, decreased 
centrosomal Syk could result in lower centrosomal levels of PTyr142 β-cat in mitosis (see 
below).   
Apart from the mitotic downregulation of PTyr142 β-cat, the putative involvement of this 
β-catenin form in centrosome separation can not be ruled out, considering the roles of β-
 Discussion 
 
187 
 
catenin in this step of the centrosome cycle (Bahmanyar et al., 2008; Hadjihannas, 
Brückner, & Behrens, 2010). Indeed, centrosomes separation is a requirement for cells to 
enter into mitosis. 
 
Tyrosine kinases phosphorylating β-catenin localize to 
centrosomes 
Having localized PTyr142 β-cat at centrosomes, we aimed at identifying the putative 
kinase(s) regulating centrosomal PTyr142 β-cat. Until now different tyrosine kinases have 
been reported to modify different tyrosine residues in β-catenin, which dictate signaling 
activation in different cellular contexts. For example, Src phosphorylates β-catenin at 
Tyr86, (Roura et al., 1999) and Fer phosphorylates β-catenin at Tyr142 (Piedra et al., 
2003). Here we focused on Met as one such candidate, as Met is overexpressed in GBM 
cells (Koochekpour et al., 1997) and we and other authors have demonstrated that Met 
phosphorylates β-catenin at Tyr142 in vitro and downstream of HGF signaling (David et 
al., 2008; Brembeck et al., 2004; Monga et al., 2002). Although Met was not localized to 
centrosomes before, overexpression of constitutively-active Met lead to extra numerary 
centrosomes, aberrant MT spindles and chromosome instability (Nam et al., 2010). We 
demonstrated that PTyr1234/35 (active) Met is found in centrosomes in basal conditions in 
glioma cells. PTyr1234/35 Met levels at centrosomes were however unaffected upon 
treatment with a Met inhibitor (SU11274) in U87MG cells or by stimulation with HGF 
(results not shown), the Met ligand. This correlated with PTyr142 β-cat centrosomal levels 
remaining apparently unaffected upon addition of HGF (not shown) or Met inhibitor in 
comparison to untreated cells. The reason for this lack of regulation of active Met at 
centrosomes is not known, but it could be part of the deregulated Met signaling operating 
in GBM. Therefore, these results do not allow us to conclude whether PTyr1234/35 Met 
and PTyr142 β-cat at centrosomes are functionally related.  
Another candidate tyrosine kinase that could be related with centrosomal PTyr142 β-cat is 
Syk. The presence of active Syk at centrosomes has been established (Zyss et al., 2005), 
where the increased kinase activity (at Tyr130Glu residue of Syk) appears critical for both 
its centrosomal localization and its transportation from the plasma membrane via 
dynein/dynactin-dependent MT motors (Fargier et al., 2013). In addition, centrosomal Syk 
controls cell division and it is lost during mitosis (as similarly observed for PTyr142 β-
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cat). Overexpression of stable Syk forms leads to abnormal mitosis, aberrant cell division 
and multipolar spindles (Zyss et al., 2005). A recent report searching for potential Syk 
substrates identified centrosomal Nek9 as a Syk substrate in breast cancer cells (Xue et al., 
2012). To investigate whether Syk could regulate the centrosomal pool of PTyr142 β-cat, 
we expressed WT and Syk mutants in glioma cells: a kinase-dead mutant (Lys402Arg) 
which does not localize to centrosomes, and a mutant possessing increased intrinsic kinase 
activity (Tyr130Glu) that basally and almost exclusively localizes to the centrosome. 
Transfecting U251MG and U87MG cells with these mutants, however, did not 
significantly affect the centrosomal levels of PTyr142 β-cat. Thus, exogenously 
modulating Syk activity by expression of active or inactive Syk forms did not produce 
apparent changes in centrosomal PTyr142 β-cat. This made us examine the possible 
variations in PTyr142 β-cat levels upon inhibition of endogenous Syk by cell treatment of 
cells with the Syk inhibitor, Pic (Larive et al., 2009; Seow, Chue, & Wong, 2002). Pic 
suppresses proliferation of a variety of tumor cells (including leukemia, lymphoma, cancer 
of breast, prostate, colon and melanoma), promotes apoptosis and inhibits NFκB pathway 
(Piotrowska, Kucinska, & Murias, 2012). Interestingly, immunostainings demonstrated a 
decrease in centrosomal PTyr142 β-cat levels in cells treated with Pic, in comparison to 
control cells, in the two glioma cell lines. Quantification of the intensity of centrosomal 
PTyr142 β-cat levels confirmed these observations. Changes in the centrosomal levels of 
PTyr142 β-cat following treatment with pervanadate (a tyrosine phosphatase inhibitor and 
Syk activator; Nagai et al., 1995) were not significant (versus control). We also performed 
co-immunostaining for Syk and PTyr142 β-cat that illustrated their colocalization at 
centrosomes, as expected because Syk was also present in centrosomal fractions isolated 
from U251MG cells. These findings suggest that Pic inhibition of Syk results in reduced 
PTyr142 β-cat from the centrosome and point to Syk as a kinase regulating centrosomal 
PTyr142 β-cat. More experiments, like silencing of Syk, would be needed to further 
support this result. Syk was proposed as a tumor supressor (Coopman et al., 2000) and its 
high expression in astrocytes and Hek293T cells (results not shown) could thus account 
for the centrosomal PTyr142 β-cat pools in those cells. Interestingly, Syk has been 
reported to associate and phosphorylate other cell-cell adhesion components such as E-
cadherin and α-catenin (Larive et al., 2009).  
The localization of PTyr142 β-cat, active Syk and active Met at centrosomes reinforces the 
view of centrosomes as more than MT-organizing centers, but as important signaling 
 Discussion 
 
189 
 
platforms that regulate the coupling of the centrosome cycle and the cell cycle. Alteration 
of the phosphorylation status of centrosomal proteins likely contributes to centrosomal 
abnormalities and affects the complex coordination of both cycles. EGF signaling has been 
recently implicated in centrosome separation and accelerating mitosis with fewer errors, a 
finding with implications in EGFR-positive cancers (Mardin et al., 2013). Understanding 
centrosomal PTyr142 β-cat signaling in normal and cancer cells in the context of cell cycle 
and cell migration control could provide us with new hypothesis for cancer therapy.  
A general view of the results presented in this thesis work is summarized in Figure 32.  
 
Figure 32. Summary model for the role of β-catenin and PTyr142 β-cat in different cell 
compartments. β-catenin interacts with cadherins (C) (in a region including Tyr654 β-cat) 
and with α-catenin (α-cat) (in a region including Tyr142 β-cat) at cell-cell junctions. 
Results obtained in hippocampal neurons indicate that upon HGF binding to Met, Met 
activation leads to phosphorylation of β-catenin at Tyr142 that promotes its detachment 
from the adhesion complex and translocation to the nucleus, where it acts by activating 
transcription of TCF target genes. Here we showed that chemokines are targets of 
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HGF/Met/β-catenin/TCF signaling that promote axon outgrowth and branching in 
hippocampal and DRG neurons. Dashed arrow indicates other pathways downstream of 
HGF/Met regulating chemokine expression. A pool of PTyr142 β-cat localizes to 
centrosome (in addition to the nucleus) in glioma cells. At the centrosome, Syk tyrosine 
kinase helps in maintaining the phosphorylation status of PTyr142 β-cat. Since both Syk 
and PTyr142 β-cat are decreased at centrosomes during mitosis, we postulate that they 
would block mitotic progression. Active Met (PTyr1234/35 Met) also localizes to 
centrosome. We also demonstrated the role of β-catenin in the correct orientation of 
centrosome during cell migration, and the requirement of PTyr142 β-cat in cell migration 
downstream of HGF signaling. Whether PTyr142 β-cat signaling in cell migration 
implicates gene transcription, centrosomal function and/or regulation of the cytoskeleton 
is not known. 
We studied PTyr142 β-cat in the context of neuron develepment, where it was previously 
proposed to regulate transcription of genes important for axon morphogenesis downstream 
to HGF/Met signaling. In chapter 1, we identified several CC chemokines and CXCL2 as 
novel secreted molecules regulating axon outgrowth and branching. In chapter 2, we 
addressed the involvement of β-catenin and PTyr142 β-cat in cell migration. We 
demonstrated the participation of β-catenin in the positioning of the centrosome during 
cell migration. Last but not least, we localized PTyr142 β-cat at centrosome, where β-
catenin is likely phosphorylated by Syk at Tyr142. Centrosomal Syk and PTyr142 β-cat 
are downregulated in mitosis, suggesting that they impose a blockade on mitotic 
progression.    
 
 
 
 
 
 
 191 
 
 
 
 
 
 
 
 
CONCLUSIONS 
 
 
 
 
 
 192 
 
 
 
 
 
 
 
 
 
 Conclusions 
 
193 
 
1. Chemokines of CC and CXC families are upregulated downstream to HGF signaling in 
developing hippocampal neurons. 
2. Recombinant chemokines CCL5, CCL7, CCL20 and CXCL2 promote axon outgrowth 
in hippocampal neurons. 
3. CXCL2 promotes significant axon branching in hippocampal neurons. 
4. Endogenous chemokine signaling acts downstream to HGF during axon outgrowth, as 
blocking antibodies against CCL20 and CXCL2 and SB225002 and SB328437 
(chemokine receptor antagonists) reduce the HGF-induced axon morphogenesis. 
5. Met and TCF inhibition reduce the axon outgrowth promoted by HGF in hippocampal 
neurons. 
6. CXCL2 and CCL5 expression are regulated by HGF/Met/β-catenin/TCF pathway in 
hippocampal neurons.  
7. CXCL2 promotes neurite outgrowth from the sensory neurons of DRG, directly or 
through stimulation of SGC proliferation / migration.  
8. HGF signaling promotes the migration of rat primary astrocytes in wound-healing 
assays, which is inhibited by the Met inhibitor SU11274.  
9. Phosphorylation of β-catenin at Tyr142 is important in the promotion of cell migration 
downstream to HGF signaling in Hek293T cells. 
10. β-catenin plays a role in the orientation of centrosomes during directional migration in 
rat primary astrocytes. 
11. PTyr142 β-cat localizes to centrosome and co-migrates with centrosomal-enriched 
fractions in different cell types, including astrocytes and glioblastoma cells.  
12. PTyr142 β-cat centrosomal levels decrease during mitosis, suggesting that they 
regulate cell cycle progression in a negative manner.  
13. PTyr1234/35 Met is found at centrosomes in glioblastoma cell lines.   
14. The Syk inhibitor Piceatannol decreases PTyr142 β-cat from the centrosomes, 
suggesting that Syk regulates centrosomal PTyr142 β-cat.
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